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Scope of thesis 
 
Ageing is associated with increased prevalence of metabolic syndrome, as well as impaired 
glucose metabolism, hyperinsulinemia and insulin resistance. The mechanism underlying 
these associations is poorly understood and is likely to be complex and multifactorial. The 
liver is the key target for insulin action and while the endothelium has been shown to 
influence insulin activity in muscle and fat, the role of the liver sinusoidal endothelium on the 
action of insulin in the liver is unknown.  
 
The liver sinusoidal endothelium is unique: it is perforated with transcellular pores called 
fenestrations that facilitate unimpeded passage of substrates between blood and hepatocytes. 
A constellation of age-related morphological changes in the liver sinusoidal endothelium 
known as pseudocapillarisation have been described in various species including rats, 
baboons and humans. During ageing, the liver sinusoidal endothelium thickens, there is 
basement membrane deposition, and the fenestrations are significantly reduced in size and 
number (defenestration). Age-related pesudocapillarisation has been shown previously to 
impede the transfer of lipoproteins and medications across the hepatic sinusoidal 
endothelium. 
 
This thesis tests the hypothesis that changes in the ageing liver contribute to age-related 
insulin resistance, with alterations of the liver sinusoidal endothelial cell leading to age-
related impairment of insulin action and insulin resistance/glucose metabolism.  
 
This work aims to improve the understanding of the effects of ageing processes in the liver on 
insulin action and glucose metabolism. It investigates the role of age-related 
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pseudocapillarisation and the acutely induced poloxamer 407 (P407) model of defenestration 
in hepatic disposition of insulin and glucose metabolism. This thesis also investigates the 
effect of P407 on the relationship between membrane rafts and fenestrations in SKHep1 cells, 
a cell line of liver endothelial origin and isolated LSECs. Finally, the effects of dietary 
macronutrients and calorie intake on fenestrations in old age are examined.  
 
The work contained in this thesis aims to examine the role of age-related 
pseudocapillarisation in one of the major causes of age-related disease and disability, insulin 
resistance. In doing so it explores the potential mechanisms involved in these changes and 
how we may alter the progression of ageing through nutritional intervention.  
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
2 
 
1.1 THE LIVER 
 
1.1.1 Anatomy and function of the liver 
 
The liver is the largest internal organ in the body and is responsible for multiple, dynamic 
functions (Schiff et al., 2007, Cattley and Popp, 2002). As the principle organ for maintaining 
systemic homeostasis, the liver has a major role in the metabolism, synthesis, storage, 
detoxification and secretion of numerous substrates. The liver synthesises plasma proteins such 
as albumin and is involved in the metabolism of lipoproteins and bilirubin, together with bile 
formation and secretion (Higuchi and Gores, 2003). The liver plays a key role in nutrient storage, 
processing and the regulation of plasma glucose. The liver also has a major role in maintaining 
and establishing immune functions such as immune tolerance (Holz et al., 2008) and 
detoxification of endogenous chemicals, drugs and pathogens (Arias et al., 2011). 
 
The liver is located in the upper right quadrant of the abdominal cavity and contributes to 
between 2 and 5% of total body weight, with the average adult human liver weighing 
approximately two kilograms. The liver is functionally divided into four main lobes: left, right, 
median or quadrate, and caudate, surrounded by a fibrous capsule of connective tissue (Glisson’s 
capsule) and further subdivided into 8 segments by divisions of the right, middle and left 
hepatic veins, with each segment receiving blood from its own portal pedicle (Fig. 1.1). The 
histological lobular architecture of the liver is similar in all species (Malarkey et al., 2005). 
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Uniquely, the liver receives its blood supply from two sources and this bi-channel blood flow is 
important when considering liver function and structure. Seventy percent of its blood is from the 
portal vein, which carries deoxygenated blood directly from the splanchnic circulation and 
contains micro and macro nutrients for processing and storage, and pathogens, drugs, and toxins 
for metabolism and/or elimination. The remaining 30% of the blood flow comes via the hepatic 
artery carrying oxygenated blood to the liver. Blood then percolates through the liver sinusoids 
and collects in the central vein, emptying into hepatic veins before completely draining from the 
liver via the inferior vena cava (Malarkey et al., 2005, Cattley and Popp, 2002). The bile 
canaliculus network transfers bile produced in the hepatocytes via the canals of Hering (Saxena 
and Theise, 2004) to the larger bile ducts and then to the gall bladder or duodenum. 
 
The microscopic structure of the liver consists of repetitive functional units known as ‘classic 
lobules (Kiernan, 1833). Lobules are roughly hexagonal in shape and contain a central vein 
surrounded by repeating branches of the portal vein, bile ducts and hepatic artery (known as the 
portal triad, Fig 1.2). Within each lobule, the anatomical zones are classified as: the 
periportal/portal zone; midzonal/midlobular; and centrilobular/central zones, depending on the 
areas proximity to the central veins and portal triads. These zones are depicted in Fig 1.2. 
 
In addition to the classical lobular delineation the liver is divided into acini according to the level 
of oxygenation and nutrient exposure of the cells (Fig 1.2). Zone 1 (periportal) contains the cells 
receiving the most oxygenated and nutrient rich blood located closest to the portal triad while 
zones 2 and 3 respectively contain cells that are exposed to less oxygenated and less nutrient 
rich blood as they are remote from arteriolar blood and located in the microcirculatory 
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periphery of the acinus. Each acinus contains approximately one thousand sinusoids that run 
between the columns of hepatocytes and connect the afferent portal triads to the central vein. 
This provides an extensive surface area for blood and hepatocytes exchange (McCuskey and 
Reilly, 1993, McCuskey, 2000, Le Couteur et al., 2008). 
 
The ‘classic lobule’ is the most widely used model describing the liver anatomical unit, and the 
acinus most commonly used to describe the liver functional unit. Other alternative models of the 
functional and anatomical units of the liver that have been proposed including the ‘portal lobule’ 
defined by the central venules with a portal tract at the centre, and the ‘primary lobule’ 
combining function and anatomy (MacSween et al., 2002, Malarkey et al., 2005, Matsumoto et 
al., 1979, McCuskey, 2008, Teutsch et al., 1999).  
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Figure 1.1: Segmental anatomy of the liver showing eight hepatic segments (Schiff et al., 
2007) 
 
Figure 1.2: A diagrammatic representation of the classic lobule and liver acinus (Cattley and 
Popp, 2002) 
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1.2 ULTRASTRUCTURE OF THE LIVER 
 
The liver vasculature is uniquely structured with the main blood vessels separated by a 
parenchymal mass of cells and connected by the smaller capillaries (sinusoids) at the same time 
(Arias et al., 2011). The liver is composed of parenchymal cells known as hepatocytes, 
cholangiocytes and several varieties of resident non-parenchymal cells namely liver sinusoidal 
endothelial cells (LSEC), hepatic stellate cells, Kupffer cells, natural killer cells and dendritic 
cells, with each cell having a specific morphology and function. All cells are arranged in a matrix, 
allowing a coordination of synthesis, metabolism and clearance of a variety of molecules. Each 
cell type can undergo morphologic or quantitative changes under different disease pathological 
challenges (Wisse et al., 1996, Fraser et al., 1986). 
 
1.2.1 Hepatocytes 
 
Hepatocytes constitute about 80% of the total volume of the liver and 60% of the liver cells 
(Kmiec, 2001). They are polyhedral in shape and arranged into plates of single cells, (hepatocyte 
cords) supported by a fine reticular fibre (collagen III) framework, and are separated by 
continuous sinusoidal networks, allowing the hepatocytes to have a close contact with the blood 
(Cattley and Popp, 2002). The hepatocytic membrane has three regions: the sinusoidal domain, 
the intercellular junction and the bile canalicular surface. The sinusoidal domain/basolateral area 
of the hepatocyte faces the sinusoid and is characterised by abundant microvilli that increase the 
area by six-fold for hepatocyte substrate uptake and exchange and extend into the space of Disse 
(SoD) and even into the sinusoidal lumen through fenestrations (Wisse et al., 1985). The 
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hepatocyte intercellular regions contain junctional complexes for attachment to and 
communication with adjacent hepatocytes (Ross et al., 2003). This membrane extends to the 
sinusoidal lumen and undertakes the extraction of a wide variety of molecules from the blood and 
simultaneous secretion of molecules synthesised by the hepatocytes (Medlock and Haar, 1983). 
The canalicular surface of the hepatocytes has villous projections and exporter pumps including 
the bile salt transporter for biliary excretion (Kullak-Ublick et al., 2000). It is positioned between 
the lateral surfaces that face adjacent hepatocytes and contain tight junctions that seal the bile 
canaliculi, and the adhering junctions that link neighbouring hepatocytes and express gap 
junctions facilitating intercellular communication and exchange (Kuntz and Kuntz, 2009). 
 
The many functions of the hepatocytes include the regulation of carbohydrate, lipid, and amino 
acid metabolism and storage, blood glucose regulation, and bile, cholesterol, and plasma protein 
synthesis namely albumin, carrier proteins, coagulation factors, growth factors and hormones 
(Ghany and Hoofnagle, 2005). They are also the main site of xenobiotic metabolism and 
transamination reactions in the body (Steinberg et al., 1987) and have the capacity for antigen 
presentation and T-cell activation (Warren et al., 2006, Crispe, 2011). 
 
Hepatocytes also contain a high density of cytoplasmic organelles that take up 20-30% of the 
cell volume, and are abundant in mitochondria, smooth and rough endoplasmic reticulum 
(ER), free ribosomes, Golgi apparatus, lysosomes, and peroxisomes (Kuntz and Kuntz, 2009, 
Kmiec, 2001, Blouin et al., 1977). They possess significant regenerative capacity, being able to 
proliferate rapidly in order to replace lost or damaged cells after partial hepatectomy and 
during disease and toxicity (Fausto and Campbell, 2003). 
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1.2.2 Cholangiocytes 
 
The cholangiocytes are cells that line the bile ducts and form 1 % of the liver parenchyma. 
These cells are responsible for the modification of the canalicular bile composition, which 
occurs through a series of secretory and absorptive processes (Strazzabosco, 2004, Masyuk et 
al., 2008). Cholangiocytes also interact with other liver cells such as hepatocytes, LSEC, HSC 
and KC by releasing growth factors, peptides, nucleotides, pro-inflammatory and chemotactic 
cytokines and other signaling molecules (Strazzabosco, 2004). These cells are involved in 
regulation of bile formation, liver inflammatory processes, angiogenesis and fibrogenesis 
because of their interaction with the other liver cells (Masyuk et al., 2008). 
 
1.2.3 Hepatic stellate cells 
 
The hepatic stellate cells (HSC), also known as Ito cells, fat-storing cells, vitamin A-storing cells 
or lipocytes, are located in the SoD and comprise approximately 1.5% of the total liver cell 
population (Wake, 1980, Kmiec, 2001). HSC store 80% of the body’s retinoids as retinyl 
palmitate in cytoplasmic fat droplets. The main physiological function of the stellate cells is 
storage and regulation of retinoids, but also storage of triglycerides, cholesterol and free fatty 
acids. HSC also synthesise and degrade components of extracellular matrix and other proteins 
(Senoo, 2004). 
 
During liver injury, HSC respond to inflammatory cytokines such as IL-6 and TGF-β, become 
activated and acquire a myofibroblast-like phenotype that produces abundant quantities of 
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collagen types I, III and IV stage. They undergo morphological changes, start proliferating and 
become contractile, lose their lipid stores and start to secrete fibrogenic and inflammatory 
cytokines, which can lead to fibrosis (Friedman, 2008). In addition, HSCs are antigen presenting 
cells, eliciting T-cell responses as efficiently as dendritic cells. Their location in the SoD serve as 
an early detection point for any pathogens that have crossed the endothelium (Winau et al., 
2007). 
 
1.2.4 Kupffer cells 
 
Kupffer cells (KC) are endogenous liver macrophages. They account for 80-90% of the body’s 
resident macrophages (Arii and Imamura, 2000) and are located in the lumen of the hepatic 
sinusoids, usually in close proximity to the endothelial cells (Wisse, 1972). KC contribute to host 
defence and tissue homeostasis, and their major function is to clear particulate and foreign 
materials from the portal circulation. Substrates including microorganisms, endotoxin, old and 
foreign cells, complement components and immune complexes can be phagocytosed by the KC 
and broken down by both oxygen dependent and independent mechanisms. KCs also act 
synergistically with pit cells in the killing of tumour cells (Wisse et al., 1997) and are classified 
as potential antigen-presenting cells (Bouwens and Wisse, 1992). KC are located within close 
proximity to the luminal membrane of LSECs, projecting their cytoplasmic processes through 
fenestrations for further anchorage and contact with HSCs and hepatocytes (McCuskey, 2008). 
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1.2.5 Natural killer cells 
 
Hepatic natural killer cells or pit cells are located in the hepatic sinusoidal lumen in portal tracts 
in granuloma-like cellular aggregates. They are often in contact with KCs and are adherent to 
LSECs by pseudopodia (Wisse et al., 1976). They are considered to be more cytotoxic than other 
natural killer variants (Melmed et al., 2011). This has significant implications for the liver’s early 
defence against tumours and microbes/virus- infected cells (Nakatani et al., 2004). The liver-
associated NK cells exert anti-tumour functions through exocytosis of toxic granules, induction 
of apoptosis and production of cytokines that augment the activities of other immune cells. The 
discovery and recognition of the pit cell and their function in the liver helped to establish the 
liver’s early role in the defence against tumour and microbial targets, and the liver as an 
immunological organ (Nakatani et al., 2004). 
 
1.2.6 Dendritic cells and lymphocytes 
 
Dendritic cells are bone marrow-derived professional antigen presenting cells that travel along 
the liver sinusoids, capturing and processing antigens before translocating to the portal 
interstitium and lymphatic vessels (Ohtani et al., 2003). They eventually accumulate in lymph 
nodes to present the antigens to T- and B-cells for initiation of immune response or tolerance 
(Matsunol and Ezaki, 2000). Dendritic cells are structurally long, with thin membrane extensions 
with microvilli for interaction with T-cells (Fisher et al., 2008). Along with LSECs, HSCs, KCs, 
and hepatocytes, dendritic cells present antigens to lymphocytes from the innate and adaptive 
immune systems that are located throughout the liver sinusoids and portal tracts (Crispe, 2009). 
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1.2.7 Liver sinusoidal endothelial cells and fenestrations 
 
The LSECs line the liver sinusoidal capillary wall and are located between the hepatocytes and 
blood vessels. They are flattened and perforated by transcellular holes/pores termed 
fenestrations (Bouwens et al., 1991, Wisse et al., 1996). The sinusoidal endothelium lacks a 
basement membrane, which makes it distinct from all other endothelial cells. They perform a 
large number of specialised functions and are now considered to play a significant role in liver 
function. Through their scavenger receptors LSECs are responsible for the clearance by 
endocytosis of various macromolecules in the sinusoidal blood (Smedsrød et al., 1990). They are 
also essential components of the liver-centred innate immune system that includes Kupffer cells, 
natural killer cells and dendritic cells (Arias et al., 2011). 
The essential role of the LSEC in liver function is the focus of this thesis and will be discussed in 
detail in the following sections.  
 
1.2.7.1 Structure and morphology 
 
The LSECs line the vascular lumen of the terminal capillaries of the liver sinusoids. As described 
above, they lack basement membrane (Bouwens et al., 1991, Wisse et al., 1996) and possess 
fenestrations with diameters ranging from 50 to 200 nm (Wisse et al., 1996). One of the 
earliest electron microscopic descriptions of the fenestrated LSEC was by Wisse (Wisse, 1970). 
This observation described the endothelial cells as containing open fenestrations grouped into 
sieve plates surrounded by the thin extensions of the cytoplasm.  Further studies found that the 
total area covered by the fenestrations is approximately 5-10% of the LSEC surface area 
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(Wisse, 1970). Some studies have shown that the diameter of fenestrations decreases and their 
frequency increases from the periportal (zone 1) to centrilobular zones (zone 3), consistent with 
an increase in porosity from 6 to 8% (Wisse et al., 1985). Vidal-Vanaclocha and co-workers 
observed approximately double the number of sieve plates and number of fenestrations per 
sieve plate in the pericentral sinusoids than the periportal sinusoids (Vidal-Vanaclocha and 
Barbera, 1985). They classified fenestrations into two types, clustered pores, which are more 
prevalent in the pericentral sinusoids, and free pores, which are more prevalent in the periportal 
sinusoids (Vidal-Vanaclocha and Barbera, 1985). Electron microscopy of the sinusoidal 
endothelium is shown in Fig 1.3. 
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Figure 1.3: Scanning electron micrograph of the liver sinusoidal endothelial cells (Le Couteur et 
al., 2001). (a) Scanning electron micrograph showing the luminal surface of the liver sinusoidal 
endothelium. The circular fenestrations that are perforated in the endothelium can be clearly seen 
(→).The sieve plates (SP) which contains the clusters of fenestrations are clearly visible. 
Continuous sheets of these cells form a porous endothelium that filters the blood. (b) 
Transmission electron micrograph showing a cross section through the sinusoids. The thin 
endothelial cytoplasm (E) is clearly seen with fenestrations (→) through the SoD, which is a low 
density matrix. The combination of fenestrations and the lack of basement membrane allow 
direct communication between the sinusoidal lumen and the hepatocytes (H). Hepatic stellate 
cells (SC) can also be seen in the micrograph. 
14 
 
Fenestrations and sieve plates are structurally supported and demarcated by cytoskeleton 
elements within the LSEC (Braet et al., 1995). The subendothelial space that lies between the 
sinusoids and hepatocytes is called the SoD, which contains a low-density matrix of basement 
membrane constituents and stellate cells. The LSECs containing fenestrations in sieve plates, and 
the subendothelial SoD, containing extracellular matrix (ECM), together constitute the liver 
sieve. Molecules from the sinusoidal lumen can translocate directly through the fenestrations, to 
the low-density matrix of the SoD, to be in contact with hepatocyte microvilli, and vice versa 
(Wisse et al., 1996, Fraser et al., 1995). Blood constituents that are too large to pass through 
fenestrations, such as erythrocytes and chylomicrons are excluded from the SoD, while smaller 
molecules, such as chylomicron remnants are able to pass directly through the fenestrations 
(Wisse, 1970). 
 
The flow of plasma and macromolecules in and out of the SoD via fenestrations is influenced 
by the passage of blood cells through the sinusoidal lumen and the composition of ECM. 
Blood cells are larger than the diameter of the sinusoid and thus squeeze through the 
luminal space, sometimes modulating their shape to do so. This action has been proposed to 
promote ‘forced sieving’ of substances through fenestrations, and compression of the SoD by 
the movement of larger more rigid white blood cells along the lumens promotes the 
downstream movement of fluid in the SoD (McCuskey et al., 1978, Wisse et al., 1985). This 
creates an ‘endothelial massage’, where erythrocytes and leukocytes may flush plasma through 
the fenestrations in the endothelium (Wisse et al., 1985). Permeation selectivity of different 
molecules is regulated by the fenestration and molecule sizes, and the transport kinetics of the 
molecules relative to steric and frictional properties of the fenestrations (Wisse et al., 1996). 
15 
 
Fenestrations in the LSECs have been described in a very wide range of species with a variation 
in diameter and frequency has been observed between species as shown in Table 1.1. 
Fenestrations are conserved and quite similar in size and distribution in animals and humans. 
All LSECs are fenestrated and these fenestrations are arranged in sieve plates except for rainbow 
trout (Braet and Wisse, 2002). Porosity is the percentage of the surface area of the sinusoid 
covered with fenestrations. The frequency of fenestration refers to the number of fenestrations 
per unit area. 
 
Table 1.1: Inter-species variations in fenestration parameters (Cogger and Le Couteur, 2009) 
 
Species Porosity 
(Area %) 
Diameter 
(nm) 
Frequency 
(per µm
2
) 
Rat (zone 1) 6.0±0.2 111±1 9.1±0.3 
Rat (zone 3) 7.9±0.3 105±0.2 13.3±0.5 
Rat 4.1±2.3 73±1 2.7±1.1 
Mice 4.1±2.2 74±4  
Rabbit 5.2±0.9 60±5 17.3±3.8 
Chicken 3.6±1.6 99±15 3.9±0.9 
Rainbow trout - 123 - 
Gold Fish - 50-200 - 
Dog 6.7 118±2
 
7.2 
Sheep - 60±2
 
- 
Baboon
 
2.6±0.2 50±1 12.1±0.8 
Human (zone 1) 3.4±0.2 170±12 9.8±1.8 
Human (zone 3) 4.0±0.4 160±10 11.2±2.6 
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1.2.7.2 Formation and regulation 
 
There is evidence that LSEC fenestrations are formed by a calcium-calmodulin-actomyosin 
cytoskeleton (Oda et al., 1986, Van Der Smissen et al., 1986). Fenestrations are arranged into 
sieve plates, creating a network with the cytoskeleton (Braet and Wisse, 2002). The calcium-
calmodulin-actomyosin cytoskeleton regulates fenestrations diameter and controls dynamic 
contraction and dilatation of the fenestrations. Maintenance and induction of this unique 
endothelial cell phenotype is regulated via paracrine secretion of vascular endothelial growth 
factor (VEGF) by neighbouring hepatocytes and HSCs, and autocrine production of nitric oxide 
by endogenous nitric oxide synthase (DeLeve et al., 2004). 
 
An alternative hypothesis has been that fenestrations are formed through the static fusion of 
caveolae (Oda et al., 2001). Caveolae are plasmalemmal invaginations, which are implicated in 
endocytosis and transport of substances across the capillary endothelium, signal transduction 
pathways and calcium regulation (Parton, 2003). Calveolin-1 (Oda et al., 2001) and Ca
2+
-
ATPase pump (Fujimoto, 1993) have been observed both in fenestrations and in caveolae. 
However, this hypothesis has been largely discounted because the LSEC of caveolin-1 knockout 
mice are fenestrated and despite the absence of caveolin 1 the fenestrations are arranged in sieve 
plates (Warren et al., 2010). 
 
Recently it has been shown that the properties of the plasma membrane are highly influential in 
the formation of fenestrations (Cogger et al., 2013a). Membrane rafts are highly dynamic sterol 
and sphingolipid enriched lipid-ordered domains of the cell membrane that compartmentalise 
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cellular signaling molecules. Rafts range from 10-200 nm in diameter and may aggregate into 
micrometer sized structures that serve as platforms for signal transduction (Viola and Gupta, 
2007). They are tethered to the actin cytoskeleton, which is essential for the maintenance of 
their structure and integrity. Actin disruptors decrease the presence of membrane rafts and 
increase the number of sieve plates, thus rafts and sieve plates may have an inverse relationship 
in the LSEC cytoplasm (Svistounov et al., 2012). Fenestrations have been observed to form in 
non-raft lipid-disordered regions once the stabilising effects of actin and rafts are depleted, 
and it is possible that fenestrations are created as a result of vesicles that spontaneously form in 
the cell membrane after it is destabilised (Svistounov et al., 2012). Agents or conditions that 
increase fenestration number contract or disrupt F-actin, therefore it is also possible that 
fenestrations spontaneously form in response to stretching and thinning of the cytoplasm 
between the contracted ring of F-actin (Cogger et al., 2010) that is similar to the manufacture 
of expanded film ultrafiltration membrane (Baker, 2004). Areas of cytoplasm containing 
fenestrations are about 50 nm from apical to basolateral surface, approximately half as thick as 
the cytoplasm surrounding the sieve plates (Cogger et al., 2013a). 
 
Fenestration diameter and number can be altered through induction of cytoskeletal changes 
(Braet et al., 1995) using acute and chronic exposure to a number of substances and conditions, 
as shown in Table 1.2. Endothelial fenestration formation has been induced through ‘fenestration 
forming centres’ within minutes of administration of actin disrupting agents such as cytochalasin 
B (Steffan et al., 1987). Other actin-disruptor agents including marine-sponge-derived 
macrolides such as latrunculin A, jasplakinolides, swinholide A and misakinolide A, each with 
its distinct specific actin-disrupting property, have also been used to study LSEC cytoskeletal 
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changes and fenestration dynamics (Braet et al., 1996, Braet et al., 2003, Braet et al., 1998, Braet 
et al., 2002, Spector et al., 1999). Vascular endothelial growth factor receptor expression in 
endothelial cells is reported to enhance caveolae expression, their fission and fusion, and 
formation of fenestrations (Chen et al., 2002). 
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Table 1.2: Modulations of fenestration diameter and number by numerous substances in vivo 
and in vitro (Arias, 1990, O'Reilly et al., 2010, Braet and Wisse, 2002, Cogger et al., 2013a) 
 
Treatment 
Diameter of 
fenestrations 
Number of 
fenestrations/cell 
Actin disruptors   
Cytochalasin B 
and D 
↑↓ ↑ 
Dihydrohalichondra
mide 
↓ ↑ 
Latrunculin A ↓ ↑ 
Misakinolide ↓ ↑ 
Swinholide A ↓ ↑ 
Other                                               Acetylcholine ↑ ? 
Adrenaline ↓ ? 
Bethanechol ↑ ? 
Calmodulin agonist 
W-7 
↑ ? 
Carbon tetrachloride ↑ ↓ 
Cocaine and ethanol ? ↓ 
Collagen IV n.c. ↑ 
Diethyl nitrosamine ? ↓ 
Dimethyl nitrosamine n.c. ↓ 
DOI (2,5-dimethoxy-4-iodoamphetamine) ↑    ↓ 
Endothelin 1 ↓ ↓ 
ETA-R antagonist (BQ123) ↑ ? 
Ethanol acute dose ↑ ↓ 
Ethanol chronic dose ↑↓ ↓ 
Fatty liver ? ↓ 
Hypoxia ↑ ? 
Hepatectomy ↑ ↓ 
Hepatitis C ↓ ↓ 
Ionophore A23187 ↓ ? 
Irradiation ↑ ? 
Isoproterenol ↑ ? 
Jasplakinolide ↓ ↑ 
Laminin n.c. ↓ 
Neuropeptide Y ↓ ? 
Noradrenaline ↓ ? 
Nicotine ↓ ? 
Pantethine ↑ ↑ 
Phalloidin ↑ ? 
Phorbol myristate acetate n.c. ↑
↓ Pressure ↑ ? 
Prostaglandin E1 ↑ ? 
Serotonin ↓ ? 
Temperature 4 ºC ? ↓ 
Thioacetamide ↓ ↓ 
Tumour cells ↓ ↓ 
TNF-α ? ↓ 
Vasoactive intestinal peptide  ↑ ? 
Vascular Endothelial Growth Factor ↑ ↑ 
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1.2.7.3 Functional aspects of sinusoidal endothelial cells 
 
In addition to, but as part of the sieving function that has been discussed previously, LSECs are 
also important for the process of drug clearance. Fenestrations allow the passage of bound and 
unbound drugs to the SoD for uptake and clearance by the hepatocytes (Braet and Wisse, 2002). 
The presence of fenestrations also optimises the oxygen delivery from the sinusoids to the 
hepatocytes (Arias et al., 2011). 
 
The LSECs are the primary scavenger system of the liver and indeed for the entire body. They 
contain numerous coated pits on their surface which creates a cationic surface charge that allows 
for endocytosis of negatively charged molecules. Different types of scavenger receptors such as 
hyaluronan receptors, mannose macrophage receptors and Fc gamma receptors are expressed by 
LSECs, which allow the removal of various macromolecules from the blood such as proteins, 
polysaccharides, lipids and nucleic acids (Elvevold et al., 2008). The LSECs internalise 
macromolecular waste such as extracellular matrix breakdown products (McGary et al., 1989), 
lysosomal enzymes (Magnusson and Berg, 1989), immune complexes (Mousavi et al., 2007), 
advanced glycation end products (AGE) (Tamura et al., 2003), acetylated and oxidised low 
density lipoproteins (Li et al., 2011) and modified proteins (Smedsrød, 2004). There are recent 
studies that suggest that LSECs might be involved in viral clearance (Ganesan et al., 2011, Liu et 
al., 2013).  
 
LSECs also express Stabilin-1, a component of stabilin receptor that mediates endocytosis of 
acetylated LDL (Prevo et al., 2004), secreted protein acidic and rich in cysteine (SPARC) 
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(Kzhyshkowska et al., 2006), placental lactogen (Kzhyshkowska et al., 2008) and 
phosphatidylserine (Park et al., 2009). Stabilin-1 also functions as a bacteria-binding protein and 
modulates angiogenesis (Adachi and Tsujimoto, 2002). It helps in the lymphocyte migration and 
entry of leukocytes to the site of inflammation (Karikoski et al., 2009). 
 
1.3 PATHOLOGY OF THE LIVER SINUSOIDAL ENDOTHELIAL CELL 
 
Under physiological conditions LSECs are a highly efficient ultrafiltration system; therefore the 
influence of fenestrations on liver function is mostly seen in diseases and old age where their 
diameter and frequency are diminished (Cogger and Le Couteur, 2009, Le Couteur et al., 2005, 
Fraser et al., 2012). Pathology of LSECs in many chronic liver diseases such as cirrhosis is 
marked by hepatic sinusoidal capillarisation, where the LSEC becomes defenestrated and 
thickened, resembling the phenotype of a vascular capillary endothelial cell. LSEC 
capillarisation is generally accompanied by an increased deposition of excessive extracellular 
matrix and build up in the subendothelial SoD (DeLeve, 2009) and formation of a continuous 
basement membrane due to deposition of collagen and laminin (Le Bail et al., 1990). 
Defenestration and capillarisation significantly affects liver function, mainly due to impaired 
plasma exchange between the sinusoidal lumen and the SoD (Henriksen et al., 1984). 
Furthermore, it also contributes to hepatocyte hypoxia (DeLeve, 2009, Le Couteur et al., 2005), 
reduced drug clearance (DeLeve, 2007, Le Couteur et al., 2005), hindered hepatocyte-blood 
substance exchange (Fraser et al., 1978, Fraser et al., 1995), vasoconstriction and portal 
hypertension (Iwakiri and Groszmann, 2007), and altered immune function (Iwakiri, 2012, 
Warren et al., 2007). 
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1.3.1 Pathology in liver diseases 
 
Capillarisation of the sinusoids in liver disease was first documented by Popper et al. in 1952 and 
is now well established in many studies (Popper et al., 1952). Capillarisation is associated with 
hypertrophy and defenestration of the endothelial cells, development of basement membrane, 
profuse extracellular matrix deposition in the SoD and alterations in HSC morphology.  
 
In cirrhosis, following sinusoidal capillarisation, bridging fibrosis develops along the portal 
triad-central vein axis, altering blood flow through the liver (Onori et al., 2000). In cases of 
chronic liver injury, a continuous wound-healing (fibrotic) process is activated that progresses to 
hepatic cirrhosis in a large number of diseases and drug induced toxicity (Le Bail et al., 1990, 
Govindarajan and Bonacini, 2003). During cirrhosis, liver function is severely affected as 
capillarisation of sinusoids, vasoconstriction, and anatomical remodelling, leading to increased 
vascular resistance that contributes to portal hypertension and venous thrombosis (Iwakiri, 
2012). Progressive accumulation of extracellular matrix results in areas of permanent fibrous 
scar tissue replacing those areas once filled with hepatocytes and sinusoids, a feature that defines 
cirrhosis (Bosch, 2007, Sánchez-Valle et al., 2012). 
 
Defenestration precedes fibrosis and has been observed in various disease conditions such as 
primary biliary cirrhosis (Mori et al., 1993), hepatitis (Steffan et al., 1995), specific viral 
infection of the LSEC (Xu et al., 2003) and with venous administration of endotoxin (Braet and 
Wisse, 2002, Dobbs et al., 1994). The capillarised LSEC becomes “hypoactive” (Iwakiri and 
Groszmann, 2007) and loses the ability to revert activated HSCs to a quiescent phenotype (Xie 
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et al., 2012, DeLeve et al., 2008). HSCs subsequently produce large quantities of ECM, 
particularly fibrillar collagens type I and III (Bataller and Brenner, 2009, Benyon and Arthur, 
1998, Burt, 1993, Reeves and Friedman, 2002). At the same time, there is a decrease in 
production of NO and other vasodilators in hypoactive capillarised LSECs, enhancing sinusoidal 
vasoconstriction (Iwakiri, 2012). Fibrosis is also associated with chronic hepatic diseases (Le 
Bail et al., 1990, Sánchez-Valle et al., 2012) and drug toxicity (Cederbaum, 2006, Iwakiri and 
Groszmann, 2007, de Araújo et al., 1993).  
 
Concurrent with morphological changes, progressive deterioration of liver function is seen in 
liver diseases. Impaired exchange and metabolism of substances including lipoproteins and 
medications are observed in experimental models and clinical cases of liver disease such as 
cirrhosis (Clark et al., 1988, Martinez‐Hernandez and Martinez, 1991, Rogers et al., 1992, 
McLean and Morgan, 1991). One explanation for progressive loss of liver function is that 
capillarisation of the sinusoid impedes the passage of substances to the liver parenchyma 
(McLean and Morgan, 1991, Wanless et al., 1996, Le Couteur et al., 2005). 
 
The study of lipoproteins and the liver sieve has provided more evidence for the formation of a 
barrier to substrate transfer in sinusoidal capillarisation. Loss of fenestrations in a rat model of 
cirrhosis inhibits the hepatic uptake of chylomicron remnants, consequently disturbing 
cholesterol and retinol metabolism (Rogers et al., 1992). Increased blood lipids are found in 
alcoholics (Clark et al., 1988), and in adults and children with liver disease (SelimoĞlu et al., 
2002). Chronic effects of alcohol on the liver sieve may explain the hyperlipidemia associated 
with cirrhosis, where a chronic high dose of alcohol decreases the number of fenestrations in the 
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sinusoidal endothelium (Horn et al., 1987). Defenestration may contribute to the hyperlipidemia 
seen in cirrhosis through capillarisation of the sinusoidal endothelium with the presence of 
endothelial basement membrane (Schaffner and Poper, 1963). Capillarisation prevents 
chylomicron remnants from reaching hepatocytes and removes the inhibition of hepatic 
cholesterol synthesis (Clark et al., 1988).  
 
1.3.2 Pathology in ageing  
 
The ageing liver can be observed macroscopically as undergoing ‘brown atrophy’ due to brown 
pigmentation caused by the accumulation of lipofuscin, an end product of lipid peroxidation, in 
hepatocytes (Popper, 1985, Jansen, 2002, Le Couteur and McLean, 1998). It is estimated that the 
liver mass is reduced by 44% with age (McLean and Le Couteur, 2004) and blood flow to the 
ageing liver decreases by up to 53% (Wynne et al., 1989, McLean and Le Couteur, 2004). 
 
On a microscopic level, hepatocytes are seen to increase in size, with increased nuclear 
polyploidy and binucleation (Watanabe et al., 1984). There are also reported changes in 
organelle size with age, for example decreased size of smooth endoplasmic reticulum 
(Schmucker, 1998). The amount of vitamin A that is stored by the liver increases with age 
(Vollmar et al., 2002) and changes in the extracellular matrix in livers of old rats have been 
reported (Andrew, 1969). Fibrosis seen in the ageing liver is reportedly due to a reduction in the 
proteolytic activity of hepatic matrix metalloproteinase (Gagliano et al., 2002). A number of age-
related changes in hepatocyte function have already been identified including reduced drug 
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clearance, changes in enzyme expression and activity and altered transport of drugs across the 
hepatocyte cell membrane (Schmucker, 2005). 
 
Age-related changes in the ultrastructure of the hepatic sinusoids have been thoroughly 
described. It was first reported that the sinusoidal endothelium only undergoes a few changes 
with age (Margreet De Leeuw et al., 1990). Further examinations of the livers of ageing rats with 
electron microscopy and immunohistochemistry have reported a constellation of age-related 
changes that have been named pesudocapillarisation (Le Couteur et al., 2001). These changes 
include reduction in the diameter and density of the fenestrations in the sinusoidal endothelium, 
thickening of the endothelium, and deposition of collagen and basement membrane with 
increasing age. Chronic changes in fenestrations are now well established in ageing and become 
a part of increasingly recognised age-related changes in the liver (Le Couteur and Lakatta, 2010). 
Vascular endothelial markers, such as von Willebrand  factor (vWF) an endothelial glycoprotein 
that mediates attachment of platelets after endothelial injury, which is not expressed by the 
sinusoidal endothelium of young rats, is seen in the sinusoids of old rats. The upregulation of 
vWF in the LSEC is indicative of the pathophysiological state of these cells and has been 
reported in hepatitis and cirrhosis due to numerous causes (Fukutomi et al., 2005, Albornoz et 
al., 1999). Increased vWF expression with age likely represents altered platelet adherence with 
age (Le Couteur et al., 2008).  
 
Pseudocapillarisation is evident across a range of animal models inclusive of rats (Le Couteur et 
al., 2001), humans (McLean et al., 2003), mice (Warren et al., 2005), and baboons (Cogger et al., 
2003) (Table 1.3), an indication that this is a fundamental age-related change. Examples of 
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electron micrographs of young and old rat livers are shown in Fig. 1.4 and 1.5. Similar changes 
have been reported in sinusoidal endothelial cells cultured from livers of older humans and in 
hepatic sinusoidal cells in ageing mice (Ito et al., 2007). 
 
Table 1.3: The effects of old age on porosity (%), fenestration diameter (nm) and thickness (nm) 
of the hepatic sinusoidal endothelium across four species (Warren et al., 2005). Porosity and 
fenestration diameter were elucidated using SEM and endothelial thickness using TEM. Y: 
young, O: old.  
 
Species Rat Baboon Human Mouse 
Y O Y O Y O Y O 
Porosity (%) 
 
4.1±2.3 
 
2.5±1.2 
 
4.2±0.5 
 
2.4±0.4 
 
Not done 
 
4.1±2.2 
 
2.2±3.5 
Fenestrations 
diameter (nm) 
 
73±1 
 
60±1 
 
58±1 
 
70±2 
 
Not done 
 
74±4 
 
58±12 
Endothelial 
thickness (nm) 
 
230±50 
 
320±80 
 
130±8 
 
186±9 
 
165±17 
 
289±9 
 
154±4 
 
245±8 
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Figure 1.4: Scanning electron micrographs of the sinusoidal surface of the endothelium of (a) 
young (6 months) and (b) old (26 months) rat showing defenestration of the endothelium of the 
old rat liver (Le Couteur et al., 2001). Scale bars =1 um.  
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Figure 1.5: Transmission electron micrographs of liver biopsies from a young rat aged 6 months 
(a) and an old rat aged 26 months (b) showing cross sections of sinusoids (S) with age-related 
thickening of the sinusoidal endothelium, (E), decreased fenestrations, (*) and laying down of 
basement membrane in the SoD, (D). H=hepatocytes. (Le Couteur et al., 2001).   
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1.3.3 Functional implications of morphologic changes in the ageing liver 
 
The study of the ageing process of the liver is important as the liver is the main site for 
metabolism of many substrates associated with age-related problems such as diabetes, vascular 
disease, neurotoxicity, xenobiotic detoxification and adverse drug reactions (Le Couteur et al., 
2002, Le Couteur and McLean, 1998) and old age is a major risk factor for many liver diseases.  
 
As discussed above the liver undergoes significant changes with age that contribute to the 
increase risk of the development of disease with age: impaired detoxification and metabolism 
leading to increased systemic exposure and adverse drug reactions (Le Couteur et al., 2004, 
Herrlinger and Klotz, 2001), impaired lipid clearance leading to hyperlipidemia (Cassader et al., 
1996), a significant risk factor for vascular disease (Weintraub et al., 1996, Krasinski et al., 
1990).  
 
The implications of ageing in the liver are also demonstrated by several genetic models of 
premature ageing, for example the Werner progeria syndrome (Lebel, 2001). Mice with this 
syndrome have a premature ageing condition that is associated with LSEC pseudocapillarisation, 
hyperlipidemia (Murata and Nakashima, 1985), and significantly raised levels of serum 
hyaluronan indicative of decreased LSEC endocytotic capability (Tanabe and Goto, 2001). 
Pseudocapillarisation was ameliorated with antioxidant (vitamin C) treatment in this animal 
model of Werner’s syndrome (Massip et al., 2010). There are also animal models with 
ameliorated pseudocapillarisation secondary to caloric restriction, a dietary intervention that 
delays ageing (Jamieson et al., 2007b).  
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1.4 INSULIN RESISTANCE 
 
The hypothesis that fenestrations are involved in hepatic insulin action was recently studied by 
Raines et al (Raines et al., 2011). They studied transgenic mice with partial inactivation of 
platelet derived growth factor-β (PDGF-β). These mice had leaky, disrupted LSECs as measured 
by TEM and in vivo fluorescein isothiocyanate (FITC)-dextran uptake. This enhanced 
transendothelial transport was associated with a dramatic increase in insulin action in the liver, 
with increased hepatic insulin signaling, improved glucose tolerance tests, increased insulin 
clearance and an 80% reduction in circulating insulin levels despite euglycemia. These results 
suggest that insulin and glucose metabolism is also dependent on the LSEC fenestrations, and 
that pseudocapillarisation might contribute to increased susceptibility with age to 
hyperinsulinemia, insulin resistance and diabetes. A key focus of this thesis is to study the role of 
fenestrations on insulin action in the liver, and to determine whether age-related 
pseudocapillarisation provides a novel mechanism for impaired insulin sensitivity in old age. 
 
1.4.1 Insulin  
 
Insulin was discovered by Best and Banting in 1922 while investigating the role of the pancreas in 
diabetes mellitus (Banting et al., 1991). It is a hormone that is essential for regulating energy 
storage and glucose metabolism in the body (Pessin and Saltiel, 2000). Following an increase in the 
plasma concentration of glucose, insulin is released from the pancreas and stimulates the liver, 
muscle, adipose tissues and other insulin target cells to commence glucose uptake. The glucose can 
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be utilised for fuel or stored as glycogen in the liver and muscle. Insulin also reduces glycogenolysis 
and gluconeogenesis in the liver, decreasing hepatic glucose production (Sesti, 2006).  
 
Insulin resistance is an impaired biological response to insulin where cells become resistant to the 
effects of insulin, causing normal physiological insulin levels to be insufficient to regulate glucose 
homeostasis by peripheral target tissues (Petersen and Shulman, 2002). Consequently, a higher 
amount of insulin is needed to achieve an adequate insulin response. Insulin resistance is one of 
the earliest changes in individuals with normal glucose tolerance who are progressing towards 
impaired glucose tolerance and potentially type 2 diabetes. Insulin resistance also has been 
associated with conditions such as cardiovascular disease, hypertension, obesity, and non-alcoholic 
fatty liver disease (Cohn et al., 2005). 
 
To understand the insulin mechanism of action, the following section will discuss the insulin 
network, from insulin secretion, hepatic insulin clearance and insulin signaling. 
 
1.4.1.1 Insulin secretion 
 
Insulin is produced and secreted by β-cells located in the pancreatic islets of Langerhans as a 
polypeptide hormone with a molecular weight of 58 kDa. It is first synthesised as a single 
polypeptide, preproinsulin, and undergoes processing in the endoplasmic reticulum to proinsulin, 
consisting of an α and β chain linked together by disulfide bonds and a C-peptide bridge. After 
being trafficked to the trans-Golgi network, endopeptidases cleave the C-peptide bridge creating 
mature insulin which is packed into granules and stored on the plasma membrane. Upon glucose 
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entry into the pancreatic β-cells through the glucose transporter (GLUT) 2 channels, glucokinase is 
phosphorylated which stimulates insulin release into the circulation via exocytosis (Melmed et al., 
2011). 
 
Impaired insulin secretion can be observed by a reduction in frequency and amplitude of insulin 
release in response to glucose. This is reported in both individuals with normal fasting plasma 
glucose and individuals with impaired glucose tolerance, suggesting it can precede insulin 
resistance and hyperglycaemia (Melmed et al., 2011). Failure of the β-cell to compensate for the 
insulin resistance is considered an early step for development of impaired glucose tolerance and 
type 2 diabetes (Abdul-Ghani et al., 2006, Reaven et al., 1989, Weyer et al., 1999a). 
 
1.4.1.2 Hepatic insulin clearance 
 
The liver plays a major role in extracting insulin from the circulation (Meier et al., 2005). Once 
released from the pancreas, insulin travels to the liver via the hepatic portal vein, followed by 
binding to the insulin receptor and is either degraded or released into the systemic circulation. 
The liver is exposed to the highest insulin concentrations of any tissue, with a range between 
1,000-5,000 pmol/l (Song et al., 2000), while the systemic circulation receives only ~1% insulin 
compared to the liver (Song et al., 2000). In addition, the liver reacts directly to changes in insulin 
concentration by decreasing hepatic insulin clearance when the demand for insulin is increased 
and vice versa. Therefore, insulin clearance by the liver has major consequences for the 
maintenance of normal systemic glucose concentrations (Meier et al., 2005). 
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In general, 80% of total insulin in the body is bound to the insulin receptors in the liver, which 
extracts ~50% of the secreted insulin during first pass transit (Duckworth et al., 1998, Hovorka et 
al., 1993). Two molecules have been identified in insulin internalization and degradation: 
carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) and insulin degrading 
enzyme (IDE). CEACAM-1 i s  involved in mediating the internalization of the insulin-insulin 
receptor complex (DeAngelis et al., 2008, Najjar, 2002, Poy et al., 2002) and IDE is involved in 
the inactivation and removal of insulin from the circulation. However, the insulin that is 
removed from the circulation is not necessarily degraded. A significant amount of receptor bound 
insulin is released back into the circulation (Hovorka et al., 1993). 
 
Hepatic insulin clearance has been found to be diminished in obesity and type 2 diabetes 
(Bonora et al., 1983, Bonora et al., 1986, Jones et al., 1997, SANDO et al., 1980). Increased 
insulin secretion by the pancreas, leading to hyperinsulinemia is a potential compensatory 
mechanism for maintaining normal blood glucose when hepatic insulin action and clearance is 
impaired (Rudovich et al., 2004). 
 
1.4.1.3 Insulin Signaling 
 
Insulin regulates a wide range of biological processes that are dependent on tissue type. Apart 
from regulating glucose/lipid homeostasis, insulin is also responsible for regulating cell 
growth and differentiation (Dumont et al., 2002). The insulin signaling pathway consists of a 
complex network of proteins that are also involved in regulating signaling pathways initiated by 
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other biological stimuli. Although insulin can elicit many biological outcomes, the most 
important processes are presented as follows and illustrated in Figure 1.6. 
 
a. Insulin receptor 
 
The insulin receptor is the first main component in the insulin signaling pathway. The insulin 
receptor is a member of the receptor tyrosine kinase superfamily (Ullrich and Schlessinger, 
1990),
 
and is present in the form of large heterodimers that consist of two α and β subunits. The 
α-subunit is located in the extracellular matrix and linked to the intracellular β-subunit via 
disulfide bonds. Insulin binding to the α-subunit on the surface of target cells leads to 
conformational changes that induce autophosphorylation of several tyrosine residues on the β-
subunit (Kahn and White, 1988, Kasuga et al., 1982, Roth and Cassell, 1983). 
Autophosphorylation of the β-subunit activates the receptor’s protein tyrosine kinase, which 
activates intracellular substrates responsible for the metabolic consequences of insulin signaling. 
 
b. Insulin receptor substrate (IRS) proteins 
 
The autophosphorylation of tyrosine kinase on insulin receptor activates phosphorylation of the 
insulin receptor substrate (IRS) proteins. There are several intracellular substrates of IRS that 
have been identified (Taniguchi et al., 2006), six of them are structurally similar and have been 
termed insulin receptor substrate proteins 1-6 (IRS1-6) (Cai et al., 2003, Fantin et al., 1999, Lavan 
et al., 1997, Sun et al., 1991, Sun et al., 1995, White, 1998), with IRS-1 and IRS-2 being the main 
IRS involved in insulin-mediated metabolic functions in the liver (Thirone et al., 2006). 
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IRS proteins contain a pleckstrin homology (PH) domain, a protein tyrosine binding domain 
(PTB) and tyrosine residues that can be phosphorylated by the IR tyrosine kinase (White, 
1998). Phosphorylation of IRS tyrosine residues creates docking sites for intracellular molecules 
with a src-homology-2 (SH2) domain-containing protein. Thus, IRS proteins serve as scaffolds 
on which the insulin-signaling complex can be arranged in response to the activation of IR 
(Shaw, 2011, Sun et al., 1993) to facilitate propagation of the insulin signal throughout the cell. 
Following phosphorylation, IRS proteins are responsible for mediating activation of the two main 
pathways in insulin signaling which are the phosphatidylinositol 3-kinase (PI3K)-AKT pathway 
and the Ras-mitogen activated protein kinase (MAPK) pathway (Taniguchi et al., 2006). They 
also interact with other intracellular targets including Shc (Gustafson et al., 1995), Cbl (Baumann 
et al., 2000), p62dok (Wick et al., 2001), and GRB2-associated binding proteins (GAB) (Lehr 
et al., 2000). 
 
Insulin-induced down regulation of IR is a well-established feedback mechanism (Caro and 
Amatruda, 1980, Knutson et al., 1982, Ramos et al., 2006, Youngren, 2007) that regulates the 
strength of insulin signaling and is common in hyperinsulinaemic states (Friedman et al., 1997). 
IRS-1 knockout mice are reported to have glucose intolerance and peripheral insulin resistance 
(Araki et al., 1994, Tamemoto et al., 1994), whereas IRS-2 knockout mice develop diabetes 
because of hepatic insulin resistance and lack of pancreatic β-cell compensatory response 
(Kubota et al., 2000, Withers et al., 1998). 
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c. PI3-K/AKT pathway 
 
PI3-K is an important kinase involved in mediating metabolic outcomes of insulin signaling 
(Shepherd et al., 1998). It consists of a regulatory p85 (Escobedo et al., 1991) and a catalytic 
p110 subunit (Hiles et al., 1992), both of which present in several isoforms (Taniguchi et al., 
2006). The p85 subunit has two SH2 domains that interact with the phosphotyrosine residues 
on IRS-1 (Myers et al., 1992).
 
The PI3-K catalytic subunit is then able to phosphorylate the 
plasma membrane glycolipid phosphatidylinositol-4,5-bisphosphate (PIP2) to 
phosphatidylinositol-3,4,5- triphosphate (PIP3) (Carpenter and Cantley, 1996). The generation 
of PIP3 within the vicinity of the IR/IRS complex allows for the recruitment of protein kinase 
B, also known as AKT, one of the principal mediators of the metabolic effects of insulin 
signaling, via its pleckstrin homology (PH) domain (Franke et al., 1997).  Once localised to the 
plasma membrane by binding to PIP3, AKT can be activated by 3-phosphoinositide-
dependent kinase-1 (PDK1) via phosphorylation of threonine 308 (T308) and serine 473 
(S473) within AKT’s activation loop (Alessi et al., 1997). Following activation, AKT is thought 
to mediate the majority of the hepatic metabolic outcomes stimulated by insulin (Taniguchi et al., 
2006). PDK-1 also activates atypical protein kinase C (aPKC) isoforms ζ and λ for further 
signaling action. 
 
i. PI3-K/AKT-mediated regulation of glycogen synthesis 
 
AKT and PKCs are essential for insulin-stimulated translocation of glucose transporters, such as 
GLUT4 that is expressed mainly in muscle and fat, from intracellular pools to the cell surface 
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(Saltiel and Kahn, 2001). AKT also increases glycogen synthesis by activating glycogen 
synthase (GS) via inhibition of glycogen synthase kinase 3 (GSK-3) and decreasing 
glycogenolysis simultaneously (Cross et al., 1995). Insulin has also been shown to target protein 
phosphatase 1 (PP1) which further increases the dephosphorylation and activation of GSK-3. In 
addition, AKT promotes protein synthesis by reversing GSK-3-induced inactivation of protein 
synthesis, eukaryotic initiation factor (eIF)-2B (Pap and Cooper, 2002). AKT also activates 
mammalian target of rapamycin (mTOR), promoting protein synthesis through p70 ribosomal S6 
kinase (S6K1) and inhibition of eIF-4E binding protein (Liu et al., 2002). 
 
ii. PI3-K/AKT-mediated regulation of hepatic glucose output 
 
Insulin regulates hepatic glucose output through direct effects on gene expression (Pilkis and 
Granner, 1992) and indirect regulation of substrate availability (Saltiel and Kahn, 2001). Insulin 
inhibits transcription of gluconeogenic genes that code for phosphoenolpyruvate carboxy kinase 
(PEPCK) (Hall et al., 2007, Hanson and Reshef, 1997), glucose-6-phosphatase (Nakae et al., 
2001, Nakae et al., 1999) and fructose-1,6-bisphosphatase, while increasing transcription of 
genes that code for glycolytic enzymes such as glucokinase (Barzilai and Rossetti, 1993) and 
pyruvate kinase (Yamada and Noguchi, 1999). Forkhead transcription factor 1 (FOXO-1) (Cheng 
and White, 2011, Nakae et al., 1999) and the transcriptional co-activator PGC-) (Yoon et al., 
2001) are involved in regulating gluconeogenesis in the liver. Specifically, AKT 
phosphorylates FOXO-1 and prevents it from entering the nucleus and activating transcription of 
genes that code for glucose-6-phosphatase and PEPCK, an enzyme that catalyses the rate limiting 
step in gluconeogenesis (Nakae et al., 2001, Puigserver et al., 2003).  
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iii. PI3-K/AKT-mediated regulation of lipid homeostasis 
 
In addition to the regulatory action of glucose homeostasis, insulin also has a critical role in lipid 
homeostasis. Insulin deactivates hormone sensitive lipase (HSL) through the PI3-K/AKT 
pathway thus inhibiting lipolysis in adipose tissue and depriving the liver of fuel from free fatty 
acids for glucose production (Holm et al., 2000). In the liver, insulin promotes lipogenesis by 
increasing transcription of lipogenic genes such as acetyl-CoA carboxylase (Munday and 
Hemingway, 1999). Sterol regulatory element binding protein 1c (SREBP-1c) mediates many of 
insulin’s effects on lipogenesis (Horton et al., 2002). Induction of SREBP-1c transcription 
appears to be dependent both on AKT (Azzout-Marnich et al., 2000, Fleischmann and Iyendjian, 
2000, Matsumoto et al., 2002) and liver X receptor activation (Chen et al., 2004) 
 
iv. Ras/MAPK pathway 
 
The Ras/MAPK pathway is involved in mediating cell growth, differentiation and survival. 
Insulin causes tyrosine phosphorylation of IRS-1, Gab1 and Shc, thus facilitating binding of 
growth factor receptor binding protein-2 (Grb-2) (Ogawa et al., 1998). Grb2 recruits the guanyl 
nucleotide exchange protein, Sos, to the plasma membrane resulting in the activation of G protein 
Ras (Ogawa et al., 1998). Activated Ras induces a phosphorylation cascade that begins with Ras 
and ends with activation of the Mitogen activated protein kinase (MAPK)/ Extracellular signal 
regulated kinases (ERK) pathway. The activated ERKs phosphorylate various intracellular 
substrates and translocate to the nucleus to phosphorylate transcription factors to promote gene 
expression. Studies with Ras or SOS dominant negative mutants and with IRS-1 
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siRNA/antibodies have shown that the Ras/MAPK pathway is important for insulin’s effect on 
cell growth and DNA synthesis (Maassen et al., 1992, RoSE et al., 1994, Sakaue et al., 1995, 
Waters et al., 1993).  
 
This section has described the upstream components of the insulin-signaling pathway, where 
AKT is the pivotal step of the pathway because it ties together insulin’s major roles in 
glucose and lipid metabolism (Leavens and Birnbaum, 2011). A detailed description of insulin 
target tissues following signal transmission will be discussed below. 
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Figure 1.6: Signal transduction in insulin action. The insulin receptor is a tyrosine kinase that 
undergoes autophosphorylation and catalyses the phosphorylation of cellular proteins, such as 
members of the IRS family, Shc and Cbl. Upon tyrosine phosphorylation, these proteins interact 
with signaling molecules through their SH2 domains, resulting in a diverse series of signaling 
pathways. This includes activation of PI (3) K protein kinases, Ras and the MAP kinase cascade, 
and the Cbl/CAP and the activation of TC10. These pathways act in a concerted fashion to 
coordinate the regulation of vesicle trafficking, protein synthesis, enzyme activation and 
inactivation, and gene expression. This results in the regulation of glucose, lipid and protein 
metabolism (Saltiel and Kahn, 2001).  
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1.4.2 Insulin target tissues 
 
Insulin regulates major biological processes including glucose and glycogen metabolism, lipid 
metabolism and protein synthesis. The effect of insulin in maintaining normoglycaemia in the 
setting of variable glucose availability is achieved by regulating glucose uptake and endogenous 
glucose production. The effect of glucose action on target tissues is summarised in Table 1.4.  
 
The three main target tissues of insulin action are liver, muscle and adipose tissue (DeFronzo, 
1988). In the postprandial state, insulin levels rise and inhibit the breakdown of glycogen via 
inhibition of glycogenolysis in muscle and liver tissue as well as inhibiting gluconeogenesis in 
the liver (Kumar and O'Rahilly, 2005). Insulin also stimulates glucose uptake by muscle and 
adipose tissue for storage in a form of glycogen and lipids (DeFronzo, 1988). The liver stores 
both glycogen and lipids, whereas in the normal state the muscle stores only glycogen and the 
adipose tissue only lipids. In fasting conditions the liver releases glucose via glycogenolysis and 
gluconeogenesis.  
 
Insulin also has indirect effects on glucose metabolism by decreasing the release of 
gluconeogenic precursors through regulation of lipid metabolism and protein turnover. Insulin 
inhibition of lipolysis in adipose tissue reduces the release of free fatty acids and glycerol used 
for hepatic glucose production. Likewise, insulin inhibition of proteolysis in  muscle tissue 
decreases the release of amino acids necessary for gluconeogenesis (Lewis et al., 1996, Rebrin et 
al., 1995). 
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Table 1.4: Classical and non-classical target organs for insulin-regulated glucose metabolism.  
A direct effect of insulin on glucose metabolism is defined as an insulin-stimulated change in the 
flux of glucose through a specific metabolic pathway that is initiated by the insulin receptor in 
the same tissue. An indirect effect is the regulation of glucose metabolism in one organ resulting 
from the effect of insulin on other micronutrients (such as lipids) or in other organs (Kumar and 
O'Rahilly, 2005). 
Organ/tissue 
Main effect of insulin on glucose metabolism 
Direct Indirect 
Classical targets 
Skeletal and cardiac muscle ↑ Glucose uptake ↓ NEFA availability and 
oxidation 
 ↑ Glucose oxidation  
 ↑ Glycogen synthesis  
Liver ↓Glucose output 
- ↓Glycogenolysis 
- ↓ Gluconeogenesis 
↓ NEFA availability and 
oxidation 
 ↑ Glycogen synthesis  
 ↑ Glycolysis  
 ↑ Lipogenesis  
Adipose tissue ↑ Glucose uptake Regulation of adipokines 
synthesis and/or secretion 
 ↑ Lipogenesis ↓ Lipolysis 
Non-classical targets   
Pancreatic beta cells ? Permissive effect on glucose-
stimulated insulin secretion 
(phase 1 release) 
Brain ? ↓ Food intake 
Vascular cells ? ↑ Blood flow 
  ↑ Capillary recruitment 
  ↑ NO secretion 
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Apart from nutrient metabolism, insulin also has effects on non-target tissues such as the central 
nervous system and vascular cells (DeFronzo, 2009). Insulin signaling in the brain is reported to 
be involved in appetite suppression (Plum et al., 2006, Schwartz et al., 2000), and has been 
shown to be reduced in obese, insulin-resistant, normal glucose tolerant individuals (Matsuda et 
al., 1999). The brain also plays an important role in the physiological control of hepatic glucose 
production as well as hepatic glucose uptake in response to insulin that usually gives a direct effect 
on hepatocytes (Rojas and Schwartz, 2014). In vascular cells, insulin is thought to stimulate 
vasodilatation and capillary recruitment thus enhancing glucose delivery and increasing muscle 
glucose uptake (Clark et al., 2003). 
 
1.4.3 Development of insulin resistance 
 
Insulin resistance is defined as a reduced biological effect for any given concentration of insulin 
(Wallace and Matthews, 2002). The characteristics of insulin resistance has been established as 
the main component in a cluster of abnormalities termed as Syndrome X or metabolic syndrome, 
that includes type 2 diabetes, obesity, hypertension, dyslipidaemia and cardiovascular disease 
(Reaven, 1995).  
 
1.4.3.1 Hepatic insulin resistance 
 
Among the three major insulin target tissues, the liver is the primary organ that directly regulates 
metabolic homeostasis, maintains normoglycaemia during fasting conditions and controls 
systemic insulin levels via hepatic insulin clearance (Cherrington and Lecture, 1999). Insulin 
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resistance in the liver is characterised by the inability of insulin to suppress glucose production. 
Uncontrolled hepatic gluconeogenesis has been shown to contribute to the fasting and overnight 
hyperglycaemia seen in individuals with type 2 diabetes (Consoli et al., 1989, DeFronzo et al., 
1989, Magnusson et al., 1992, Perriello et al., 1997, Weyer et al., 1999b). 
 
Insulin’s role in regulating lipid homeostasis is also impaired in hepatic insulin resistance. The 
overstimulation of lipogenesis by the liver due to hyperinsulinaemic conditions is thought to be a 
critical component of the overproduction of VLDL particles seen in type 2 diabetes (Adeli et al., 
2001).
 
The dyslipidaemia that is often present in individuals with type 2 diabetes is characterised 
by hypertriglyceridaemia, raised LDL-cholesterol and a low HDL cholesterol profile (Krauss, 
2004).
 
Consequently, the abnormal fat storage and ectopic fat deposition in other insulin target 
tissues has been suggested to have a role in the progressive nature of insulin resistance (Lewis et 
al., 2002). 
 
1.4.3.2 Peripheral insulin resistance 
 
Insulin resistance in peripheral tissues is characterised by the inability of tissues to take up 
glucose in response to insulin, affecting glucose disposal and lipolysis. Muscle insulin resistance 
is present when insulin-mediated glucose disposal through the GLUT4 channel is reduced to 
the lowest quartile of control subjects (Beck-Nielsen et al., 2005).
 
The progressive 
hyperinsulinaemia required to overcome the insulin resistance at the muscle is also thought to 
play a role in the development of metabolic syndrome (Vaag et al., 1995). Furthermore, insulin 
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resistance in adipose tissue leads to unregulated lipolysis and an increase in circulating free fatty 
acids, which contributes to increased hepatic glucose output (Groop et al., 1989). 
 
1.4.4 Measurement of insulin resistance 
 
Identification of insulin resistance is an important step in the diagnosis and management of 
symptoms of metabolic syndrome, especially diabetes. Quantitative measurement of biological 
action of insulin is used to determine insulin resistance. This is thought to be equal to insulin 
sensitivity that is reciprocal to insulin resistance (Bergman et al., 1985). Measurement is divided 
into two groups: non dynamic and dynamic methods (Wallace and Matthews, 2002) 
 
 
Non-dynamic methods are assessed during steady state using only glucose and insulin 
measurements. An example for this method is Homeostasis model assessment (HOMA), a 
mathematical model that calculates insulin sensitivity from fasting plasma glucose and insulin 
concentrations (Matthews et al., 1985, McAuley et al., 2001).
 
The principle of HOMA is 
based on the basic understanding of a feedback loop between the liver and the pancreas in the 
fasting state, where normoglycaemia is regulated by hepatic glucose output. HOMA-IR 
values of less than or equal to 2.4 have been shown to be reflect normal glucose tolerance and 
insulin sensitivity (Braatvedt et al., 2006, Geloneze et al., 2009). 
 
Dynamic methods are assessed by makeshift disturbance of the steady state and evaluation 
upon returning to the steady state. An example of this method is the euglycaemic clamp 
technique (Wallace and Matthews, 2002). Glucose levels are constantly maintained using an 
46 
 
intravenous infusion and insulin levels are elevated using a constant intravenous of insulin 
infusion. Once the glucose levels are fixed or ‘clamped’ at the desired concentration, insulin 
resistance is inversely related to the glucose infusion rate necessary to maintain the required 
glucose concentration (Davis et al., 1992). This method is considered a gold standard in 
measuring insulin sensitivity in vivo (Wallace and Matthews, 2002). 
 
Among these two methods, HOMA is more commonly used to determine insulin resistance due 
to the tests robustness, while euglycaemic clamp is considered to be more invasive, time 
consuming and a labor intensive procedure (Bergman et al., 1985, Matthews et al., 1985). 
 
1.4.5 Animal models of insulin resistance  
 
Techniques of transgenesis and mutagenesis in rodents have enabled researchers to understand the 
complex pathogenesis of insulin resistance. Various animal models have been developed to test 
the hypotheses for insulin resistance, involving transgenic and knockout mice with mutations in 
genes involved in insulin action and secretion (NANDI et al., 2004). Focus has been targeted at 
specific insulin target tissue that is created by removal of the insulin receptor using Cre-loxP 
system (Gu et al., 1994) as shown in Table 1.5. 
 
 
 
 
 
47 
 
Table 1.5: Insulin specific target tissue models of insulin resistance 
 
Insulin 
Receptor 
knockout 
Insulin 
secretion 
Insulin 
action 
Glucose 
tolerance 
Glucose 
homeostasis 
Lipid 
homeostasis 
Muscle 
(MIRKO) 
Normal Normal Normal Normal 
↑ FFA 
↑ Triglycerides 
Fat 
(FIRKO) 
Normal Improved insulin 
sensitivity 
Improved Normal ↓Triglycerides 
Liver 
(LIRKO) 
Increased Markedly insulin 
resistant 
Severely 
Impaired 
Hyperglycemia 
↓ FFA 
↓Triglycerides 
  
The Muscle insulin receptor knockout mouse (MIRKO) was the first insulin specific target 
tissue model to study insulin resistance because it was thought that the muscle is the most 
important tissue for glucose uptake (Brüning et al., 1998). However, while MIRKO mice have 
elevated plasma triglycerides and free fatty acids there is no impairment of glucose 
homeostasis. It is reported that although muscle was not able not perform glucose uptake, this 
is compensated by adipose tissue, resulting in increased adiposity and weight gain.  
 
In parallel, fat insulin receptor knockout mice (FIRKO) (Bluher et al., 2002) showed normal 
glucose homeostasis with improved insulin sensitivity. The mice were surprisingly protected 
against obesity-induced glucose intolerance and had increased longevity.  
 
The Liver insulin receptor knockout mouse (LIRKO) (Michael et al., 2000) is the only insulin 
specific target tissue model that exhibited glucose intolerance and insulin resistance. The animal 
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had both fasting and postprandial hyperglycemia as a result of the liver’s inability to inhibit 
hepatic glucose production. They also had increased insulin secretion and impaired hepatic 
insulin clearance resulting in marked hyperinsulinaemia with progression to secondary whole 
body insulin resistance. This indicates that liver is the most relevant tissue in the pathogenesis 
of insulin resistance compared to muscle and adipose tissue. 
 
Apart from transgenic models, insulin resistance is also studied using high fat diet-induced 
insulin resistance animals. This model induces primarily hepatic insulin resistance at week 6 and 
by week 12 there is insulin resistance in the adipose tissue, without effects on the skeletal muscle 
at any point (Kleemann et al., 2010). This is consistent with LIRKO mice where hepatic insulin 
resistance precedes systemic insulin resistance. 
 
Studies using the tissue specific insulin receptor animal models and diet-induced models are 
valuable in studying the pathogenesis of insulin resistance, however complete insulin resistance 
conditions can only be seen in rare genetic diseases like leprechaunism and type A insulin 
resistance syndrome (Kahn et al., 1976). 
 
1.4.6 Insulin resistance and the metabolic syndrome 
 
The metabolic syndrome is characterised as a cluster of abnormalities that includes obesity, 
dyslipidaemia, hypertension and hyperglycemia (Alberti et al., 2005). The pathogenesis of 
metabolic syndrome is heterogeneous, with central obesity and insulin resistance considered to 
be the most important causative factors (Anderson et al., 2001). The terms metabolic syndrome 
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and insulin resistance syndrome have often been used interchangeably, but each term indicates 
different underlying concepts and observations. The clinical syndromes associated with insulin 
resistance include, but are not limited to, type 2 diabetes and cardiovascular diseases, 
hypertension, polycystic ovary syndrome, non-alcoholic fatty liver disease, sleep apnoea and 
certain cancers (Alberti et al., 2006). The World Health Organization (WHO) has stressed the 
importance of insulin resistance in the diagnosis of the metabolic syndrome and individuals who 
are at risk of getting diabetes and cardiovascular diseases (Alberti and Zimmet, 1998).
 
 
1.4.7 Insulin resistance and diabetes 
 
There are two types of diabetes mellitus that are generally described: type 1 (T1DM) and type 2 
(T2DM). T1DM is characterised by a lack of insulin due to destruction of the insulin-secreting β-
cells of the pancreas. Treatment requires regular subcutaneous insulin administration to replace 
the insulin that would normally be secreted by the pancreas several times a day in order to 
prevent life threatening hyperglycemia (Sibal et al., 2006). T1DM is usually diagnosed in 
childhood and the major cause is reported to be from various auto-immune factors and genetic 
predisposition (Dahlquist, 1993). 
 
T2DM is characterised by hyperglycemia, insulin resistance, and decreased β-cell number and 
secretory function (Harris et al., 1998, Haslam and James, 2005, Wild et al., 2004). It progresses 
from an early ‘pre-diabetes’ stage, which is often asymptomatic, with insulin resistance, to a 
relatively mild postprandial hyperglycemia, before developing into classic symptomatic diabetes, 
requiring treatment with insulin and/or oral hypoglycaemic medications. T2DM has mostly been 
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associated with older age but its prevalence in young people and children is rapidly increasing. 
There are multiple risk factors for the development of T2DM including age, obesity, family 
history, lack of exercise and a high calorie diet. T2DM increases susceptibility to multiple 
microvascular problems such as diabetic retinopathy, diabetic nephropathy and peripheral 
vascular disease (Hartz et al., 2006). 
 
1.4.8 Liver, insulin resistance and diabetes mellitus 
 
Our understanding of the liver’s contribution to the development of insulin resistance has largely 
focussed on the role of the hepatocyte. For example, it is known that LIRKO mice, which lack 
the insulin receptor in hepatocytes, exhibit dramatic insulin resistance, severe glucose intolerance 
and failure of insulin to regulate hepatic gene expression and to suppress hepatic glucose output 
(Michael et al., 2000). In vitro studies have shown that insulin resistance is induced by 
interleukin-6 in primary hepatocytes and in human hepatocarcinoma cell line, HepG2 causing a 
decrease in tyrosine phosphorylation of IRS-1 in response to physiologic insulin levels and 
inhibition of insulin-dependent activation of AKT, that facilitates downstream insulin metabolic 
actions (Klover et al., 2002). 
 
However, prior to interaction with the insulin receptor on the hepatocyte, insulin must first cross 
the LSEC and SoD. The endothelium has been shown to be the rate limiting step for the uptake 
of insulin in most other tissues such as muscle and fat, however the role of the sinusoidal 
endothelium in hepatic insulin action has not been specifically investigated (Takamura et al., 
2012). Limited evidence has shown that in the normal liver, insulin from the portal vein will be 
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bound to the hepatocyte insulin receptor within three minutes (Bergeron et al., 1979). The LSEC 
has limited affinity for insulin and it has been shown that LSECs will only pinocytose insulin in 
situation of hepatocellular receptor saturation (Bergeron et al., 1979). Abnormalities in liver 
microcirculatory function, particularly changes in the transfer of insulin from blood to the 
hepatocytes, may be a critical factor in the development of insulin resistance. However, this 
possibility largely remains under investigated.  
 
Endothelial dysfunction in metabolic syndrome has been discussed as the cause (Baumgartner-
Parzer and Waldhausl, 2001) or the consequence (Avogaro et al., 1997) of insulin resistance. 
Evidence that endothelial damage occurs before insulin resistance has been shown in offspring 
and relatives of insulin resistant people with impaired endothelial responses (Jörneskog et al., 
2005). Hypertension is commonly associated with both vascular impairment and insulin 
resistance, hence supporting the important role of the vasculature in insulin sensitivity. A rat 
model of metabolic syndrome and insulin resistance, with features of NAFLD is shown to have 
higher in vivo hepatic vascular resistance than control, with increased portal perfusion pressure 
and decreased endothelium-dependent vasodilation. This occurs before the development of 
fibrosis or inflammation (Pasarín et al., 2012).  
 
Many liver conditions associated with defenestration and other structural changes in the LSEC 
are also associated with insulin resistance. This has been ascribed to shunts, hepatocellular 
failure and reduced hepatic insulin clearance (Takamura et al., 2012). A study in a mouse 
transgenic model with partial loss of PDGF-beta function, which is responsible for the formation 
of pericytes showed increased permeability of the LSEC and increased fenestrations. This model 
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was also associated with a dramatic increase in insulin action in the liver, including increased 
insulin signaling, improved glucose tolerance test, increased insulin clearance and reduction in 
circulating insulin levels. Tsuchiya and Accili (2013) examined the effect of knockout of FoxO 
in mouse endothelium and found that standard chow–fed mice were glucose intolerant and had 
reduced insulin sensitivity. The defect in insulin action was identified as being in the liver.  
 
With regard to the effect of diabetes on the LSEC and hepatocytes, there are well described 
changes in the liver in both forms of diabetes mellitus. Diabetes mellitus results in a lipid 
accumulation in hepatocytes termed fatty liver or hepatosteatosis. Inflammatory cells can 
infiltrate into the liver causing non-alcoholic steatohepatitis (NASH) and this is associated with 
mild elevation in liver function tests including the transaminases and alkaline phosphatase 
(Kalyan et al., 2006). Diabetes is also characterised by a reduction in hepatic insulin sensitivity 
and decreased insulin mediated suppression of lipolysis in the liver (Marchesini et al., 2001). 
Excess free fatty acids that occur in diabetes have a toxic effect on hepatocytes, mitochondria 
and cell membrane (Kaplowitz, 2001). There is also an increase in pro-inflammatory cytokines 
in the insulin resistant state, such as tumour necrosis factor alpha (TNF-α) which probably 
contributes to hepatocellular injury (Zhang et al., 2009) 
 
The microvascular complications of diabetes mellitus has been well established in several organs 
(Singleton et al., 2003), but relatively few studies have reported on the effect of diabetes on liver 
microvasculature. Bernuau et al. (1982) studied liver biopsies of 12 insulin dependent diabetic 
patients and found that there is a moderate increase in collagen and basal lamina deposition in 
the SoD. Some subjects have fatty liver and increased perisinusoidal Masson trichrome staining. 
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Two other studies (Harrison et al., 2006, Latry et al., 1987) also reported an increase in 
deposition of collagen and basal lamina in human diabetic liver biopsy samples.  
 
Inaba et al. (1984) examined livers from diabetic patients and found that there was a thickening 
of endothelium, reduced SoD width and the proliferation of collagen fibres in the SoD. They also 
reported “obscure pores in the endothelium”, which are presumably fenestrations. However this 
is not quantified and the detection of fenestrations may be below the resolution of the techniques 
used. A retrospective study of T1DM and T2DM diabetic patients who had undergone liver 
biopsy has been carried out, reporting an extensive perisinusoidal fibrosis and deposition of basal 
lamina, termed as ‘diabetic hepatosclerosis’ (Harrison et al., 2006). 
 
In rats, streptozotocin-induced T1DM rats had increased fenestrations frequency and diameter 
after five weeks, followed by decreased frequency after 8 weeks, when defenestration is thought 
to be starting to develop (Jamieson et al., 1999, Jamieson et al., 2001). In diabetic baboons, 
marked changes in the fenestrations were observed including a decrease in the diameter and the 
frequency of the fenestrations, leading to a reduction in porosity (Jamieson et al., 2007a). There 
was also a thicker endothelium compared to control with increased extracellular matrix in the 
SoD. Fibrosis was observed with increased staining of Masson trichrome and collagen IV 
immunohistochemistry. This indicates that diabetes accelerated the age-related loss of 
fenestrations (Jamieson et al., 2007a).  
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1.5 Scope and aims of this thesis 
 
This chapter has focused on describing hepatic microvasculature and its major, but largely 
unrecognised, role in liver function. There is now clinical and experimental evidence of 
diminishing liver function with ageing, while ultrastructural changes have been described in 
ageing livers that provide a mechanism for these functional changes. Pseudocapillarisation of the 
hepatic sinusoidal endothelium creates a barrier to the transfer of lipoproteins and drugs from the 
sinusoidal lumen to the hepatocyte, a barrier that is not present in healthy and young livers. 
Recent findings have indicated an important role of fenestrations in insulin and glucose 
metabolism (Raines et al., 2011) which raises the possibility that age-related 
pseudocapillarisation might contribute to hepatic insulin resistance that is common in old age. 
 
The most consistent age-related change in glucose metabolism is insulin resistance, which is a 
significant risk factor for diabetes and vascular disease in older people. Although much research 
on hepatic glucose metabolism has focused on hepatocytes, the role of LSEC, particularly 
fenestrations has been largely overlooked. This thesis investigates the effect of ultrastructural 
changes in the ageing liver on insulin resistance. 
 
Chapter 3 examines the effect of age-related pseudocapillarisation on the development of insulin 
resistance. It is well established that ageing accelerates the development of insulin resistance. It 
was hypothesised that pseudocapillarisation leads to impaired hepatic disposition of insulin and 
glucose, leading to impaired systemic glucose homeostasis. To probe this hypothesis the 
experiments in this chapter examine insulin and glucose action in the liver of young and old mice 
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and rats in addition to glucose uptake in target tissues and gene and protein expression related to 
insulin signaling.  
 
Given the significant impact of ageing on insulin and glucose metabolism found in the 
experiments outlined in Chapter 3, the experiments carried out and presented in Chapter 4 were 
designed to investigate the impact on glucose and insulin transfer and action in the liver in the 
absence of other age-related changes. Chapter 4 investigates the effect of P407 induced 
defenestration on the development of insulin resistance. P407 is a surfactant that is known to 
selectively target the liver, causing acute and reversible defenestration with severe 
hyperlipidemia. Here we hypothesised that defenestration, in the absence of any concomitant 
ageing changes interferes with hepatic disposition of glucose and insulin in the liver, leading to 
impaired systemic glucose and insulin metabolism. Similar experimental techniques including 
MID, radiolabeled glucose tolerance test, scanning electron microscopy, real time PCR, 
immunoblotting and proteomic analysis were used in both Chapters 3 and 4. 
 
Chapter 4 focusses on the implications of loss of fenestrations induced by P407 on insulin action 
in the liver. Chapter 5 then investigates the mechanisms underlying the loss of fenestrations 
induced by P407. In vitro studies on fenestration modulation are pivotal in elucidating the exact 
mechanism of fenestration control. The sieve-raft theory states that membrane lipid rafts are 
associated with the regulation of fenestrations (Cogger et al., 2013a). To further confirm this, 
Chapter 5 investigates the relationship between membrane rafts and fenestrations using the 
potent defenestrating agent used in Chapter 4, P407, in both SKHep1 cells, a cell line of 
endothelial origin and isolated LSECs. It was hypothesised that P407 induces defenestration by 
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depleting non-raft region of the cell membrane. Scanning electron and light deconvolution 
microscopy were used to observe the interaction following P407 treatment.  
 
Finally, because fenestrations are known to adapt and change depending on their exposure to 
nutrients and other substances Chapter 6 examines the role of lifelong macronutrient and caloric 
intake on fenestrations and insulin and glucose metabolism. In this study, nutritional geometry 
was used to observe the effects of energy and macronutrients diets on fenestration morphology 
into older age. Liver biopsies and serum analysis were used to assess the impact of 
macronutrients and caloric intake on LSEC health at 15 months of age. 
 
The specific hypotheses are: 
1. Fenestrations in the LSEC influence the action of insulin in the liver, 
2. Age-related pseudocapillarisation of the LSEC contributes to insulin resistance in old 
age, 
3. Loss of fenestrations induced by P407 impairs insulin action in the liver, 
4. P407 influences fenestrations by its effects on lipid rafts, 
5. Dietary macronutrients influence fenestrations and the development of 
pseudocapillarisation in old age, with implications for age-related insulin resistance. 
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CHAPTER 2: METHODOLOGY 
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2.1 MULTIPLE INDICATOR DILUTION METHOD 
 
This method is also known as tracer dilution method and can be used to measure multiple 
parameters such as microvascular exchange, transport and metabolism in the liver (Goresky, 
1963, Goresky et al., 1973). This is the definitive method to assess the transfer of substrates such 
as insulin/glucose across the liver endothelium and hepatocellular membrane as described in 
mice and rats previously (Cogger et al., 2006, Hilmer et al., 2005, Mitchell et al., 2012).  
 
2.1.1 Liver perfusion  
 
Rats were weighed and then anaesthetised by an intraperitoneal (i.p.) injection of 2 ml/kg 
ketamine (60 mg/ml) and xylazine (6 mg/ml). A midline laparotomy incision was performed 
and the intestines pushed aside to reveal the portal vein. The portal vein was cannulated with an 
18 gauge intravenous cannula (Optiva K, Livingstone, Rosebery, Australia) and the thoracic 
inferior vena cava was cannulated with a 10 cm length of polyethylene tubing. A single pass 
perfusion was performed using Krebs-Henseleit bicarbonate buffer (10 mM glucose, saturated 
with 95 % O2/5 % CO2, 2 % bovine serum albumin at 37 ºC) and the perfusate flow rate was 
maintained at approximately 1 ml/minutes/g of liver using a peristaltic pump (Masterflex L/S, 
Cole-Palmer, Boronia Australia). Portal venous pressure was measured in centimetres of H2O 
according to a manometer connected to the inflow cannula of the portal vein. 
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2.1.2 Multiple indicator dilution  
 
This step involves 2 separate tracers: (1) 
3
H-sucrose and 
14
C-insulin; (2) 
3
H-sucrose and 
14
C-
glucose (American Radiolabeled Chemicals Inc, St. Louise USA) separately. In some 
experiments Evans Blue (Sigma Aldrich, Castle Hill Australia) was also added to the injectate. 
After administration of each injectate (100 µl in volume) through the portal vein, 60 outflow 
samples were collected using a universal fraction collector (Extech Equipment, Boronia, 
Australia) at two second intervals, followed by collection at 3 minutes and 5 minutes. Analysis 
for 
14
C and 
3
H specific activity in each outflow sample was performed using a liquid scintillation 
counter (Packard 1600TR, Australia) by adding 100 µl of outflow to 8 ml of scintillation fluid 
(UltimaGold, Perkin Elmer, Australia). Radioactivity was measured via disintegration per minute 
(DPM). A spectrophotometer (BMG Labtech FLUOstar optima microplate reader, Life 
Technologies, Wembley Australia) was used to quantify the concentration of Evans Blue in the 
outflow samples.  
 
2.1.3 Data analysis 
 
All outflow data collected was used to generate dose-normalised outflow curves. The hepatic 
outflow concentrations were expressed as a fraction of the injected dose per ml of outflow. The 
area under the curve (AUC) and area under the moment of the curve (AUMC) are calculated 
using the following equations: 
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*t is the sample collection time in seconds. 
 
The mean transit time (MTT) was estimated from the ratio of the AUMC and AUC using the 
following equation: 
 
The value was corrected for the catheter and non-exchanging vessel transit time (t0), which was 
estimated from the first appearance of radioactivity above the background levels (Goresky and 
Silverman, 1964). 
 
The volume of distribution (V) for each substrate was determined from the MTT and the flow 
rate (Q) using the following equation: 
 
Hepatic extraction (E) and substrate recovery (R) from the experiment were determined from the 
AUC and flow rate (Q) by the following calculation: 
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2.2 LSEC ISOLATION 
 
2.2.1 Liver perfusion and digestion 
 
LSEC were isolated by perfusing the liver with Collagenase I (Roche, Basel, Switzerland), 
followed by removal of non-parenchymal cells and Kupffer cells as described previously 
(Svistounov et al., 2012). Rats were anaesthetised by an intraperitoneal (i.p.) injection of 2 
ml/kg ketamine (60 mg/ml) and xylazine (6 mg/ml). After laparotomy, the portal vein was 
cannulated with an 18 gauge cannula (Optiva K, Livingstone, Rosebery, Australia). Krebs-
Henseleit bicarbonate buffer (10 mM glucose, saturated with 95 % O2/5 % CO2, 2 % bovine 
serum albumin at 37 ºC) was perfused through the liver at a steady flow rate to remove the 
blood from the sinusoids. Livers were perfused with 100 ml collagenase (0.05 % 
collagenase in PBS) at approximately 5 ml per minutes or until the liver became soft. The 
liver was then carefully removed and placed in a sterile petri dish with perfusion buffer. 
Glisson’s capsule and major vessels were removed using sterile forceps, with subsequent 
gentle mincing of the liver into a paste. The cell suspension was filtered through a cell strainer 
(BD Biosciences, North Ryde, Australia) to remove any undigested tissue then centrifuged in a 
falcon tube at 100 g for 5 minutes at 20 ºC sedimenting most of the hepatocytes into a pellet at 
the bottom of the tube.  
 
 
 
62 
 
2.2.2 Cell isolation and culture 
 
The supernatant (containing a mixture of sinusoidal liver cells) was removed and centrifuged at 
350 g for 10 minutes, sedimenting LSECs into a pellet. The pellet was then resuspended in 
50 ml PBS and centrifuged for 10 minutes at 350 g. The resulting pellet was resuspended in 20 
ml PBS. Two 2-step Percoll gradients were made with 15 ml 50 % stock Percoll (in PBS) on 
the bottom layer, and 20 ml 25 % stock Percoll (in PBS) (Sigma Aldrich, Castle Hill Australia)  
on the layer above. 10 ml of the cell suspension was carefully added on top of each of the 
Percoll gradients and centrifuged for 30 minutes at 900 g. The resulting intermediate zone 
enriched in LSECs was carefully removed and diluted with an equal volume of PBS, then 
centrifuged again at 900 g for 10 minutes. The pellet was resuspended in 10 ml complete 
RPMI-1640 medium (Gibco Grand Island, NY). The cell suspension was then pipetted into 
uncoated sterile dishes and incubated for 10 minutes (37 ºC, 5 % CO2) to allow the selective 
attachment of Kupffer cells to plastic wells, enhancing LSEC purity. LSECs were then collected 
by firmly washing the dishes with complete RPMI-1640 to maximise the yield. After automated 
cell counting (Biorad, Gladesville, Australia), LSECs were cultivated at 1.0 × 10
6 
cells per ml in 
24-multiwell plates and on collagen-coated Thermanox coverslips for scanning electron 
microscopy. LSECs were cultured for 3 hours (37 ºC/5 % CO2) in 1 ml complete RPMI-1640 
per well/coverslip. Cells were rinsed in warm PBS prior to treatment. 
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2.3 ELECTRON MICROSCOPY 
 
The scanning electron microscope (SEM) has a resolving power of 2.5 nm and provides a three 
dimensional surface image of a specimen such as a cell or block of hepatic tissue. A focused 
electron beam is scanned across the surface of a prepared specimen under a vacuum. 
Morphological detail is collected as the electrons hit the specimen surface causing secondary 
electrons to be released from the specimen (inelastic collisions) and then collected by a detector. 
An image of the specimen is created according to the secondary electrons’ energy, number, and 
angle of their path. The image is then sent to a computer screen for viewing (Slayter, 1992). 
 
2.3.1 Tissue fixation 
 
To view the integrity of the liver endothelium in the animal models used, livers were prepared 
for scanning electron microscopy. At the completion of the multiple indicator dilution 
experiments, the livers were perfused-fixed via the portal vein with 2.5 % glutaraldehyde (EM 
grade)/2 % formaldehyde in sodium cacodylate buffer (0.1 M sodium cacodylate, 10 mM 
CaCl2, 1 % sucrose, pH 7.4, 440 mOsmol) as described previously (Cogger et al., 2006). 
Fixative was perfused through the liver continuously for approximately 5 minutes or until the 
liver was hardened, indicated by both pale colouration and tissue stiffness. Following fixation, 
the liver was excised and cut into 1 mm
3
 blocks. These blocks were placed in a specimen jar with 
fresh fixative and left overnight at 4 
o
C prior to subsequent processing.  
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2.3.2 Tissue preparation and processing 
 
Ten randomly selected blocks per liver were washed 3 times in 0.1 M sodium cacodylate buffer 
to remove any traces of fixative before incubation in 1 % tannic acid in 0.15 M sodium 
cacodylate buffer with 1 % sucrose for 1 hour. Blocks were then washed 3 times in sodium 
cacodylate buffer and post-fixed in 1 % osmium tetroxide in 0.1 M sodium cacodylate buffer 
(pH 7.4 with 1 % sucrose for 2 hours). The benefit of this step is twofold - osmium tetroxide 
provides superior lipid fixation to aldehyde fixatives and it saturates the tissue with heavy metal 
for better interaction with the electron beam. Following incubation, specimens were washed 3 
× 10 minutes each in sodium cacodylate buffer and then dehydrated in a series of increasing 
ethanol gradients: 3 × 50 % (5 minutes each), 3 × 70 % (5 minutes each), 3 × 95 % (5 minutes 
each), 2 × 100 % (10 minutes each) ethanol and finally 2 × 100 % ethanol (molecular sieve, 10 
minutes each). Specimens were treated with hexamethyldisilazane (Sigma Aldrich, Castle Hill 
Australia) for 10 minutes for complete drying of the tissue. Specimens were left in the fume 
hood for 10 minutes to remove remaining hexamethyldisilazane and placed in a desiccator 
overnight. Specimen blocks were then mounted onto SEM stubs using double sided carbon tape, 
and platinum coated with an autofine coater (JFC 1600, JEOL, Akishima-Shi, Japan), under 
argon (45 secs at 40 mV).  
 
2.3.3 Tissue visualisation 
 
Images of the sinusoidal endothelium were observed at 15000 × magnification for visualization 
of fenestrations. Fig. 2.1 shows an example LSEC image with fenestrations. Ten random images 
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were taken for analysis using ImageJ software (http://rsb.info.nih.gov/ij/) to determine 
endothelial porosity, average fenestration diameter and frequency. Endothelial porosity (area of 
the endothelial surface covered with fenestrations) is calculated by dividing the total area of the 
individual fenestrations in the selected field divided by the total area of the field examined. 
Fenestration frequency is the total number of fenestrations in the total area of the field examined 
(Cogger et al., 2014).  
 
 
 
Figure 2.1: An example of image of the fenestrated LSEC taken using JEOL JSM-6380 
scanning electron microscope for porosity analysis 
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2.4 LIGHT MICROSCOPY 
 
Light microscopy was performed to ensure overall tissue integrity and the absence of liver 
pathologies in all animals used for the experiments contained in this thesis. 
 
2.4.1 Tissue fixation and preparation 
 
At the completion of each experiment, pieces of liver were fixed in 4 % paraformaldehyde 
buffered saline overnight, dehydrated with ethanol, cleared in xylene and finally embedded in 
paraffin for light microscopy. Paraffin embedded liver specimens were cut at 4 µm, mounted 
on glass slides, then subjected to the staining technique of interest as discussed below. 
 
2.4.2 Tissue staining 
 
For staining slide mounted sections were cleared of paraffin and rehydrated to allow affinity for 
specific dyes. Following staining, they were again dehydrated with ethanol and cleared with 
xylene before mounted with mounting media (Pertex, Histolab AB, Canning Vale Australia). 2 
stains were used in the experiments as follows: 
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Hematoxylin and eosin 
 
Hematoxylin and eosin (H & E) is a stain routinely used to view the general pathology of the 
specimen. Hematoxylin stains cell nuclei (chromatin) blue, and eosin stains the cytoplasm and 
connective tissues different shades of pink, orange, and red, and red blood cells intensely red. 
 
Periodic acid-Schiff 
 
The periodic acid-Schiff (PAS) reaction is used to visualise glycogen, basement membranes, 
and neutral mucosubstances. Oxidation with periodic acid exposes the aldehyde groups in 
sugars that subsequently react with the chromophores in Schiff’s reagent, producing a bright 
pink colour. A basic stain such as Harris’ Hematoxylin is used as a counterstain to stain the cells 
blue. 
 
2.4.3 Tissue observation 
 
Once mounting media had completely dried, slides were viewed using EVOS FL Imaging system 
(Life Technologies, Wembley Australia) using bright field illumination. Pictures were taken at 
40 × magnification.  
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2.5 FLUORESCENCE MICROSCOPY 
 
Fluorescent labelling was used to visualise cell membranes and lipid rafts (Cogger et al., 2010, 
Svistounov et al., 2012). It is not able to be used to assess fenestrations because there are no 
fluorescent markers of fenestrations, and the pores are too small to be resolved by standard light 
microscopy. 
 
2.5.1 Cell fixation 
 
Following culture and treatment, cells were washed with PBS and fixed in 4 % 
paraformaldehyde buffered saline for 2 hours and then kept in PBS prior to staining.  
  
2.5.2 Cell staining and observation 
 
Cells on coverslips were stained with Cell-Mask Orange (Life Technologies, Wembley 
Australia), a non-specific cell membrane stain (554/567 nm), and Bodipy FL C5 ganglioside 
GM1 (505/511 nm) (Life Technologies, Wembley Australia) which stains ordered lipid 
microdomains of membranes, also known as lipid rafts. Cells were washed and fixed with 4 % 
fresh paraformaldehyde in PBS. The coverslip were mounted using Prolonged-Gold (Life 
Technologies, Wembley Australia) to preserve fluorescent signal. The cells were then imaged 
with red and green channels predetermined for each staining and convolved using Zeiss Wide-
field fluorescence deconvolution microscope/Sen Software package. Experiments were 
performed in triplicate. 
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2.6 PROTEIN ANALYSIS 
 
Levels of proteins and phosphorylated proteins associated with insulin signaling pathways was 
assessed using mass spectrometry performed at the Charles Perkins Centre by the laboratory of 
Professor David James and western blotting.  
 
2.6.1 Proteomic analysis via mass spectrophotometry 
 
Rat liver tissue was collected following the MID procedure was solubilised in SDS/Tris buffer in 
the presence of phosphatase and kinase inhibitors prior to protein precipitation. Following tryptic 
digestion, 250 µg of peptide was labelled with one of four isobaric tags (iTRAQ, Sciex) prior to 
phosphoproteomic enrichment (Jensen et al., 2009, Engholm-Keller et al., 2012). This 
enrichment generated three peptide populations, singly and multiply phosphorylated peptides (11 
fractions); and non-modified peptides (16 fractions). Identification and quantitation of 
phosphorylated and non-phosphorylated peptides was performed on an Orbitrap Velos Pro mass 
spectrometer in data dependent acquisition (DDA) mode. All experiments were performed in 
duplicate. Data was analysed using Proteome Discoverer (Version 1.4; Thermo) and searched 
using an in-house MASCOT server against the UniProt mus musculus database with the 
following parameters; 2 missed cleavages; 20 ppm mass error (MS) and 0.2 Da mass error 
(MS/MS); iTRAQ searched as a static modification; carbamidomethyl (Cys), oxidation (Met), 
acetylation (Protein N-term) and cyclization (Glu and Asp) as dynamic modifications. A false 
discovery rate of 0.05 was applied to phosphopeptides, with a stricter 0.01 FDR applied to the 
non-modified cohort. For analysis of MS data, normalization of iTRAQ reporter ions was 
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calculated using the sum all intensities approach combining both phosphorylated and non-
phosphorylated peptide spectral matches (PSM), prior to ratio calculations using young as the 
denominator for old. Log2 ratios and z-scores were calculated for each PSM, with z-scores 
determined using a sliding scale based on MS signal intensity (a measure of MS/MS data 
quality). Median z-scores were calculated with weighted average used to compare medians 
across experiments for each phosphosite (phosphoproteome enriched), peptide and protein (non-
phosphorylated only). To be deemed significantly altered, median z-scores were required to be 
greater than 1.00 or less than -1.00 for phosphosites. Median z-scores for each non-
phosphorylated peptide were calculated preceding determination of protein z-scores. For a 
protein to be deemed significantly altered, median z-scores >1.96 or <-1.96, equivalent to p 
values of <0.05 were required. Bioinformatic analysis was performed to reveal pathways 
associated with ageing using STRING (Jensen et al., 2009, Franceschini et al., 2013, Szklarczyk 
et al., 2011) and KEGG (Kanehisa and Goto, 2000, Kanehisa et al., 2014) pathway analysis.  
 
2.6.2 Western blotting 
 
Protein immunoblotting is a method used to measure relative amounts of proteins of interest 
between samples. Frozen liver tissue samples collected after the MID procedure were 
homogenised (Qiagen TissueLyser, Chadstone Australia) in RIPA buffer containing Tris-HCl, 
NaCl, Triton x-100, Na-deoxycholate, SDS (Sigma Aldrich, Castle Hill Australia) and protease 
inhibitor tablets (cOmplete, EDTA-free Protease Inhibitor Cocktail, Roche, Castle Hill 
Australia). Protein concentrations were determined using the BCA method (Pierce BCA Protein 
Assay Kit, Thermo Scientific, Scoresby Australia). 20 µg of protein was separated on 4-15 % 
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gradient mini-protean TGX gels (Bio-Rad, Gladesville Australia) and transferred to a 
nitrocellulose membrane (Trans-Blot Turbo, BioRad, Gladesville Australia). The membranes 
were blocked for 1 hour (5 % skim milk in TBS), washed in TBS 0.1 % Tween-20 and incubated 
overnight in primary antibody solution (5 % BSA, TBS 0.1 % Tween 20). Washed membranes 
were incubated for one hour in secondary antibody solution (5 % skim milk in TBS 0.1 % 
Tween, 0.01 % SDS). Probed membranes were analysed on a Licor odyssey system (Millenium 
Science, Mulgrave Australia) and densitometry analysis was measured using Licor software 
(Version 3.1).  
 
Antibodies against the following proteins were used: phospho-IRS-1 (Ser612, Cat#2386), IRS-1 
(Cat#2382), phospho-AKT (Ser473, Cat#9271), AKT (Cat#4691), and α-tubulin as 
housekeeping protein (Cat#2144) (Cell Signaling Technology, Arundel, Australia).  
 
2.7 METABOLIC VARIABLES 
 
2.7.1 Blood analysis 
 
Prior to liver perfusion, approximately 1 ml blood was taken from the inferior vena cava (IVC) 
and transferred into an EDTA tube. Blood was spun at 1500 rpm for 10 minutes at 4 
o
C. The 
plasma was transferred into a clean tube and stored at -20 ˚C. Analysis of lipid and liver function 
tests was performed by the Biochemistry Department, Diagnostic Pathology Unit, Concord RG 
Hospital, using the automated Roche Diagnostics Modular Analytics Serum Work Area (F. 
Hoffman-La Roche Ltd, Hawthorn Australia).  
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2.7.2 Glucose tolerance and tracer uptake  
 
This method was performed as described previously with modifications (Cooney et al., 2004). 
Animals were fasted for 6 hours, followed by administration of glucose (2 g/kg i.v.) spiked with 
10 µCi 
14
C-glucose for assessment of insulin storage action in liver, fat and muscle and 10 µCi 
3
H-2-deoxyglucose for assessment of glucose uptake in fat and muscle. This procedure was done 
under anaesthesia for rats and using restrainer for mice. It should be noted that 
3
H 2-
deoxyglucose is not a substrate for liver uptake and metabolism. After 15, 30, 45, 60 and 90 
minutes, glucose levels were measured with a handheld glucose meter (Accu-Check Performa, 
Roche, Hawthorn Australia). At 90 minutes, animals were sacrificed and liver, adipose tissue and 
quadriceps muscle were excised, weighed and either snap frozen in liquid nitrogen or placed in 4 
% phosphate buffered paraformaldehyde, dehydrated and embedded in paraffin for histology. 
Blood was collected at 0 (fasted) and 90 minutes (fed) to determine insulin levels (Rat 
Ultrasensitive Insulin ELISA, Alpco Diagnostics, Kurnell Australia), c-peptide levels (Rat C-
peptide ELISA, Alpco Diagnostics, Kurnell Australia) and glucagon levels (Sigma Aldrich, 
Castle Hill , Australia). This procedure was done under anaesthesia for rats and using restrainer 
for mice. 
 
2.7.3 Insulin uptake 
 
Whole body insulin extraction was performed in another batch of rats, where 
14
C-insulin (1 
µCi/g) was injected via the inferior vena cava of anesthetised animals. Five minutes later the 
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animals were exsanguinated by cardiac puncture and in addition to the blood, the liver, white 
adipose tissue (WAT) and muscle tissue were collected for measurement of 
14
C-insulin.  
 
2.7.4 Tissue processing for tracer uptake 
 
To determine the incorporation of 
14
C-labelled glucose to glycogen, liver, muscle and adipose 
tissue were digested in potassium hydroxide (KOH) (Sigma Aldrich, Castle Hill , Australia) at 70 
ºC, followed by addition of saturated NaSO4 (Sigma Aldrich, Castle Hill , Australia) and 
precipitated with 95 % ethanol for liquid scintillation counting. The amount of 
14
C glucose 
incorporated into glycogen was calculated by correcting for the area under the curve for 
14
C-
glucose during GTT and for the weight of the tissue sample used. Tissue 
3
H-2-deoxyglucose 
uptake was determined by homogenizing in 0.5 % perchloric acid (PCA) (Sigma Aldrich, Castle 
Hill, Australia) and homogenates were centrifuged and neutralised with KOH. One aliquot was 
counted directly to determine total radioactivity
 
(
3
H-2-deoxyglucose and 
3
H-2-deoxyglucose-6-
phosphate). A second aliquot was treated with barium hydroxide (BaOH) and zinc sulfate 
(ZnSO4) (Sigma Aldrich, Castle Hill , Australia) to remove 
3
H-2-deoxyglucose-6-phosphate and 
any tracer incorporated into glycogen, and then was counted to determine 
3
H-2-deoxyglucose 
radioactivity. Total 
3
H-2-deoxyglucose-6-phosphate is the difference between the two aliquots 
and normalised to tissue weight. Blood samples were deproteinised using BaOH and ZnSO4 to 
quantify plasma radioactivity by liquid scintillation counting. Tissue specific glucose uptake 
index, Rg was calculated using the following equation: 
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2.7.5 Insulin tolerance 
 
Insulin tolerance tests were performed after a 3 hours fast. Insulin (1.5 IU kg
-1
 body weight) 
(Sigma Aldrich, Castle Hill , Australia) was administered via i.p. injection and blood glucose 
levels were read using a handheld glucose meter (Accu-Check Performa, Roche, Hawthorn 
Australia) through tail bleeds at 0, 15, 30, 60 and 90 minutes.  
 
2.7.6 Pyruvate tolerance 
 
Animals were fasted for 6 hours prior to an i.p injection of pyruvate (2 g/kg; Sigma Aldrich, 
Castle Hill, Australia) and glucose levels were read using a handheld glucose meter (Accu-Check 
Performa, Roche, Hawthorn Australia) through tail bleeds at 0, 15, 30, 60 and 90 minutes. Total 
AUC was calculated using the trapezoidal formula. 
 
2.8 REVERSE TRANSCRIPTION AND QUALITATIVE REAL TIME PCR ARRAY 
ANALYSIS 
 
Total RNA was isolated from frozen liver tissue samples using RNeasy Plus Mini Kit (Qiagen 
Pty Ltd, Chadstone, Australia) according to the manufacturer’s instruction, with DNase treatment 
included. RNA quantification was performed using a Nanodrop  (Thermofischer, Wilmington, 
DE, USA) and samples with OD>2.0 were selected for subsequent step. Reverse transcription of 
1 µg of total RNA was carried out using RT
2
 First strand kit (Qiagen Pty Ltd, Chadstone, 
Australia). The cDNA was then added to the RT
2
 SYBR green qPCR mastermix, loaded onto 96-
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well RT
2
 Profiler PCR array plate (PARN-030-ZD, Qiagen Pty Ltd, Chadstone, Australia) and 
amplified on Biorad CFX Connect Real Time PCR Detection system (Roche Diagnostics, 
Hawthorn Australia) for 40 cycles. PCR array data was analysed according to the manufacturer’s 
instructions. Relative gene expression was determined using the ∆∆Ct method normalised against 
five housekeeping genes (Actb, B2m, Hprt1, Ldha and Rplp1) and changes in gene expression 
were shown as a fold increase or decrease compared to control group.  
 
2.9 STATISTICAL ANALYSIS  
 
All statistical analysis was performed using SigmaStat Statistics Software (Sigmaplot v12.5, 
Systat Software, Germany) unless specifically stated. Data are presented as the mean ± standard 
error of the mean (SEM). Statistical significance for the differences between two groups (e.g. 
young and old) was calculated using two-tailed Students T test. Correlations between two 
measures were calculated using the Pearsons Product Moment correlation coefficient. Statistical 
significance was assumed at p<0.05. 
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CHAPTER 3: AGE-RELATED DEFENESTRATION AND HEPATIC INSULIN AND 
GLUCOSE DISPOSITION 
 
Chapters 3 and 4 have been combined for the following publication: 
Mohamad, M., S. J. Mitchell, L. E. Wu, M. Y. White, S. J. Cordwell, J. Mach, S. M. Solon-Biet, 
D. Boyer, D. Nines, A. Das, S. Y. Catherine Li, A. Warren, S. N. Hilmer, R. Fraser, D. A. 
Sinclair, S. J. Simpson, R. de Cabo, D. G. Le Couteur and V. C. Cogger (2016). "Ultrastructure 
of the liver microcirculation influences hepatic and systemic insulin activity and provides a 
mechanism for age-related insulin resistance." Aging Cell 15(4): 706-715. 
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3.1 INTRODUCTION 
 
Insulin resistance, characterised by elevated basal and stimulated levels of insulin, is inextricably 
associated with older age (Fink et al., 1983, Oya et al., 2014). The liver is the key target organ 
for insulin activity and under normal physiological conditions the entire output of endogenous 
insulin from the pancreas travels through the liver vasculature before entering the systemic 
circulation (Izzo and Bartlett, 1969). Once it has entered the liver parenchyma, most likely 
through the liver sinusoidal endothelial cells (LSEC) fenestrations, insulin regulates a myriad of 
metabolic processes such as glycogen storage, gluconeogenesis and fatty acid synthesis. The 
primary role of the liver in the development of insulin resistance is demonstrated by the fact that 
insulin resistance occurs in liver-specific insulin receptor knockout mice (Fisher and Kahn, 
2003), but not in muscle-(Brüning et al., 1998) or fat-(Bluher et al., 2002) specific insulin 
receptor knockout mice. Further evidence comes from the observation that glucose intolerance 
that occurs during the early stages of high fat feeding is due to the development of insulin 
resistance in the liver before other tissues develop metabolic changes (Turner et al., 2013). 
Hyperinsulinemia and insulin resistance are common conditions associated with altered liver 
function, particularly those associated with structural changes in the liver endothelium such as 
old age and liver disease (Chai et al., 2014, Kotronen et al., 2007, Takamura et al., 2012, 
Kawaguchi et al., 2011, Fink et al., 1983, Bose and Ray, 2014, Taguchi et al., 2014, Muller et al., 
1992). 
 
The transfer of insulin across the endothelium is the rate limiting step for the uptake and action 
of insulin in muscle and fat (Majumdar et al., 2012, Sandqvist et al., 2011). Despite its important 
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impact on the disposition of many other substrates, the effect of the endothelium on insulin 
activity in the liver has largely been overlooked (Fraser et al., 1995, Cogger et al., 2006, Cogger 
and Le Couteur, 2009). As discussed in Chapter 1, the main endothelial cells in the liver are the 
LSECs, which are specialised endothelial cells that line the wall of the hepatic sinusoid. The thin 
cytoplasmic extensions of LSECs are perforated with fenestrations that are non-diaphragmed, 
transcellular pores 50-150 nm in diameter. Between 2-20% of the surface of the LSECs are 
covered by fenestrations clustered into groups called liver sieve plates (Cogger and Le Couteur, 
2009, Fraser et al., 1995, Wisse et al., 1985). These ultrastructural features facilitate transfer of 
plasma and small particulate substrates between the blood and the hepatocytes. Under normal 
conditions, LSECs are a highly efficient ultrafiltration system; therefore the influence of 
fenestrations on liver function is mostly seen in diseases and old age where their diameter and 
frequency are diminished (Cogger and Le Couteur, 2009, Cogger et al., 2006, Fraser et al., 
2012).We propose that fenestrations also provide a portal for the hepatic uptake, and subsequent 
clearance and activity of insulin, and that the loss of fenestrations, such as that which occurs with 
old age, provides a novel mechanism for hepatic insulin resistance. Such a discovery would have 
considerable clinical significance as it provides a novel mechanism for the insulin resistance seen 
in ageing and with liver diseases where there is a reduction in fenestrations (Le Couteur et al., 
2001, Cogger et al., 2006, Furrer et al., 2011). 
 
In this study the role of age-related pseudocapillarisation in hepatic insulin resistance has been 
examined; in particular the effects of loss of fenestrations on the disposition and activity of 
insulin in the liver and systemically. Defenestration seen in old age has been shown to impair the 
transendothelial transfer and hepatic clearance of several substrates including lipoproteins, 
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acetaminophen and diazepam (Cogger et al., 2006, Mitchell et al., 2010, Mitchell et al., 2012, 
Mitchell et al., 2011). Therefore, the aim of this study was to investigate the role of LSEC 
fenestrations in the hepatic disposition and action of insulin.  
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3.2 METHODS 
 
3.2.1 Animals 
 
Male Fischer 344 rats (for MID methodologies) and male C57/Bl6 mice (for metabolic 
parameter assessments) aged 3 months (young) and 24-27 months (old) were obtained from the 
National Institutes of Ageing (Baltimore, MD). Due to limited availability of older rats and the 
technical limitations of the liver perfusion studies are, rats were prioritised for the MID studies 
and mice were used for the remaining in vivo studies. The animals were allowed free access to 
water and standard chow. All animals were treated in accordance with Animal Care guidelines. 
This study was approved by the Animal Care and Users Committee of the National Institute on 
Ageing, National Institutes of Health (protocol number: 429-TGB-2017).  
 
3.2.2 Liver perfusion and multiple indicator dilution method 
 
This procedure was performed as described in Sections 2.3.2 and 2.3.3. Briefly the young and 
old F344 rats were weighed and anaesthetised and liver was perfused with Krebs buffer followed 
by a tracer injectates of either: (1) 
3
H-sucrose and 
14
C-insulin or (2) 
3
H-sucrose and 
14
C-glucose. 
Analysis for 
14
C and 
3
H specific activity from outflow samples was performed in a Packard 
1600TR liquid scintillation counter and data were used to generate dose-normalised outflow 
curves. The area under the curve (AUC), area under the moment of the curve (AUMC), mean 
transit time (MTT) and recovery of each indicator were determined. 
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3.2.3 Scanning electron microscopy 
 
At the completion of MID experiments, liver specimens were perfusion-fixed with 3 % 
glutaraldehyde/2 % paraformaldehyde in 0.1 M sodium cacodylate buffer and processed for 
scanning electron microscopy as described in Section 2.4.5. Fenestrations of the liver 
endothelium were examined using a Jeol 6380 Scanning electron microscope at 15000X 
magnification. Ten random images of sinusoids per sample were taken for each liver at 15000X 
for analysis of fenestration diameter and porosity using ImageJ software (1.41 NIH, USA) as 
described in Section 2.4.5.4. 
 
3.2.4 Metabolic parameters 
 
3.2.4.1 Glucose tolerance and tracer uptake 
 
Young and old C57/Bl6 mice were fasted for 6 hrs, followed by administration of glucose (2 
g/kg i.v.) spiked with 10 µCi 
14
C-glucose for assessment of insulin action in liver, fat and muscle 
and 10 µCi 
3
H-2-deoxyglucose for assessment of glucose uptake in fat and muscle as described 
in Section 2.6.2. 
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3.2.4.2 Insulin uptake 
 
Whole body insulin extraction was performed in another group of young and old mice, where 
14
C-insulin (1 µCi/g) was injected via the inferior vena cava of anesthetised animals as described 
in Section 2.6.3.  
 
3.2.4.3 Tissue processing for tracer uptake 
 
Incorporation of radiolabelled glucose to glycogen, 
3
H-2-deoxyglucose uptake and 
14
C-insulin 
uptake were determined using the mice liver from Sections 3.2.4.1 and 3.2.4.2 according to 
methods as described in Section 2.6.4.  
 
3.2.4.4 Insulin tolerance 
 
Young and old C57/Bl6 mice were fasted for 3 hrs followed by insulin injection (1.5 IU/kg i.p.) 
and glucose levels were read using a handheld glucose meter as described in Section 2.6.5.  
 
3.2.4.5 Pyruvate tolerance 
 
A fourth cohort of young and old C57/Bl6 mice were fasted for 6 hours prior to an i.p injection 
of pyruvate (2 g/kg; Sigma Aldrich) and glucose levels were read using a handheld glucose 
meter as described in Section 2.6.6.  
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3.2.5 Histology 
 
Liver tissue from mice described in Section 3.2.4.1 was fixed in 4% paraformaldehyde, paraffin 
embedded, sectioned and subjected to H&E and PAS staining, followed by observation as 
described in Section 2.3.2. 
 
3.2.6 Reverse transcription and quantitative real time-PCR array analysis 
 
Total RNA was isolated from frozen rat liver tissue samples using a RNeasy Plus Mini Kit 
(Qiagen Pty Ltd, Chadstone, Australia), followed by subsequent reverse transcription and real 
time-PCR as described in Section 2.8.  
 
3.2.7 Proteomic studies 
 
3.2.7.1 Mass Spectrometry 
 
This procedure was performed as described in Sections 2.6.1. Briefly rat liver tissue from the 
MID procedure was solubilised in SDS/Tris buffer in the presence of phosphatase and kinase 
inhibitors prior to protein precipitation. Following tryptic digestion, 250 µg of peptide was 
labeled with one of four isobaric tags (iTRAQ, Sciex) prior to phosphoproteomic enrichment 
(Jensen et al., 2009, Engholm-Keller et al., 2012). Identification and quantitation of 
phosphorylated and non-phosphorylated peptides was performed on an Orbitrap Velos Pro mass 
spectrometer in data dependent acquisition (DDA) mode. All experiments were performed in 
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duplicate. Data was analysed using Proteome Discoverer (Version 1.4; Thermo) and searched 
using an in-house MASCOT server against the UniProt mus musculus database, which is the 
closest one to rat available.  For analysis of MS data, normalization of iTRAQ reporter ions was 
calculated using the sum all intensities approach combining both phosphorylated and non-
phosphorylated peptide spectral matches (PSM), prior to ratio calculations using young as the 
denominator for old. Bioinformatic analysis was performed to reveal pathways associated with 
ageing using STRING (Jensen et al., 2009, Franceschini et al., 2013, Szklarczyk et al., 2011) and 
KEGG (Kanehisa and Goto, 2000, Kanehisa et al., 2014) pathway analysis.  
 
3.2.7.2 Western Blots 
 
This procedure was performed as described in Sections 2.6.1. Briefly frozen liver tissue samples 
collected after the MID procedure were homogenised in RIPA buffer containing Tris-HCl, NaCl, 
Triton X-100, Na-deoxycholate, SDS (Sigma Aldrich) and protease inhibitor tablets. Protein 
concentrations were determined using the BCA method (Pierce BCA Protein Assay Kit, Thermo 
Scientific). The protein extract were subjected to immunoblotting according to protocol as 
described previously (Hoehn et al., 2008). Antibodies against the following proteins were used: 
phospho-AKT (Ser473, Cat#9271), AKT (Cat#4691) and α-tubulin (Cat#2144) (Cell Signaling 
Technology, Arundel, Australia).  
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3.2.8 Data analysis 
 
Data analysis was performed using Microsoft Excel. All values are expressed as the mean ± 
SEM. Statistical significance was calculated using two-tailed Students T-test and Pearson’s 
Product Moment correlation coefficient (Sigmaplot v11, Systat Software, Germany). 
 
86 
 
3.3 RESULTS 
 
3.3.1 Histology and Electron Microscopy 
 
Post mortem examination of the whole animal and haematoxylin and eosin staining of liver 
sections from the old and young animals confirmed all animals included in the study were free of 
gross and liver pathology (Fig. 3.1). 
 
Figure 3.1: Haematoxylin and Eosin staining of young (a) and old (b) Fischer F344 rats. No 
signs of pathology were found in both liver groups. 
 
Scanning electron microscopy (Fig. 3.2) was performed to confirm age-related defenestration of 
the LSEC that has been described previously in many species including rats, mice and humans. 
LSEC morphology was analysed as described in Table 3.1 and an age-related reduction in 
porosity was found. These findings are consistent with previous studies (Le Couteur et al., 2001, 
Le Couteur et al., 2008a). 
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Figure 3.2: Representative Scanning electron micrographs of the perfused LSEC in young (a) 
and old (b) Fischer F344 rats. Fenestrations are indicated by an *. Significant defenestration is 
observed with age. Original micrographs taken at 15000 × magnification. 
 
Table 3.1: Quantification of the fenestrations in LSECs. There is a significant decrease in liver 
porosity (P=0.006), but no change in the fenestration diameter in the old group. Data is presented 
as mean ± SEM. 
 
Animal group n Porosity (%) Diameter (nm) Frequency 
(per um
2
) 
Young 5 4.88±0.5 96.4±0.6 4.72±0.4 
Old 5 2.64±0.2* 73.2±0.4 4.03±0.2 
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3.3.2 Age-related pseudocapillarisation impairs the access of insulin, but not glucose to the 
extracellular space of the liver 
 
To establish a causal relationship between age, age-related defenestration of the liver 
endothelium and insulin resistance, MIDs were performed in young and old rats. Outflow insulin 
curves from the MID experiments are shown in Fig. 3.3.  
 
Figure 3.3: MID outflow curves for insulin and the extracellular marker sucrose (n=9 young and 
n=9 old). Insulin exits the liver after sucrose in young rats (a) whereas the order is reversed in the 
old animals (b) indicating restricted access to the entire extracellular space with age-related 
defenestration. 
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In young animals, the insulin curve overlaps the sucrose curve (Fig 3.3a), indicating that insulin 
has unimpeded access to the entire extracellular (‘sucrose’) space. However in old animals, the 
insulin curve appears earlier than the sucrose curve (Fig 3.3b), indicating that insulin has a 
smaller volume of distribution than sucrose. The recovery and apparent volume of distribution of 
insulin and tracers are shown in Table 3.2. There was no difference in the recovery of Evans 
Blue or sucrose between the age groups.  
 
Table 3.2: The effect of age on recovery and volume of distribution (Vd) of Evans blue, insulin 
and sucrose. 
 
 
  Young (n=9) Old (n=9) 
Fractional recovery   
Evans blue 0.97±0.03 0.88±0.06 
Insulin 0.68±0.05 0.68±0.06 
Sucrose 0.73±0.05 0.76±0.05 
Vd (ml/g)   
Evans blue 0.26±0.04 0.28±0.02 
Insulin 0.28±0.04 0.28±0.01 
Sucrose 0.26±0.04 0.30±0.02 
Ratio   
Insulin/Evans blue 1.09±0.08 1.03±0.04 
Insulin/Sucrose 1.10±0.07 0.95±0.02 
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Analysis of the curves showed that old age was associated with a statistically significant 
reduction in the volume of distribution of insulin normalised to the extracellular marker sucrose 
volume of about 20 % (P=0.01, Fig. 3.4). 
 
 
Figure 3.4: Volume of distribution of insulin as a percentage of extracellular volume. There is a 
20 % reduction in the fractional volume of distribution of insulin with age (n = 9 young and 9 old 
F344 rats, P=0.01). 
 
Contrary to insulin, there was no difference in the appearance of the glucose and sucrose curves 
for young and old, indicating a similar distribution (Fig 3.5a-b). Analysis of the curves for 
recovery and volume of distribution are shown in Table 3.3. There was no difference in the 
recovery of Evans Blue, glucose or sucrose between both groups. The ratio of volume of 
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distribution of glucose compared to Evans Blue and sucrose was not influenced by age (p=0.07, 
Fig 3.6). 
 
 
 
Figure 3.5: Average MID outflow curves for glucose and the extracellular marker sucrose. Both 
the young (a) and old (b) glucose curves are delayed compared to sucrose, consistent with its 
access to extracellular and intrahepatocytic spaces; however there was no difference in the 
glucose appearance between young and old groups.  
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Figure 3.6: Volume of distribution of glucose as a percentage of extracellular volume. There 
were no differences in the fractional volume of distribution of glucose with age, (n = 9 young 
and n = 10 old F344 rats). 
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Table 3.3: The effect of age on recovery and volume of distribution (Vd) of Evans blue, glucose 
and sucrose 
 
  Young (n=9) Old (n=9) 
Fractional recovery   
Evans blue 1.00±0.03 0.88±0.10 
Glucose 0.70±0.03 0.76±0.07 
Sucrose 0.85±0.04 0.79±0.08 
Vd (ml/g)   
Evans blue 0.36±0.04 0.32±0.05 
Glucose 0.58±0.08 0.55±0.07 
Sucrose 0.40±0.05 0.34±0.04 
Ratio   
Glucose/Evans blue 1.57±0.16 1.86±0.26 
Glucose/Sucrose 1.41±0.05 1.65±0.22 
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3.3.3 Metabolic parameters 
 
3.3.3.1 Insulin levels and systemic metabolism 
 
As a consequence of reduced hepatic uptake of insulin, the basal insulin concentrations were 
significantly increased in the old mice, both in the fasted and fed states when compared to their 
younger counterparts (Fig 3.7a). C-peptide levels were unchanged in the old group during the 
fasted state (Fig. 3.7b), indicating that hyperinsulinemia is established through reduced clearance 
of insulin by the liver rather than increased pancreatic insulin secretion. In the fed state, C-
peptide levels increased significantly with age, suggesting that increased insulin secretion is 
required to maintain glucose tolerance with age. Glucagon levels were significantly lower in the 
old, compared to the young mice, when fasting (Fig. 3.7c).  
 
To determine if age is associated with only impaired liver insulin uptake hepatic, systemic 
insulin uptake was also measured using an intravenous dose of 
14
C-insulin. Although 
intraperitoneal insulin tolerance performance was similar between groups (Appendix 1), insulin 
uptake by the liver was reduced by about 30 % in 24 month old C57/Bl6 mice, but unchanged in 
fat and muscle (Fig. 3.7d).  
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Figure 3.7: (a) Fasting and fed insulin levels were significantly elevated with age in C57/Bl6 
mice (n = 6 young and 5 old C57/Bl6 mice, P < 0.05). (b) C-peptide levels were significantly 
elevated with age in the fed state (n = 4 young and 5 old C57/Bl6 mice, P = 0.02) and (c) 
Glucagon levels were supressed in the fasting state in old mice (n = 6 young and 5old C57/Bl6 
mice, P = 0.02). (d) 
14
C labelled insulin uptake by the liver was significantly reduced with age, 
but remained constant in muscle and fat (n = 10 young and 10 old C57/Bl6 mice, P < 0.05). 
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3.3.3.2 Glucose tolerance and tracer uptake 
 
Despite impaired hepatic insulin uptake associated with defenestration, glucose tolerance tests 
conducted on the 3 month and 24 month old mice showed no impairment with age and in fact 
tended to be lower (Fig. 3.8a).  
 
However, because of the very high insulin levels, the homeostatic model assessment index for 
insulin resistance (HOMA-IR), which is calculated from the fasting glucose-insulin product, was 
increased by more than two-fold in the old mice, indicating insulin resistance (Fig. 3.8b). 
 
To further determine which tissues were contributing to the insulin resistance, 
14
C-glucose and 
3
H-2-deoxyglucose and were administered during glucose tolerance tests and the uptake 
measured in muscle, white adipose tissue (WAT) and liver. The clearance of 
14
C-glucose into 
glycogen was significantly reduced in liver but this was associated with a trend for an increase in 
muscle clearance (Fig 3.9a). In addition, there was significant increase in 
3
H 2-deoxyglucose 
uptake, which is not a substrate for liver uptake and metabolism, in both muscle and fat with age 
(Fig 3.9b). The data indicate that the reduction in hepatic glucose uptake and hyperinsulinemia is 
associated with a compensatory age-related increase in glucose uptake in muscle and fat (as well 
as depleted glycogen stores, see below), thereby normalising the glucose tolerance test.  
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Figure 3.8: (a) Glucose tolerance was maintained in the hyperinsulinemic state seen with age in 
the C57/Bl6 mice (n = 8 young and 5 old C57/Bl6 mice). (b) The HOMA index was significantly 
increased with age reflecting the high insulin levels required with age to maintain glucose 
homeostasis (n = 6 young and 5 old C57/Bl6 mice, P = 0.03).  
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Figure 3.9: (a) There is a significant reduction in incorporation of 
14
C labelled glucose into 
glycogen (P < 0.05) and a trend towards increased incorporation into glycogen by muscle and fat 
with age (n = 8 young and n = 5 old C57/Bl6 mice). (b) 
3
H-2-deoxyglucose uptake into fat and 
muscle was significantly increased with age (n = 8 young and n = 5 old C57/Bl6 mice, P < 0.05). 
 
Consistent with the selective impact of age-related defenestration on hepatic insulin sensitivity, 
hepatic glycogen storage measured by PAS staining showed a marked reduction in glycogen in 
the old animals (Fig. 3.10).  
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Figure 3.10: PAS staining of the liver in young (a) and old (b) mice showing significantly 
reduced glycogen storage with age (n = 8 young and n = 5 old mice). 
 
3.3.3.3 Pyruvate tolerance 
 
We also performed a pyruvate tolerance test (Fig. 3.11) to examine the impact of age on insulin-
mediated inhibition of gluconeogenesis. Old age was associated showed a lower conversion of 
pyruvate to glucose. Although initially surprising, this is consistent with the observation that in 
rodents, some of the effects of insulin on hepatic gluconeogenesis are mediated via the brain, 
rather than a direct effect on hepatocytes (Rojas and Schwartz, 2014). Therefore age-related 
hyperinsulinemia will drive brain-mediated inhibition of gluconeogenesis even though its direct 
hepatic activity is reduced. 
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Figure 3.11: Pyruvate tolerance tests revealed impaired gluconeogenesis in the hyperinsulinemic 
setting seen with age (n = 8 young and n = 8 old C57/Bl6 mice, P = 0.003). 
 
3.3.4 Reverse transcription and quantitative real time-PCR array analysis 
 
To identify gene expression that might be altered by ageing, a quantitative RT-PCR (qRT-PCR) 
screening array for 84 key genes in the insulin signaling pathway was conducted (Appendix 2). 
Gene expression profiles showed no changes in insulin signaling pathway genes with age. Fatty 
acid synthase, a protein responsible for fatty acid synthesis was the only gene in this panel shown 
to be downregulated with age in the liver (p=0.02). 
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3.3.5 Proteomic studies 
 
Western blot analysis revealed that phosphorylation of the hepatocellular insulin receptor 
substrate AKT was reduced in the old mice (Fig. 3a-b). To  further probe phosphoprotein 
changes we utilised a large-scale, unbiased phosphoproteomic approach and liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS) to identify changes in 
protein and phosphopeptide abundances, which enabled signal pathway mapping in liver tissues 
from young and old mice. LC-MS/MS of phosphopeptide-enriched samples identified 7,208 sites 
of phosphorylation (n=5,156 phosphopeptides from n=2,400 proteins), of which 1,580 were 
statistically significantly altered in abundance (z-score <-1.00 or >+1.00; Appendix 3). Non-
phosphorylated peptides from the same samples were also identified and revealed only 281 
proteins (z-score <-1.96 or >+1.96; Appendix 3) that were significantly altered in abundance, 
confirming that the major changes at the biochemical level between young and old mouse livers 
were those associated with signaling. We next specifically examined the set of altered 
phosphopeptides and used functional cluster analysis to identify Kyoto Encyclopaedia of Genes 
and Genomes (KEGG) pathways associated with ageing in the liver. Functional clusters 
contained within this dataset were compared against the mouse genome to determine their over-
representation compared to background. The most over-represented KEGG pathways were ErbB 
(p-value 9.77 e
-9
), neurotrophin (4.10 e
-7
), GnRH (4.27 e
-7
), MAPK (7.96 e
-7
) and insulin (1.05 e
-
6
) signaling. The diversity of these pathways reflects the likely multifactorial nature of ageing, 
however changes associated with insulin signaling are consistent with reduced access of insulin 
to hepatocytes in old age. We next performed site-specific analysis of the phosphopeptides that 
were statistically significantly altered in aged livers by performing kinase recognition motif 
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analysis using MotifX. These data showed that the Akt recognition motifs R-X-R-X-X-pS and R-
S-X-pS were enriched 11.5-fold and 10-fold respectively, compared with background in the 
dataset of peptides displaying reduced phosphorylation with ageing (Fig. 3.12c), which is 
consistent with the AKT Western blot data (Fig. 3.12a-b), and confirms a significant reduction in 
AKT signaling in aged livers. Motifs containing acidic residues, consistent with casein kinase 2 
(CK2) activation were also enriched, however these were found in both the up- and down-
regulated phosphopeptide datasets.  
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Figure 3.12: (a) Representative western blots of p-AKT and AKT showing significantly 
decreased phosphorylation of AKT in insulin stimulated old rat livers compared to young. (b) 
Densitometry analysis of phosphorylated: total AKT from western blots (n = 6 young and n = 6 
old F344 rats, P = 0.002). (c) Fold over-representation of kinase recognition sequences from 
phosphoproteome analysis of young versus aged livers. Reduced Akt signaling is indicated by 
the prevalence of Akt recognition sequences * = ‘R-x-R-x-x-pS’ (11.5-fold) and ** = ‘R-S-x-pS’ 
(10-fold) in the set of phosphopeptides with reduced abundance in aged livers. Dotted line 
indicates cut-off for significant fold-change (>4-fold). 
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3.4 DISCUSSION 
 
This study demonstrates that age-related defenestration of the LSEC restricts insulin access to 
the insulin receptor on the hepatocyte membrane through impaired transendothelial transfer. This 
resulted in hyperinsulinemia, impaired hepatic insulin signaling, depleted glycogen stores, 
compensatory increases in muscle and fat uptake of insulin and glucose and dysregulated 
gluconeogenesis. In fat and muscle, the blood vessels are the rate limiting step for the uptake of 
insulin (Majumdar et al., 2012, Sandqvist et al., 2011) The data show that under physiological 
conditions, the liver endothelium does not provide a barrier for the uptake of insulin which 
attests to its remarkable role in facilitating the transfer of substrates between blood and liver cells 
(Le Couteur et al., 2005) However, in conditions associated with structural changes in the 
LSECs, the liver blood vessels become a barrier for the transfer of insulin. This is a significant 
development in our understanding of insulin resistance seen with age and liver disease.  
 
As we have previously reported, ageing is associated with significant defenestration of the 
LSECs (Cogger et al., 2006, Warren et al., 2011, Mitchell et al., 2010). Using the multiple 
indicator dilution methodology we have determined the disposition of insulin in perfused livers, 
and shown that ageing restricts access of insulin to the extravascular space. My laboratory has 
previously shown that defenestration associated with old age is mechanistically linked to reduced 
transendothelial transfer of other substrates including lipoproteins (Hilmer et al., 2005, Cogger et 
al., 2006) and both albumin-bound and dissolved medications (Mitchell et al., 2010, Le Couteur 
et al., 2005). Fenestration loss is also known to occur in streptozotocin-induced diabetic baboon 
and in rat models (McMahon et al., 2013, Jamieson et al., 2007a). Fenestrations appear to be an 
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important portal for the efficient transfer of many xeno- and endo-biotics (Cogger and Le 
Couteur, 2009). There was no change seen in glucose transfer across the LSEC with age, 
suggesting fenestrations are not a rate limiting step in glucose transfer across the endothelium to 
the hepatocellular membrane. 
 
Accompanying the impaired transendothelial access of insulin to the hepatocytes, there were 
significant systemic changes including reduced hepatic insulin uptake and clearance, and 
increased insulin levels and insulin resistance. This was associated with insulin resistance as 
assessed by the HOMA-IR calculation, but surprisingly the glucose tolerance test was normal, or 
actually slightly improved in the aged mice. We propose that this might be secondary to the long 
term age-related compensatory effects on glucose uptake in muscle and fat, and the reduction in 
hepatic glycogen storage. 
 
Despite elevated circulating insulin levels, ageing was associated with impairment of hepatic 
insulin signaling as measured by a full hepatic proteome screen using LCMS/MS and glycogen 
stores. The full proteome screen showed that the most age-related changes observed in the liver 
are at the biochemical level rather than due to protein expression changes. Western blot 
confirmed this with no change detected in protein levels but significant reductions seen in 
hepatic AKT phosphorylation in insulin-stimulated livers. 
 
No age-related changes were found in the expression of genes associated with the insulin 
signaling pathway as measured by qRT-PCR. This further supports the suggestion that all 
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changes we are seeing in hepatic insulin signaling with age are occurring post translationally, 
which we propose is secondary to defenestration.  
 
It has recently been postulated that the LSEC plays a significant role in insulin action in the liver. 
Tsuchiya et al. (2013) proposed a causal relationship for insulin resistance through LSEC 
mediated nitric oxide pathways (Tsuchiya and Accili, 2013). Raines et al. 2011 reported the 
effects of LSEC structure on insulin activity in a murine transgenic model with partial loss of 
platelet-derived growth factor-beta (PDGF-β) function. These mice developed highly permeable, 
disrupted LSECs as measured by transmission electron microscopy and in vivo FITC-dextran 
uptake (Raines et al., 2011). Such changes in the LSEC were associated with a dramatic increase 
in insulin action in the liver, evidenced by increased insulin signaling in liver, improved glucose 
tolerance tests, increased insulin clearance and an 80% reduction in circulating insulin levels 
despite euglycemia (Raines et al., 2011). 
 
While this work clearly indicates that patent fenestrations are essential for efficient hepatic 
insulin uptake, clearance and signaling, there are some limitations in the study which require 
further investigation. Ageing is a multifactorial process during which the entire body undergoes 
significant adaptations and changes which all could play a role in overall metabolic homeostasis, 
but are not within the scope of this project. Further investigation of the role of LSEC 
defenestration in the absence of all other systemic age-related adaptations will further 
substantiate the key role of fenestrations in hepatic insulin transfer, which will be addressed in 
Chapter 4. A further limitation is the use of mixed rodent models. Australia does not presently 
hold an ageing rat or mouse facility, all animals used were acquired through the National 
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Institutes of Ageing, USA. The combination of rats for the MIDs and proteomics and mice for all 
of the metabolic parameters was a decision made to allow the most rigorous probing of the role 
of fenestrations in hepatic insulin uptake. Ageing rats are considerably more expensive and more 
difficult to obtain than ageing mice but are essential for technically sound MID experiments, 
animal usage was prioritised on the grounds of these considerations. The combination of rats and 
mice was well considered and this is not thought to reduce the novelty or validity of the findings. 
Furthermore, defenestration as a result of ageing is well established in both the mouse and rat 
models used within this study, thus we believe that our results are valid despite this limitation. 
 
In conclusion, defenestration of the LSECs provides a novel mechanism that contributes to 
insulin resistance associated with advanced age and potentially other conditions associated with 
loss of fenestrations such as chronic liver disease. Maintaining the structural integrity of the 
LSECs is a potential therapeutic target for insulin resistance in old age. 
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CHAPTER 4: P407 INDUCED DEFENESTRATION AND HEPATIC INSULIN AND 
GLUCOSE DISPOSITION 
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4.1 INTRODUCTION 
 
It is recognised clinically and experimentally that many conditions associated with impaired 
hepatic microcirculation such as ageing, cirrhosis, non-alcoholic fatty liver disease are also 
associated with impaired insulin handling by the liver (Chai et al., 2014, Fink et al., 1983, 
Kawaguchi et al., 2011, Muller et al., 1992). One of the hallmark changes of the liver 
microcirculatory system in ageing and cirrhosis is the loss of liver sinusoidal endothelial cell 
(LSEC) integrity with defenestration, endothelial thickening and deposition of basal lamina (Le 
Couteur et al., 2001, McLean et al., 2003). The importance of the impacts of these changes on 
substrate exchange between the blood and hepatocyte is gaining recognition (Furrer et al., 2011, 
Lesurtel and Clavien, 2014). 
 
In Chapter 3 it was shown that age-related defenestration is causally associated with impaired 
hepatic insulin transfer and subsequent signaling and control. The results in Chapter 3 strongly 
supported the key role of fenestrations in insulin transfer from the sinusoidal blood vessels to the 
hepatocellular membrane and the insulin receptor. However, it is recognised that ageing is a 
multifactorial process where many fundamental cellular processes are affected and considerable 
adaptations develop overtime to support metabolic homeostasis. 
 
Given the complexity of ageing, testing the role of LSEC fenestrations in insulin transfer in a 
singular model of defenestration is important. One model for testing the acute effects of loss of 
fenestrations (‘defenestration’) on liver function is poloxamer 407 (P407). This is a non-ionic 
surfactant that causes marked defenestration of the LSEC without the development of fibrosis 
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(Warren et al., 2011, Cogger et al., 2006). Defenestration induced by P407 has been shown to 
impair the transendothelial transfer and hepatic clearance of several substrates including 
lipoproteins, acetaminophen and diazepam (Cogger et al., 2006, Mitchell et al., 2010, Mitchell et 
al., 2012). Here P407 was used to determine whether acute defenestration interferes with the 
hepatic disposition and action of insulin and whether this has any systemic implications. This 
would also provide further evidence that defenestration is a mechanism for the development of 
hepatic insulin resistance and hyperinsulinemia. 
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4.2 METHODS 
 
4.2.1 Animals and P407 treatment 
 
Male Fischer 344 rats aged 8-10 weeks and weighing 200 g were obtained from Animal 
Research Centre (Perth, Australia). The animals were allowed free access to water and standard 
chow. The treatment group received an intraperitoneal injection (i.p.) of P407 (1 g/kg, BASF 
Ltd, Southbank, Australia) 24 hrs prior to liver perfusion, prepared by mixing with normal saline 
and kept in liquid form at 4 ºC. Control animals included those that received a volume-matched 
i.p. injection of normal saline or were untreated. There were no differences between control 
animals given saline or no treatment, therefore their data were pooled. All animals were treated 
in accordance with Animal Care guidelines. This study was approved by the Sydney Local 
Health District Animal Welfare Committee (AWC Protocol #2012/005A).  
 
4.2.2 Liver perfusion and multiple indicator dilution method 
 
This procedure is described in detail in sections 2.3.2, 2.3.3 and 3.2.2. 
 
4.2.3 Blood analysis 
 
Prior to liver perfusion, approximately 1 ml blood was taken from the inferior vena cava (IVC) 
during surgery and transferred into an EDTA tube, followed by processing and analysis as 
described in section 2.7.1.  
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4.2.4 Scanning electron microscopy 
 
Liver tissue was perfused for scanning electron microscopy for measurement of intact 
endothelial fenestrations as described in 2.2.2.  
 
4.2.5 Metabolic parameters 
 
4.2.5.1 Glucose tolerance and tracer uptake 
 
Animals were fasted for 6 hrs, followed by administration of glucose (2 g/kg i.v.) spiked with 10 
µCi 
14
C-glucose for assessment of insulin action in liver, fat and muscle and 10 µCi 
3
H-2-
deoxyglucose for assessment of glucose uptake in fat and muscle as described in 2.6.2. 
 
4.2.5.2 Insulin uptake 
 
Whole body insulin extraction was performed in another batch of rats, where 
14
C-insulin (1 
µCi/g) was injected via the inferior vena cava of anesthetised animals as described in 2.6.3.  
 
4.2.5.3 Pyruvate tolerance 
 
A third cohort of P407 and control animals were fasted for 6 hours prior to an i.p injection of 
pyruvate (2 g/kg; Sigma Aldrich, Castle Hill Australia) and glucose levels were read using a 
handheld glucose meter as described in section 2.6.6.  
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4.2.6 Histology 
 
Liver tissue was fixed in 4 % paraformaldehyde, paraffin embedded, sectioned and subjected to 
H&E and PAS staining, followed by observation as described in section 2.3.2. 
 
4.2.7 Reverse transcription and quantitative real time-PCR array analysis 
 
Total RNA was isolated from liver tissue samples using a RNeasy Plus Mini Kit (Qiagen Pty 
Ltd, Chadstone, Australia), followed by subsequent reverse transcription and real time-PCR as 
described in section 2.8.  
 
4.2.8 Proteomic studies 
 
4.2.8.1 Mass Spectrometry 
 
Mass Spectrometry was performed as described in Section 2.6.1. Bioinformatic analysis was 
performed to reveal pathways associated with P407 treatment using STRING (Jensen et al., 
2009, Franceschini et al., 2013, Szklarczyk et al., 2011) and KEGG (Kanehisa and Goto, 2000, 
Kanehisa et al., 2014) pathway analysis.  
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4.2.8.2 Western Blots 
 
Frozen liver tissue samples were processed as described in section 2.6.2. The protein extract 
were subjected to immunoblotting according to protocol as described previously (Hoehn et al., 
2008). Antibodies against the following proteins were used: phospho-IRS-1 (Ser612, Cat#2386), 
IRS-1 (Cat#2382), phospho-mTOR (Ser2448, Cat#2971), mTOR (Cat#2972), IRS-2 (Cat#4502) 
and α-tubulin (Cat#2144) (Cell Signaling Technology, Arundel, Australia).  
 
4.2.9 Data analysis 
 
Data analysis was performed using Microsoft Excel. All values are expressed as the mean ± 
SEM. Statistical significance was calculated using two-tailed Student’s T test and Pearson’s 
Product Moment correlation coefficient (Sigmaplot v11, Systat Software, Germany). 
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4.3 RESULTS 
 
4.3.1 Histology, blood analysis and Electron Microscopy 
 
At 24 hr following P407 treatment, blood samples were observed to be lipemic. Blood analysis 
showed a significantly higher serum cholesterol and triglycerides in the treated group compared 
to control (Fig. 4.1a) with no difference in aspartate transaminase (AST) and alanine 
transaminase (ALT) levels between groups (Fig. 4.1b). Post mortem examination of the whole 
animal and haematoxylin and eosin staining of liver sections from the control and P407 animals 
confirmed all animals included in the study were free of gross and liver pathology (Fig. 4.2).  
 
Scanning electron microscopy (Fig. 4.3) was performed to confirm P407 induced defenestration 
of the LSEC that has previously been described (Mitchell et al., 2012, Warren et al., 2011, 
Cogger et al., 2006). LSEC morphology was analysed as described in Table 4.1. P407 
administration led to reduced fenestration diameter and porosity. These findings are consistent 
with previous studies (Warren et al., 2011, Cogger et al., 2006). 
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Figure 4.1: Blood analysis of serum (a) lipid and (b) liver function parameters for control and 
P407 treated rats. Blood cholesterol and triglycerides were markedly increased 24 hours after 
P407 administration (* P<0.001) while serum ALT and AST is similar between groups. Data is 
presented as mean ± SEM, n = 5 control and n=5 P407 treated F344 rats. 
 
Figure 4.2: Representative Haematoxylin and Eosin staining of (a) control and (b) P407 F344 
rats. No signs of pathology were found. 
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Figure 4.3: Representative Scanning electron micrographs of the perfused the LSEC in (a) 
control and (b) P407 F344 rats. Significant defenestration is observed with P407 administration. 
Original micrographs taken at 15000 × magnification. 
 
Table 4.1: Quantification of the LSEC fenestrations. There is decreased liver porosity in P407 
treated group (P=0.02). Data is presented as mean ± SEM. 
 
Animal group n Porosity (%) Diameter (nm) Frequency 
(per um
2
) 
Control 
n = 10 
5 5.44±0.5 104.5±3.5 3.68±0.2 
P407-treated 
n = 11 
5 3.64±0.5* 85±4.3 4.04±0.3 
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4.3.2 P407 induced defenestration impairs the access of insulin and glucose to the 
extracellular space of the liver 
 
To further probe the relationship between defenestration of the liver endothelium and insulin 
resistance, MIDs were performed on livers from rats treated with P407 and their matched 
controls. Outflow insulin curves from the MID experiments are shown in Fig. 4.4.  
 
 
Figure 4.4: Average MID outflow curves for insulin and the extracellular marker sucrose (n=12 
control and n=8 P407). Insulin exits the liver after sucrose in (a) control rats whereas the order is 
reversed in the (b) P407 animals indicating restricted access to the extracellular space with acute 
defenestration. 
 
In control animals, the insulin curve overlaps the sucrose curve (Fig. 4.4a), indicating that insulin 
has unimpeded access to the entire extracellular (‘sucrose’) space. Following P407 treatment, the 
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insulin curve appears earlier than the sucrose curve (Fig. 4.4b), indicating that insulin has a 
smaller volume of distribution than sucrose. The recovery and apparent volume of distribution of 
insulin and tracers are shown in Table 4.2. There was no difference in the recovery of Evans 
Blue or sucrose between groups. Analysis of the curves showed that P407 was associated with a 
significant reduction in the volume of distribution of insulin, normalised to sucrose volume, of 
about 20 % (Fig. 4.5, P<0.05). P407 induced defenestration was associated with a trend towards 
higher recovery of insulin (75 ± 10% controls vs 86 ± 4% P407-treated). 
 
 
Figure 4.5: There was a 20 % reduction in the fractional volume of distribution of insulin with 
acute defenestration (n = 12 control and n= 8 P407 F344 rats, P = 0.01). 
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Table 4.2: The effect of P407 on recovery and volume of distribution (Vd) of Evans blue, insulin 
and sucrose. * P<0.05. 
 
 
There was a similar trend seen with the glucose outflow curves (Fig 4.6). In control animals the 
glucose curves were delayed compared with the sucrose curves (Fig. 4.6a), indicating that in 
normal livers, glucose has access to the entire extracellular space and enters the hepatocytes as 
well. Following P407 treatment, the glucose curves appear earlier than seen in the control 
experiments (Fig. 4.6b), indicating a reduction in its volume of distribution. Analysis of the 
curves for recovery and volume of distribution are shown in Table 4.3. There was no difference 
in the recovery of Evans Blue, glucose or sucrose between both groups. The ratio of volume of 
  Control (n=12) P407 (n=8) 
Fractional recovery value value 
Evans blue 0.83±0.08 0.77±0.07 
Insulin 0.78±0.07 0.83±0.05 
Sucrose 0.93±0.06 0.83±0.05 
Vd (ml/g)    
Evans blue 0.25±0.02 0.23±0.03 
Insulin 0.27±0.03 0.23±0.03 
Sucrose 0.26±0.03 0.29±0.04 
Ratio    
Insulin/Evans blue 1.07±0.09 0.97±0.05 
Insulin/Sucrose 1.02±0.07 0.81±0.04* 
121 
 
distribution of glucose compared to Evans Blue was not influenced by P407. However, there was 
a reduction in the volume of distribution of glucose compared to sucrose. Analysis of the curves 
showed that P407 was associated with a significant reduction in the volume of distribution of 
glucose, normalised to sucrose volume, of about 24 % (Fig. 4.7, P<0.05). 
 
Figure 4.6: Average MID outflow curves for glucose and the extracellular marker sucrose. 
Glucose exits the liver after sucrose for both a. control and b. P407 rats, with P407 rats shows an 
earlier appearance of glucose compared to control. 
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Figure 4.7: There was a 24 % reduction in the fractional volume of distribution of glucose with 
acute defenestration (n = 12 control and n= 8 P407 F344 rats, P = 0.01). 
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Table 4.3: The effect of P407 on recovery and volume of distribution (Vd) of Evans blue, 
glucose and sucrose 
 
  Control (n=12) P407 (n=8) 
Fractional recovery   
Evans blue 0.87±0.07 0.73±0.09 
Glucose 0.82±0.05 0.71±0.09 
Sucrose 0.89±0.04 0.82±0.1 
Vd (ml/g)    
Evans blue 0.24±0.02 0.22±0.03 
Glucose 0.37±0.04 0.31±0.05 
Sucrose 0.25±0.02 0.29±0.06 
Ratio   
Glucose/Evans blue 1.56±0.06 1.34±0.10 
Glucose/Sucrose 1.50±0.06 1.10±0.10* 
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4.3.3 Metabolic parameters 
 
4.3.3.1 Insulin levels and systemic metabolism 
 
Impaired hepatic uptake of insulin due to P407 induced defenestration led to significantly 
elevated basal and fed insulin levels in the P407 rats when compared to their control counterparts 
(Fig. 4.8a).  
 
The elevated circulating insulin was not due to increased insulin secretion by the pancreas as 
shown in Fig. 4.8b. C-peptide levels were unchanged in the P407 group during the fasted state, 
indicating that hyperinsulinemia is established through reduced clearance of insulin by the liver 
rather than increased pancreatic insulin secretion. In the fed state, C-peptide levels increased in 
the control animals while remaining steady in the P407 animals, reflecting impaired secretion of 
insulin in the acutely defenestrated animal. Glucagon levels were significantly lower in the P407 
compared to the control mice when fasting (Fig. 4.8c).  
 
Whole body insulin handling assessed by intravenous injection of 
14
C-insulin revealed that 
insulin uptake by the liver was reduced by 20% in P407-treated animals (Fig. 4.8d P=0.04), but 
was unchanged in muscle and fat. 
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Figure 4.8: (a) Fasting and fed insulin levels were significantly elevated following P407 induced 
defenestration (n = 6 control and 6 P407 F344 rats, fasting P < 0.05, fed P = 0.005). (b) C-
peptide levels were significantly decreased with P407 induced defenestration in the fed state (n = 
5 control and 5 P407 F344 rats, P = 0.03) and (c) Glucagon levels were supressed in the fasting 
and fed states in P407 treated rats (n = 4 control and 4 P407 F344 rats, fasting P = 0.02, fed, P = 
0.16). (d) 
14
C labelled insulin uptake by the liver was significantly reduced with defenestration, 
but remained constant in muscle and fat (n = 6 control and 6 P407 F344 rats P = 0.04). 
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4.3.3.2 Glucose tolerance and tracer uptake 
 
To determine whether altered hepatic disposition of insulin had any effect on systemic glucose 
metabolism, we performed glucose tolerance tests. The incremental area under the curve (iAUC), 
calculated from the glucose tolerance curve (Fig. 4.9a, n=13 controls n=10, P=0.04). indicated 
impaired glucose tolerance in the P407 animals Further, because of the very high insulin levels, 
the homeostatic model assessment index for insulin resistance (HOMA-IR), which is calculated 
from the fasting glucose-insulin product, was increased by more than two-fold in the P407 mice, 
indicating insulin resistance (Fig.. 4.9b). 
 
 
Figure 4.9: (a) Glucose tolerance curve of control and P407 rats. The iAUC calculated the curve 
was increased by P407-induced defenestration (n = 10 control and 8 P407 F344 rats). (b) The 
HOMA-IR index was significantly increased by P407 induced defenestration (n = 6 control and 6 
P407 F344 rats, P = 0.002) 
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To further determine which tissues were contributing to the insulin resistance, 
14
C-glucose and 
3
H-2-deoxyglucose and were administered during glucose tolerance tests and the uptake 
measured in muscle, WAT and liver. The incorporation of 
14
C-glucose into glycogen was 
significantly reduced in liver of P407 treated rats with no change in WAT or muscle 
incorporation (Fig. 4.10a). There was no change in 
3
H 2-deoxyglucose uptake, which is not a 
substrate for liver uptake and metabolism, in both muscle and fat with P407 treatment (Fig. 
4.10b). The data indicate that the reduction in hepatic glucose incorporation into glycogen and 
hyperinsulinemia lead to abnormal glucose tolerance in acutely defenestrated rats.  
 
 
Figure 4.10: (a) There was a significant reduction in hepatic incorporation of 
14
C labelled 
glucose into glycogen, with no change in muscle and fat incorporation (n = 10 control and 8 
P407 F344 rats, P < 0.05). (b) 
3
H-2-deoxyglucose uptake into fat and muscle was unchanged 
following P407 treatment, although muscle uptake was more pronounced in P407 but it is not 
significant (n = 10 control and 8 P407 F344 rats, P = 0.06). 
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Consistent with the significant impact of acute defenestration on hepatic insulin sensitivity and 
glucose homeostasis hepatic glycogen storage measured by PAS staining showed a marked 
reduction in glycogen in the P407 animals (Fig. 4.11). 
 
Figure 4.11: PAS staining of the liver in (a) control and (b) P407 treated rats showing 
significantly reduced glycogen storage with defenestration (n = 10 control and 8 P407 F344 rats). 
  
4.3.3.3 Pyruvate tolerance 
 
The pyruvate tolerance test demonstrated a paradoxical reduction in gluconeogenesis in P407 
rats upon injection of pyruvate as a substrate for gluconeogenesis (Fig. 4.12). MID experiments 
were further conducted and the results showed that pyruvate disposition was not restricted by 
loss of fenestrations (Appendix 4, Vd: 1.64 ± 0.1 ml/g n=6 controls vs 1.58 ± 0.1 ml/g n=6 P407 
treated). This indicates that reduced gluconeogenesis associated with P407 is not caused by the 
effects of defenestration on pyruvate uptake. 
129 
 
 
Figure 4.12: Pyruvate tolerance tests revealed impaired gluconeogenesis in the hyperinsulinemic 
setting (n = 13 control and 9 P407 F344 rats, P < 0.05). 
 
 
4.3.4 Reverse transcription and quantitative real time-PCR array analysis 
 
To identify gene expression that might be altered by reduced transendothelial access of insulin to 
the hepatocyte insulin receptor, a qRT-PCR screening array for 84 key genes in the rat insulin 
signaling pathways was conducted (Appendix 5). As outlined in Table 4.4 gene expression 
profiles showed that IRS-2 was upregulated (1.76-fold; p=0.02) and thyroglobulin, which has a 
role as secondary effector target genes for insulin signaling was downregulated (1.88-fold; 
p=0.01, Table 4.4). There was also upregulation of leptin coding gene Cebpa that is a primary 
target gene for insulin signaling (6.08-fold) and downregulation of G6pc gene involved in 
glucose and glycogen metabolism (3.53-fold), but this was not significant.  
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Table 4.4: Significant changes in PCR array profiles with following administration of P407 in 
rats. 
Symbol Gene name Up or down 
regulation 
p value 
Irs2 Insulin receptor substrate 2 1.76 0.02* 
Tg Thyroglobulin -1.88 0.018* 
Cebpa CCAAT/enhancer binding protein (C/EBP), 
alpha 
6.08 0.95 
G6pc Glucose-6-phosphatase, catalytic subunit -3.53 0.84 
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4.3.5 Proteomic studies 
 
Western blot analysis revealed that phosphorylation of IRS-1, the phosphorylation target of the 
activated insulin receptor, was significantly reduced by over 50% in P407 rats as compared to 
controls (0.98 ± 0.3 n=9 controls vs 0.4 ± 0.10 n=10 P407-treated, P<0.05). Conversely, the 
expression of total IRS-2 protein was increased in the P407 rats (0.21 ± 0.03 n=4 controls vs 0.78 
± 0.06 n=4 P407-treated, P<0.05). There is no difference in the phosphorylation of mTOR which 
is involved in downstream insulin signaling (Fig 4.13a-c). 
 
We again utilised large-scale phosphoproteomics to determine the effects of P407 on hepatic cell 
signaling pathways, which further highlighted loss of fenestration-specific effects without the 
multi-factorial processes involved in ageing. LC-MS/MS identified 1,480 sites of 
phosphorylation that were statistically significantly altered in abundance (z-score <-1.00 or > 
+1.00; Appendix 3). Analysis of non-phosphorylated peptides revealed only 189 proteins that 
were significantly altered in abundance, and these contained no discernible functional or spatial 
pattern. Proteins containing significantly altered phosphopeptides were subjected to functional 
cluster analysis and compared against the mouse genome as background. The most over-
represented KEGG functional pathway was the insulin signaling pathway (p-value 9.24 e
-10
). 
Site-specific analysis using MotifX again showed an 11-fold over-representation of the Akt 
recognition sequence (R-X-R-X-X-pS) in the set of phosphopeptides significantly reduced by 
P407 treatment (Fig. 4.14), which is consistent with the data observed for aged liver tissue.  
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Comparison of significantly altered phosphoproteins between the ageing and P407-related 
samples revealed that 396 and 481 non-redundant gene products were unique to P407 and ageing 
respectively, with 530 common to both comparisons. The sets of phosphoproteins unique to 
P407 and ageing showed no statistically significant over-represented KEGG functional 
pathways, however proteins contained in the overlapping set with phosphopeptides altered in 
abundance by both P407 and ageing were functionally most typically associated with insulin 
signaling (p-value 1.83 e
-8
). We next took the large-scale data and performed phosphosite level 
interrogation using PhosphoSite Plus (www.phosphosite.org) to specifically examine changes to 
known insulin-regulated sites from proteins within the KEGG insulin signaling pathway in aged 
and P407-treated liver. In total, we identified 49 phosphopeptides containing known insulin-
regulated sites from 23 insulin signal pathway proteins. In aged liver, 39/49 phosphopeptides 
were significantly altered and 34 of these were reduced in phosphorylation (from IRS-1, SHC-1, 
Sos1, Raf1, Erk1/2, PI3K, Foxo1, Gys1, Trip10, Acaca, PP1, Rps6 and Eif4ebp1; Appendix 3), 
which is consistent with reduced insulin signaling. Fifteen of these phosphopeptides also showed 
reduced phosphorylation in P407-treated livers (from IRS-1, SHC-1, Erk1/2, PI3K, Foxo1, Gys1, 
PP1 and Trip10). Four phosphopeptides were elevated in abundance in both aged and P407-
treated liver (from Akt1, PP1 and IRS-2). Seven phosphopeptides containing known insulin-
regulated sites (from BAD, TSC1/2, mToR and p70S6K) were unaltered by either ageing or 
P407. While we did not observe the IRS-1 tyrosine sites targeted by the insulin receptor (Fig. 
14), we did observe the phosphorylation target of the insulin receptor on SHC-1 (Tyr423), which 
was significantly reduced in abundance in both aged and P407-treated livers (Appendix 3). These 
data confirm that defenestration leads to altered hepatic insulin signaling that strongly correlates 
with the effects of ageing on this pathway.  
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Figure 4.13: (a) Representative Western Blots of p-IRS-1, IRS-1, p-mTOR, mTOR and IRS-2 
from control (n=6) and P407 livers (n=6). (b) Densitometry showing significantly decreased 
phosphorylation of IRS-1 in insulin stimulated P407 livers compared to control (P=0.002) while 
there are no changes in mTOR phosphorylation as a downstream target protein. (c) Densitometry 
showing significantly increased total IRS-2 protein in P407 livers compared to control 
(P<0.001), probably as a compensatory mechanism due to decreased IRS-1 activation.  
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Figure 4.14: Fold over-representation of kinase recognition sequences from phosphoproteome 
analysis of control versus P407-treated livers. Reduced Akt signaling is indicated by the 
prevalence of Akt recognition sequence *= ‘R-x-R-x-x-pS’ (11-fold) in the set of 
phosphopeptides with reduced abundance in P407-treated livers. Dotted line indicates cut-off for 
significant fold-change (>4-fold). 
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4.4 DISCUSSION 
 
This study assesses the effect of acute defenestration of the LSEC, induced by the synthetic 
surfactant, P407, on hepatic disposition of insulin and glucose. In addition, it examines the 
implications of these changes in hepatic glucose and insulin disposition for whole body glucose 
homeostasis.  
 
As previously reported, within 24 hours of a single injection of P407 there was a marked 
hyperlipidaemia with normal liver function (Johnston, 2004, Palmer et al., 1998, Cogger et al., 
2006, Mitchell et al., 2010, Mitchell et al., 2012, Warren et al., 2011, Johnston and Palmer, 1993, 
Dumortier et al., 2006). P407 is a ubiquitous block co-polymer surfactant that has been widely 
studied as a model for hyperlipidaemia (Johnston, 2004) and also used as a vehicle for 
nanoparticle drug delivery (Kabanov et al., 2002, Moghimi, 1999). The hyperlipidaemic 
response to P407 has been linked to altered activity of enzymes involved in lipoprotein 
metabolism, in which hypertriglyceridemia is caused by lipoprotein lipase inhibition and 
hypercholesterolemia by indirect effects on HMG CoA reductase activity (Johnston, 2004). It is 
reported that this condition is also caused by inhibition of lipid metabolizing enzyme activities 
(Wasan et al., 2003). However, P407 also induces defenestration of the LSEC which has been 
shown to impair the chylomicron passage into the hepatocytes, thus providing an additional 
explanation for hyperlipidaemia (Cogger et al., 2006).  
 
P407 targets the liver after intraperitoneal injection (Li et al., 1996) and the observation of 
lipemic blood is an indicator that it has successfully enter blood circulation (Wout et al., 1992). 
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Apart from causing hyperlipidaemia, P407 is regarded as a non-toxic substance and is widely 
used in pharmaceutical preparations (Dumortier et al., 2006). P407 is used for the study of 
pharmacokinetics and pharmacodynamics of various medications used to treat hyperlipidaemia 
(Shayeganpour et al., 2008, Lee et al., 2012).  
 
Scanning electron microscopy of the LSEC revealed ultrastructural changes of defenestration as 
previously reported (Cogger et al., 2006, Mitchell et al., 2010, Mitchell et al., 2012, Warren et 
al., 2011). P407 significantly defenestrates LSECs within 12 - 36 hours after injection in mice in 
association with a 10 fold increase in plasma lipids (Cogger et al., 2006). Transmission electron 
microscopy analysis of mouse livers one day after P407 injection showed that LSECs developed 
large vacuoles full of lipids and/or P407 micelles in conjunction with LSEC defenestration and 
swelling observed on scanning electron microscopy, as a response to remove excess lipid and 
P407 from the blood (Warren et al., 2011). Mitochondria and ATP production are not affected by 
P407, therefore it is most likely that it interacts directly with the cell membrane (Cogger et al., 
2006).  
 
Using multiple indicator dilution methodology, the disposition of insulin and glucose was 
studied in perfused livers. These studies showed that P407-induced defenestration was associated 
with restricted access of insulin and glucose to the extracellular space. In control animals, both 
substrates had access to the entire sucrose space (extracellular and vascular space) but following 
P407, this was reduced by approximately about 20% for insulin and glucose as compared to the 
sucrose space (equivalent to the vascular space). Defenestration associated with P407 has been 
reported to be associated with restricted access of substrates transiting from the sinusoidal lumen 
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across into the SoD. These substrates include lipoproteins (Cogger et al., 2006) and medicines 
such as acetaminophen and diazepam (Mitchell et al., 2010, Mitchell et al., 2012). It is of note 
that the hepatic clearance of several other medicines has been found to be reduced following 
P407 (Lee et al., 2012), but in these reports, the effect on endothelium and transfer across the 
endothelium were not specifically investigated.  
 
Systemically, P407 was associated with relatively normal glucose levels, but impaired glucose 
tolerance, increased insulin levels and insulin resistance (as assessed by the fasting insulin-
glucose product, HOMA-IR). The hyperinsulinemic condition of the P407-treated animals was 
not secondary to increased insulin secretion by the pancreas because there was suppression of C-
peptide levels. Instead, it can be inferred from the data that hyperinsulinemia was caused by 
reduced hepatic insulin clearance; a conclusion also supported by decreased liver insulin uptake 
in the whole body insulin uptake experiments. Glucagon levels were also significantly lower in 
P407-treated animals, which is possibly a response to the serum high insulin levels measured in 
the study.  
 
Despite elevated circulating insulin levels, glycogen content of the livers as shown by PAS 
staining was significantly diminished in P407-treated animals. This is again consistent with 
reduced activation of insulin signaling pathways in the liver. Insulin resistance has been shown 
to decrease glycogen synthetase activity and glycogen content in skeletal muscle (Cline et al., 
1999) and the liver (Kusunoki et al., 2002) as a result of impaired insulin action.  
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Following P407, there was reduced gluconeogenesis in the pyruvate tolerance test which is 
consistent, paradoxically, with increased insulin activity. This was not secondary to impaired 
pyruvate transfer across the endothelium as determined by multiple indicator dilution study. This 
is most likely caused by hyperinsulinemia acting via brain control of hepatic glucose metabolism 
(Rojas and Schwartz, 2014) and parallels the changes seen in old age.  
 
After establishing that defenestration reduces the hepatic volume of distribution of insulin and 
glucose, the impact of this reduced transfer of hepatocyte insulin signaling was examined using 
large scale proteomics and western blots. Large scale proteomics showed that in the acute 
defenestration, the most significantly affected pathway is insulin signaling. Western blots 
showed P407-induced defenestration were associated with reduced hepatic IRS-1 
phosphorylation consistent with reduced access of insulin to the hepatocellular membrane.  
However, consistent with the exponential nature of signaling pathways and with previous work 
(Hoehn et al., 2008), alteration at the level of IRS-1 signaling was insufficient to cause changes 
in the expression of downstream signaling intermediates proteins such as mTOR. 
 
Interestingly, there was an increase in total IRS-2 expression with P407 treatment. A similar 
finding was observed in the liver insulin stimulated-LIRKO mice, where there was a 5-fold 
increase in IRS-2 expression in the liver due to loss of insulin signaling (Michael et al., 2000). 
IRS-2 is reported to have a predominant role in β-cell development and compensation of 
peripheral insulin resistance, working with IGF-1 to maintain glucose homeostasis (Withers et 
al., 1999) and the increase in IRS-2 expression is likely to be a compensatory response to the 
reduction in IRS-1 phosphorylation. 
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In agreement with the protein expression findings PCR array analysis of gene expression profiles 
showed that IRS-2 gene expression was upregulated, in parallel with increased total IRS-2 
protein expression from western blotting. Increased IRS-2 expression is also associated with 
steatohepatitis and altered lipid and insulin metabolism in humans (Rametta et al., 2013). The 
pattern of downregulation in G6pc gene expression observed is subsequently reflected by 
decreased gluconeogenesis in P407 during the pyruvate tolerance test. 
 
It is of note that repeated administration of P407 has recently been reported to induce type 2 
diabetes mellitus in rats, with sustained hyperglycemia occurring after several weeks of daily 
treatment (Bharti et al., 2013). In another study, a single dose of P407 did not influence glucose 
or insulin, however a smaller dose (0.5 g/kg) was used in mice rather than rats (Johnston and 
Waxman, 2008). In this study of rats, a single dose of P407 (1 g/kg) induced insulin resistance 
with elevated insulin levels and impaired glucose tolerance, although the glucose levels were still 
within the normal range. Our data indicate that this is mediated, at least in part, by defenestration 
of the LSEC. 
 
In conclusion, defenestration of the LSEC induced by P407 reduced the transfer of insulin and 
glucose from the sinusoid into the extracellular space and reduced insulin action in hepatocytes 
with an impact on glucose homeostasis. This was associated with hyperinsulinaemia, glucose 
intolerance and deranged glucose metabolism in the liver. These results are in agreement with 
previous reports showing that defenestration of the LSEC leads to impaired transendothelial 
transfer of various other substances such as lipoproteins and medications into the liver (Hilmer et 
al., 2005, Mitchell et al., 2012, Mitchell et al., 2011). Therefore the endothelium in the liver, as 
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in other tissues, can have a significant impact on insulin action. Moreover, the results suggest a 
novel mechanism linking defenestration associated with liver diseases and ageing with insulin 
resistance and possibly diabetes mellitus. 
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CHAPTER 5: THE RELATIONSHIP OF FENESTRATIONS AND LIPID RAFTS IN 
VITRO 
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5.1 INTRODUCTION 
 
LSECs have a unique phenotype compared to the endothelial cells of other organs. They are 
highly differentiated cells with attenuated cytoplasmic extensions approximately 100 nm thick 
that are perforated by non-diaphragmed transcellular fenestrations and have no associated 
basement membrane. The fenestrations which cover approximately 5-20 % of the LSEC surface 
area function as a filter for substrate transfer between blood and hepatocytes. Individual 
fenestration diameter ranges from 50-150 nm and the majority are arranged into groups known as 
sieve plates. As discussed previously the size and number of the fenestrations is important for the 
passage of selective substrates, such as insulin across the LSEC (Wisse et al., 1985). 
 
Due to their small size, fenestrations are below the optical resolution limit and their observation 
has been significantly performed by electron microscopy (Cogger and Le Couteur, 2009). This 
technical limitation has hampered the use of living cells or fluorescent probes to investigate the 
distinctive biological structure of LSECs (Braet et al., 2007). While the details of fenestration 
ultrastructure have been observed and documented many times, there remains no specific cell 
surface protein that can reliably differentiate fenestrations from the non-fenestrated membrane 
sections of the LSEC or that assists in probing the exact spatial and temporal events of 
fenestration formation and loss.  
 
Advancement in microscopy has recently provided opportunities that overcome the diffraction 
limit of optical resolution. Fenestrations are now able to be resolved using three-dimensional 
structured illumination microscopy (3D-SIM), an ultra-high resolution light microscopy that uses 
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interference patterns to convert structures below the resolution limit of light microscopy into 
observable construct by generating difference frequency called moiré fringes (Cogger et al., 
2010). The three dimensional structure of fenestrations has been successfully resolved using Cell 
Mask Orange membrane stain, where fenestrations are seen clustered in sieve plates, similar to 
observation with scanning electron microscopy. Additional structures were observed intercalated 
with between the sieve plates, postulated as membrane rafts, highly dynamic sterol and 
sphingolipid enriched lipid-ordered domains of the cell membrane that compartmentalise 
cellular signaling molecules.  
 
To confirm this hypothesis, studies were undertaken in our laboratory on the relationship 
between fenestrations, actin and lipid rafts have been conducted using 3D-SIM, TIRFM and 
SEM (Svistounov et al., 2012). It was found that fenestrations form in non-rafts regions of LSEC 
once the membrane-stabilizing effects of actin cytoskeleton and membrane rafts are diminished. 
The inverse relationship between fenestrations and membrane rafts has raised the hypothesis of 
sieve-raft theory for the regulation of fenestrations (Cogger et al., 2013a) whereby lipid rafts 
regulate the formation of fenestrations in sieve plates.  
  
The mechanisms for the loss of fenestrations induced by P407 such as seen in Chapter 4 have not 
been investigated. P407 has previously been shown to cause loss of fenestrations by examination 
with scanning electron microscopy (Cogger et al., 2006), but the effects of P407 on the lipid rafts 
of the LSEC membranes are unknown. The objective of this study is to investigate the effect of 
P407 on the relationship between membrane rafts and fenestrations in SKHep1 cells (a cell line 
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of liver endothelial origin) and isolated LSECs. It is proposed that P407 induces defenestration 
by depleting non-raft region of the cell membrane (Cogger et al., 2008).  
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5.2 METHODS 
 
5.2.1 Animals 
 
Male Fischer 344 rats aged 8-10 weeks and weighing 200 g were obtained from Animal 
Research Centre (Perth, Australia). The animals were allowed free access to water and standard 
chow. All animals were treated in accordance with Animal Care guidelines. This study was 
approved by the Sydney Local Health District Animal Welfare Committee (AWC Protocol 
#2012/005A).  
 
5.2.2 SKHep1 cell culture and treatment  
 
SKHep1 cells were obtained from the American Type Tissue Culture Collection (ATCC, VA). 
Cells were cultured in a humidified 5 % CO2 incubator at 37 ºC and grown in DMEM 
supplemented with 10 % fetal calf serum and antibiotics. Cells were grown on Thermanox 
coverslip for SEM and collagen coated glass coverslip for fluorescent microscopy. Once cells 
were 75 % confluent, cells were treated with normal saline or 0.5 mg/ml P407. After 1 hr of 
treatment, cells were rinsed 3 times with PBS and fixed as described in section 5.2.4 and 5.2.5. 
 
5.2.3 LSEC isolation and treatment 
 
This procedure is described in detail in sections 2.3.2 and 2.3.3. Briefly the animals were 
weighed and anaesthetised and liver was perfused with Collagenase solution. Cell suspension 
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was centrifuged and the supernatant was layered on a two-step Percoll gradient for the removal 
of non-parenchymal cells other than LSECs. LSEC purity was enhanced by selective adherence 
of Kupffer cells to plastic. LSECs were quantified and seeded on Thermanox coverslips for SEM 
and collagen coated glass coverslips for fluorescence microscopy in serum free RPMI-1640 
media. After 3 hours, cells were treated with normal saline or 0.5 mg/ml P407. Following 1 hr of 
treatment, cells were rinsed 3 times with PBS and fixed as described in section 5.2.4 and 5.2.5. 
 
5.2.4 Cell fixation, processing and imaging for SEM 
 
Following treatment, Thermanox-mounted SKHep1 cells and isolated LSECs were fixed for 
scanning electron microscopy in 2.5 % glutaraldehyde in 0.1 M Cacodylate buffer (0.1 M 
sodium cacodylate buffer with 1 % sucrose pH 7.4) for 1 hour. Cells were washed, filtered and 1 
% Tannic acid in 0.1 M Cacodylate buffer (pH 7.4) was added to cells for 1 hour and rinsed 
thoroughly. Cells were osmicated (1 % OsO4/0.1 M Cacodylate buffer pH 7.4 for 1 hour) and 
dehydrated in an ethanol gradient. After treatment with hexamethyldisilazane, coverslips were 
left to dry in a desiccator. Coverslips were then mounted on stubs using double-sided tape, 
coated with platinum in a sputter coater and examined using a Jeol 6380 Scanning Electron 
Microscope. Experiments were performed in triplicate. 
 
5.2.5 Cell fixation, processing and imaging for fluorescence microscopy 
 
Following treatment, cells, SKHep1 cells and isolated LSECs on glass coverslips were fixed with 
4 % paraformaldehyde in PBS overnight. Cells were washed and stained with Cell Mask Orange, 
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a cell membrane marker and Bodipy FL C5 ganglioside GM1 (Life Technologies, Wembley 
Australia) which is a marker of membrane rafts. The cells were then fixed and mounted with 
Prolong Gold (Invitrogen, Scoresby Australia). Imaging was performed using Zeiss Wide-field 
fluorescence deconvolution microscope and images were convolved using Sen Software package 
(Carl Zeiss AG, Hamburg Germany). Experiments were performed in triplicate. 
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5.3 RESULTS 
 
5.3.1 Loss of fenestrations is observed in P407 treated SKHep1 cells and isolated LSECs  
 
Scanning electron microscopy of the untreated SKHep1 cells showed numerous pores similar to 
fenestrations (Fig. 5.1). Some of the pores are grouped evenly representing a sieve plate. 
Following one hour treatment with P407, there is a reduction of pore size and number as 
compared to saline treated cells (Fig. 5.1).  
 
LSECs were successfully isolated and grown in RPMI culture. Fenestrations clustered in sieve 
plates are seen on scanning electron microscopy (Fig. 5.2a-b). Treatment with P407 reduced the 
size and number of fenestrations in isolated LSECs (Fig. 5.2c-d) as reported previously (Cogger 
et al., 2006). The sieve plates of the treated cells are smaller compared to saline treated cells. 
The presence of gaps in the cytoplasm is an artefact caused by isolation and culture of the 
LSECs.  
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Figure 5.1: Scanning electron microscopy of saline-treated SKHep1 cells showing numerous 
pores on the cell membrane (a). Following treatment with P407 (b) cells showed a reduced 
number of fenestrations.  
  
b a 
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Figure 5.2: Scanning electron microscopy of saline-treated isolated LSECs in lower (a) and 
higher (b) magnification, showing numerous fenestrations clustered into sieve plates. Following 
treatment with P407, lower magnifications showed a smaller cell diameter (c) and higher 
magnification showed loss of fenestrations and smaller sieve plates (d) of LSECs. 
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5.3.2 Lipid rafts are increased in P407 treated SKHep1 cells and isolated LSECs 
 
In order to determine whether P407 induces defenestration by depleting the non-raft component 
of the LSEC membranes, both cells were stained with the cell membrane marker Cell Mask 
Orange and the specific raft marker Bodipy FL C5 ganglioside GM1. SKHep1 cells showed a 
capillary-like structure under fluorescence microscopy with 95 % confluency (Fig. 5.3a). The 
cells have a consistent distribution of rafts along the perimeter of the cells. Following P407 
treatment SKHep1 cells exhibited a strong staining of lipid rafts seen as clusters at the 
perinuclear region (Fig. 5.3b). This indicates a marked change in the distribution and intensity of 
lipid rafts compared to control. 
 
Low magnification fluorescence microscopy of the isolated LSECs revealed the cells were 
growing in a monolayer with about 50 % confluency (Fig. 5.4). Higher magnification of 
individual LSECs revealed multiple unresolvable regions representing sieve plates in the 
peripheral regions of the cell (Fig. 5.5a). As reported previously sieve plates are present in 
attenuated areas of the cell membrane. These regions can be less than 100nm in thickness which 
renders them unresolvable under conventional confocal microscopy. Lipid rafts can be seen 
localised to the perinuclear region of the saline treated LSEC. There was a marked increase in 
raft staining following treatment with P407 indicating depletion of non-raft cell membrane areas 
(Fig. 5.5b). A very thin and discontinuous cytoplasm is seen in between sieve plates as a result of 
disordered cell membrane. As revealed by the merged images (Fig. 5.5) after P407 treatment the 
LSEC membrane is predominantly characterised by Bodipy positive membranes, indicating a 
predominance of raft microdomains. 
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Figure 5.3: Fluorescent image of SKHep1 cells stained with cell membrane and lipid raft marker 
showing low distribution of lipid raft in saline-treated cells (a) Following treatment with P407, 
there was an increase green staining, at the perinuclear region of the cells (b) with inverse 
distribution of cell membrane. 
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Figure 5.4: Low magnification (20X) of the isolated LSECs showing cells growing in a 
monolayer with about 50 % confluency. 
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Figure 5.5: Fluorescent image of isolated LSECs stained with cell membrane and lipid raft 
marker showing a minimal lipid raft distribution at the perinuclear region in saline-treated cells 
(a). Following treatment with P407, there was an increase green staining at the perinuclear and 
peripheral region of the cells (b) consistent with depletion of non-lipid raft membrane.  
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5.4 DISCUSSION 
 
This study assesses the relationship between membrane rafts, fenestrations and defenestration 
following P407 treatment in SKHep1 and isolated LSECs.  
 
Concordant with its in vivo effect, this study has shown that P407 induced significant loss of 
fenestrations in isolated LSECs. While this has previously been reported, here it was also found 
that P407 treatment leads to an increase in fluorescent staining for lipid raft membranes (Bodipy 
FL C5 ganglioside GM1) in SKHep1 cells and isolated LSECs, consistent with the sieve-raft 
theory. Although deconvolution microscopy is not able to visualise individual fenestrations, the 
distribution of the fluorescent raft stains confirmed the findings from 3D-SIM, where rafts are 
preferentially distributed in the perinuclear regions of LSECs and are inversely distributed with 
respect to sieve plates (Svistounov et al., 2012). Utilizing deconvolution microscopy, isolated 
LSECs are seen to be growing intact on the coverslip in a monolayer. The lace-like network of 
the sieve plates are identified by their F-actin stress fibres via 3D-SIM (Cogger et al., 2010) and 
the membrane of these F-actin fibres can be seen in these studies (Fig. 5.4). The net-like 
structure of LSEC has also been reported to be formed by clathrin heavy chain coated vesicles 
via fluorescent microscopy. This is a unique feature of LSEC compared to other cell types that 
show a well-known punctate staining pattern representing the clathrin-coated vesicles 
(Falkowska-Hansen et al., 2007).  
 
In previous studies using Triton X, another non-ionic detergent that is known to deplete non-raft 
regions of the cell membrane, LSEC porosity was reduced by ~90% (Svistounov et al., 2012) 
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and it is plausible that P407 induced defenestration is triggered by the same mechanism. Millar 
et al. (2005) has compared Triton WR-1339 and P407 in the determination of triglyceride and 
lipoprotein metabolism and concluded that P407 is equivalent to Triton WR-1339 in triglyceride 
production but without the unwanted side effects of Triton (Millar et al., 2005). It is interesting 
to note that Poloxamer 188, a related polymer has been shown to insert into fluid phase lipid 
membranes and act as a stabiliser of these domains (Maskarinec et al., 2002) while this process 
does not extract lipids from non-raft regions of membranes it acts to increase raft regions of 
membranes through stabilisation. 
 
As supported by the data presented here defenestration by P407 most likely occurs by a direct 
mechanism on the cell membranes of the target cell without influence from other residents cells 
of the liver such as Kupffer cells, stellate cells or hepatocytes (Cogger et al., 2006). 
 
Multiple studies on the regulation of fenestrations have reported that the actin cytoskeleton plays 
a role in the maintenance of fenestrations (Vermijlen et al., 2002, Nagai et al., 2004, Van Der 
Smissen et al., 1986), and VEGF has the ability to increase fenestration via retraction of the actin 
cytoskeleton (Cogger et al., 2008, Funyu et al., 2001, Yokomori et al., 2003). It has been shown 
that membrane fusion and pore formation is restricted by dynamic resistance of the actin network 
in experimental membrane fusion models (McGuire et al., 1992), and in the generation of 
membrane vesicles, which are also associated with increased lipid-disordered, non- raft 
microdomains (Owen et al., 2010). This suggests that the formation of fenestrations requires 
retraction and/ or rearrangement of the normal sub-membrane actin cytoskeleton, while 
stabilisation of the membrane requires actin support. 
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Lipid rafts have been associated with numerous physiological and pathological conditions in 
individual types of liver cells (Dolganiuc, 2011). Beyond the reciprocal relationship between 
fenestration and lipid rafts described here, the more proximal details of fenestration formation in 
LSECs are not known. In other endothelial cells of vascular system, lipid rafts play a major role 
in functionality where disruptions of lipid rafts causes loss of cell viability and altered cell 
morphology (Bao et al., 2010, Kline et al., 2010). Membrane lipid rafts have been studied using 
fluorescent microscopy, showing higher lipid order for the areas of the membrane associated 
with active signaling and adhesive events (Owen et al., 2006). Various agents have been applied 
to isolate raft or non-raft membranes including 7-ketocholesterol which disorders membrane 
rafts (Kahn et al., 2011). Treatment of isolated LSECs with 7-ketocholesterol causes a marked 
increase in the number and size of sieve plates associated with the increase in disordered non-raft 
membranes (Svistounov et al., 2012). In hepatocytes lipid rafts have also been associated with 
the triggering of calcium waves, which regulate fluid and electrolyte secretion and exocytosis 
(Ito et al., 1997, Kasai and Augustine, 1990). Immunofluorescence studies in isolated 
hepatocytes showed that the disruption of lipid rafts impairs accumulation of the inositol 1,4,5-
triphosphate receptor responsible for calcium wave polarization (Nagata et al., 2007).  
 
Research on LSECs has been limited by multiple factors. In vivo experiments are restricted to a 
single treatment for each animal (Cogger et al., 2008). In vitro work is limited because isolation 
of LSECs involves lengthy, complicated procedures that yields only sufficient LSEC for 6-12 
single experimental samples and the in vitro viability of the differentiated cells is limited to less 
than 12 hours (DeLeve et al., 2006, Elvevold et al., 2008). To overcome low yields of LSEC, 
Gerlach (2001) developed a method of isolation from pig livers but this not feasible in most 
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animal facilities due to ethical considerations, complicated equipment needs and procedures 
(Gerlach et al., 2001). The M1 (MILEC) cell line has been established as an immortal LSEC cell 
line, but observation with electron microscopy revealed it is not fenestrated unless treated with 
actin disruptors and co-cultured with other cells (Saito et al., 2004). While this is the first 
observation of P407 effect on SKHep1 cells, previous studies have utilised this cell to study 
fenestrations. SKHep1 cells are catalogued as immortalised cell lines derived from the ascetic 
fluid of a 52 year old male with hepatic adenocarcinoma. It is described as a hepatoma origin but 
various results have shown that this cell is actually an endothelial origin (Heffelfinger et al., 
1992, Kawai et al., 2001, Seow et al., 2001). This is further confirmed by observation of pores 
and thin cytoplasmic extension via SEM (Cogger et al., 2008). VEGF has shown to increase 
SKHep1 porosity and diameter, observed by contraction of actin cytoskeleton and attachment of 
caveolin-1 towards the nucleus via fluorescent microscopy. This makes SKHep1 cells a good 
model for LSEC research, similar to the use of HepG2 cells to study hepatocytes (Javitt, 1990). 
 
The establishment of fluorescent microscopy for the study for fenestrations has continued to 
evolve with a recent, promising study using direct stochastic optical reconstruction (dSTORM). 
This work further resolved LSECs to a spatial resolution of ~20nm by using a dSTORM add on 
to an Olympus IX71 microscope (Mönkemöller et al., 2014). The characteristics of LSEC were 
readily identified including the very thin membranes that divide individual fenestrations. This 
improved technical capacity will potentially expand the LSEC field and allow dynamic and 
greater probing of fenestration biology without the technical limitations of electron microscopy. 
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The important physiological role of the LSEC has become increasingly recognised in normal and 
various pathological conditions of liver, as well as ageing. While these studies are not able to 
address how defenestration occurs in ageing it will be interesting to observe the cell membrane 
of LSECs isolated from old animals to see if there are increased raft membranes in these cells 
with age. This would provide a plausible mechanism for age-related defenestration and would be 
in line with the observations of other studies that have reported detrimental lipid raft changes in 
ageing (Marquet-de Rouge et al., 2013, Eckert et al., 2003). Future studies will be aimed at 
addressing these questions in an ageing LSEC model. 
 
In conclusion, loss of fenestrations by P407 is caused by the depletion of the non-raft areas in 
LSEC membrane, inhibiting the formation of fenestrations. Fluorescence imaging has been used 
to observe the increased raft area and defenestration has been confirmed by SEM. This finding 
has strengthened the sieve-raft hypothesis and further facilitates the study of fenestration biology 
as the changes can be detected by fluorescence rather than electron microscopy. As there is 
increased recognition of the role of LSECs in liver pathology, an understanding of the 
mechanisms that regulate fenestrations is essential for the development of therapies directed to 
the management of diseases and old age where there is reduction in fenestrations.  
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CHAPTER 6: DIETARY MACRONUTRIENTS AND THE AGEING LIVER 
SINUSOIDAL ENDOTHELIAL CELL 
 
A manuscript version of Chapter 6 has been published in the following publication: 
Cogger, V. C., M. Mohamad, S. Solon-Biet, A. M. Senior, A. Warren, J. N. O'Reilly, B. T. Tung, 
D. Svistounov, A. McMahon, R. Fraser, D. Raubenheimer, A. J. Holmes, S. Simpson and D. G. 
Le Couteur (2016). "Dietary macronutrients and the aging liver sinusoidal endothelial cell." 
American Journal of Physiology - Heart and Circulatory Physiology 
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6.1 INTRODUCTION 
 
Liver sinusoidal endothelial cells (LSEC) have key physiological roles in endocytosis, immune 
function and the transfer of substrates between blood and hepatocytes via patent pores called 
fenestrations (Sorensen et al., 2008, Sorensen et al., 2012, Fraser et al., 2012). With ageing, there 
are significant ultrastructural changes in the LSEC that have been termed pseudocapillarisation 
(Le Couteur et al., 2001, Le Couteur et al., 2008a). These include a marked reduction in 
fenestration porosity, diameter and frequency, associated with increased endothelial thickness 
and altered expression of several endothelial and extracellular matrix proteins including von 
Willebrand factor and collagen. Pseudocapillarisation has been detected in old age in mice, rats, 
non-human primates and humans (Le Couteur et al., 2001, Le Couteur et al., 2008a) and has 
been documented in premature ageing syndromes in mice (Cogger et al., 2013b, Gregg et al., 
2011). Fenestrations are dynamic, non-diaphragmed, transcellular pores that allow the free 
passage of substrates between the sinusoidal blood and hepatocytes (Fraser et al., 2012). 
Therefore loss of fenestrations with pseudocapillarisation contributes to impaired hepatic 
clearance of substrates such as lipoproteins and medications in old age (Hilmer et al., 2005, Le 
Couteur et al., 2005). 
 
Caloric restriction (CR) has been known as the most robust, non-genetic intervention that for 
increasing lifespan and reducing disease (Everitt et al., 2005), including age-related loss of liver 
function, is associated with increased LSEC porosity, reduced extracellular matrix deposition 
and significantly attenuated LSEC thickening into very old age (Jamieson et al., 2007b). CR also 
improves blood lipoprotein profiles and delays the development of vascular disease in animal 
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models function (Zhu et al., 2004). Given our understanding of the role of fenestrations in 
lipoprotein uptake by the liver it can be hypothesised that improved LSEC morphology into old 
age through CR is at least partially responsible for CR mediated improvements in liver function 
and blood lipid profiles. Fenestration number and size are altered with fasting (O'Reilly et al., 
2010), caloric restriction (Jamieson et al., 2007b) and following systemic exposure to any 
bioactive molecule of gut bacterial origin, which are delivered via the portal vein directly to the 
liver (Dobbs et al., 1994, Cheluvappa et al., 2008). These properties suggest that fenestrations are 
regulated by diet perhaps via the effects of diet on the composition of the gut microbiome. 
Therefore, in this study we determined the effects of dietary macronutrients and calorie intake on 
fenestrations in old age. Livers were studied from a large cohort of 15 month old mice that had 
been ad libitum-fed one of 25 diets varying in the amounts of protein, fat, carbohydrate and 
energy density in order to study the relationship between energy intake, macronutrients, ageing 
and lifespan (Solon-Biet et al., 2014, Solon-Biet et al., 2015, Le Couteur et al., 2014). In addition 
to the direct role of individual macronutrients on fenestrations we were able to explore the 
potential effect of different populations of gut-derived bacteria on the structural integrity of the 
LSEC. 
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6.2 METHODS 
 
6.2.1 Animals and Husbandry  
 
C57/Bl6 male and female mice (3 weeks old; n = 858) (Animal Resources Centre, WA, 
Australia) were housed three per cage in standard approved cages (Technoplast, Varese, Italy) in 
the Molecular Physiology Unit of the ANZAC Research Institute, a specific pathogen-free 
facility designed for housing transgenic mice. A custom-designed two-chamber Perspex insert, 
designed to collect food spillage (Sorensen et al., 2008), was placed beneath the food hopper of 
each cage to collect food waste for quantification. Mice were maintained at 24 ºC-26 ºC and 
44%-46% humidity under a 12 hr light:12 hr dark photoperiod, with lights on at 0600hrs. All 
protocols were approved by the Sydney Local Health District Animal Welfare Committee 
(Protocol No. 2009/003). 
 
25 experimental diet treatments were custom-designed and manufactured in dry, pelleted form 
by Gordon’s Specialty Feeds, Sydney, Australia (Solon-Biet et al., 2014). The diet treatments 
were adequate in terms of addressed both nutritional quantity and quality. To manipulate diet 
quantity, indigestible cellulose was added to diet treatments, yielding 3 total energy (caloric) 
density regimes fixed at 8, 13 and 17 kJ g
-1
 (referred to as low, medium and high energy).  
 
Mice were provided ad libitum access throughout their lifetime to 1 of 25 diets varying in 
content of protein, carbohydrate, and fat and overall energy density. Food intake was closely 
monitored throughout life to accurately determine food intake. Mice were checked daily, and 
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body weight measurements were recorded to correspond with food intake measurements. 
Animals losing more than 20% body weight were excluded from the study. 
 
6.2.2 Tissue and blood collection 
 
At 15 months of age, one-third of the animals were anaesthetised using ketamine and xylazine (1:1) 
via i.p injection. Animals were culled, blood was collected via cardiac puncture and tissues 
harvested for a variety of analyses. Liver samples were obtained and perfused-fixed for 1 minute 
with electron microscope fixative solution ( 3% glutaraldehyde, 2% paraformaldehyde, 2 mM 
calcium chloride, 1% sucrose in 0.1 M sodium cacodylate buffer). Following fixation, 1 mm
3 
samples were taken, post-fixed, washed and then stored in 0.1M sodium cacodylate buffer at 4 °C 
as previously described (Cogger et al., 2014). 
 
6.2.3 Blood parameters 
 
Blood parameters were all measured in the fasting state. Blood glucose levels were determined 
using tail bleeds and a handheld glucometer (Accu-Check Performa, Roche, Hawthorn 
Australia). Blood was analysed for insulin and leptin by ELISA (ALPCO Diagnostics, Kurnell 
Australia). Circulating amino acid determinations were analysed at the Australian Proteome 
Analysis Facility, Macquarie University, using the Waters AccQ-Tag Ultra Chemistry Kit 
(Waters Corporation, Rydalmere, Australia). Free fatty acids were analysed by Metabolomics 
Australia. 
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6.2.4 Tissue processing and observation 
 
This procedure is described in section 2.3.2 and 2.3.3 in Chapter 2: Methodology. Briefly, fixed 
liver blocks were treated with 1% osmium tetroxide in 0.1M sodium cacodylate buffer for two 
hours, followed by dehydration in an increasing ethanol gradient and final critical point drying 
with hexamethyldisilazane. Samples were mounted on stub and sputter coated with platinum, 
followed by observation using JEOL JSM-6380 scanning electron microscope (SEM). Ten 
random sinusoids pictures were taken at 15000x magnification for analysis using ImageJ for liver 
porosity, fenestrations diameter and fenestrations frequency per surface area. Samples were 
analysed in random order and category was blinded during analysis. In addition to electron 
microscopy haematoxylin and eosin staining was undertaken to ensure the livers were free of 
pathology. 
 
6.2.5 Gut microbiome 
 
The cecum contents were collected, metagenomic DNA recovered and the microbial community 
sampled by 454 sequencing of the 3’ end of the 16S ribosomal RNA (907-1492) using primers 
specific for the domain Bacteria. Sequence reads were assigned to OTUs at 97% identity and then 
classified using both QIIME and Mothur. 
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6.2.6 Statistical analysis 
 
The effects of macronutrients on fenestrations were analysed according to the Geometric 
Framework approach, with response variables fitted as response surfaces onto macronutrient 
intake (protein, carbohydrate and fat) arrays, using thin-plate spline procedures in R, 
accompanied by Generalised Additive Modelling (GAMs) to test the main and interactive effects 
of the three macronutrients. These methods are described elsewhere (Solon-Biet et al., 2014, 
Solon-Biet et al., 2015, Le Couteur et al., 2014).  
 
To explore the relationship between fenestrations, dietary macronutrients and the gut 
microbiome correlations with fenestrations were performed using the Spearman’s test in 
SigmaPlot (SPSS Version 12.5) were performed in the first instance (data presented are mean ± 
SD and P<0.05 considered significant). To further explore these relationships we then tested 
whether abundance of circulating metabolites (fatty acids and amino acids) and bacterial families 
correlated with fenestration morphology using an information theoretic, model averaging 
approach with linear models (LMs) (Burnham & Anderson, 2002). We assessed whether dietary 
correlates affected three aspects of fenestrations: 1) percent porosity (converted to a proportion 
and logit transformed to normalise; (Warton and Hui, 2010)), 2) diameter of the fenestration and 
3) fenestration frequency (+0.5 and log transformed to normalise;(Yamamura, 1999)). LMs were 
fitted using the ‘lm’ function in the base package of R (R-Development-Core-Team, 2015 ), and 
model averaging was performed using the package MuMIn (Bartoń, 2015). These analyses were 
undertaken by Dr Alistair Senior in the laboratory of Professor Simpson at the Charles Perkins 
Centre, University of Sydney. 
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6.3 RESULTS 
 
6.3.1 Geometric framework analysis of the relationship between macronutrients and LSEC 
fenestrations. 
 
Response surfaces showing the relationship between macronutrients, dietary energy and 
fenestration morphology are shown in Fig. 6.1 (n=129 mice) and representative scanning 
electron micrographs are shown in Fig. 6.2. Fenestration porosity was influenced by dietary fat 
intake (P=0.016, for GAMs tables see Table 6.1), with low to intermediate fat intakes (around 20 
kJ/mouse/day) associated with highest porosity, and porosity falling both as fat intake increased 
or decreased to very low levels indicating a non-linear effect (quadratic). There was no 
statistically significant impact of the intake of energy, protein or carbohydrate on porosity. The 
response of fenestration frequency was similar to that of porosity, being associated only with fat 
intake (P=0.001). On the other hand, fenestration frequency was inversely associated with 
protein and carbohydrate intakes (P=0.028 and P=0.006, respectively). Low carbohydrate or low 
protein intake were both associated with increased fenestration diameter. However, there were no 
interactions between protein and carbohydrate, and their impact on diameter was not sufficient to 
translate into a change in total porosity. 
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Figure 6.1: Geometric Framework analysis showing relationship between macronutrients and 
fenestration porosity (a) and diameter (b). In each surface the blue represents the lowest value 
while the red represents the highest value. Each graph represents a slice through the median 
value of the third macronutrient (value provided in parenthesis below the x-axis label). Three 
graphs are provided demonstrating the interactions between protein and carbohydrate, protein 
and fat, and carbohydrate and fat. The regions with the highest fenestration diameter porosity or 
diameter are encircled in red, while those with the lowest are encircled with blue. Fat had a 
significant effect on porosity (P=0.016) while protein and carbohydrate had significant effects on 
diameter (P=0.028 and P=0.006, respectively). 
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Table 6.1: Generalised Additive Modelling (GAMs) for Figure 6.1. 
 edf Degrees of 
freedom 
F p-value 
Porosity (Fig. 1a)     
Protein eaten 5.447e-05 8 0.000 0.5569 
Carbohydrate eaten 5.508e-01 8 0.153 0.1218 
Fat eaten  1.874 8 0.698 0.0157 * 
Protein, carbohydrate eaten 1.595e-05 3 0.000 0.7683 
Protein, fat eaten 8.597e-01 3 0.538 0.1076 
Carbohydrate, fat eaten 5.143e-05 3 0.000 0.5844 
Frequency (Fig. 1b)     
Protein eaten 7.904e-01 8 0.000 0.02760* 
Carbohydrate eaten 8.628e-01 8 0.000 0.00633** 
Fat eaten  6.362e-05 8 0.000 0.38350 
Protein, carbohydrate eaten 2.451e-06 3 0.000 0.89405 
Protein, fat eaten 4.171e-06 3 0.000 0.73794 
Carbohydrate, fat eaten 7.106e-06 3 0.000 0.88118 
 
Fig. 1a: R sq. (adj.) = 0.0942. Deviance explained = 11.7%. REML = 234.77. Scale est. = 
2.1008; n = 129. Fig 1b: R sq.(adj.) = 0.052. Deviance explained = 6.42%. REML = 272.02. 
Scale est. = 3.8373; n = 129. GAMs, generalized additive modelling; edf, estimated degrees of 
freedom; REM, restricted maximal likelihood. *P < 0.05; **P < 0.01. 
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Figure 6.2: Scanning electron micrographs of the luminal surface of the liver sinusoidal 
endothelial cells. Some fenestrations are indicated with an arrow. (a). Increased fenestration 
diameter induced by diets low in carbohydrate or protein. (b) fenestration diameter is decreased 
in diets high in carbohydrates or protein, (c) Increased porosity induced by fat intake of 
approximately 20 kJ/mouse/day and (d) Diets high in fat lead to reduced endothelial porosity 
through loss of fenestrations (Original magnification 15000 ×). 
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6.3.2 Relationship between fenestrations and gut microbiome. 
 
There were 78 mice where a complete dataset was available for both electron microscopy of the 
LSEC and gut microbiome analysis. In this cohort of samples the most abundant taxa were the 
Firmicutes and Bacteroidetes phyla, followed by Clostridia, Bacillae, Erysipelotrichia, 
Deferribacteres, Verrucomicrobia, Lachnospiraceae, Clostridiaceae, Ruminococcaceae, 
Eubacteriaceae, Rikenellaceae, and Bacteroidaceae. There were significant positive 
relationships between fenestration porosity and diameter with the abundance of the Firmicutes 
phylum (Fig. 6.3, P=0.046 and P=0.0057 respectively). There was a significant negative 
relationship between fenestration diameter and the abundance of the Bacteroidetes phylum 
(P=0.045) and a non-significant negative trend with fenestration porosity and Bacteroidetes (Fig. 
6.3, P=0.087).  
 
Model averaging of lower taxonomic orders suggested no bacterial families were particularly 
good predictors of fenestration diameter or porosity (all families had a relative importance < 0.6), 
and for both responses the top model sets included the null models (see Supplementary Tables 2, 
3, 4 and 5). However, in concordance with the relationships suggested above, model averaging 
suggested that increasing Bacteroidaceae abundance (a member of the Bacteroidetes Phylum) 
was associated with a decreasing frequency of fenestrations (LM Est. [LCI to UCI] = -0.603 [-
0.954 to -0.252]; Supplementary Table 6) and increasing abundance of Lachnospiraceae (a 
member of the Firmicutes phylum) was associated with an increase in fenestrations (LM Est. 
[LCI to UCI] = 0.422 [0.063 to 0.781]; Supplementary Table 7). 
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Figure 6.3: The relationship between fenestrations (diameter, porosity) and gut microbiome 
phyla (Firmicutes, Bacteroidetes). There was a significant positive relationship between 
fenestration porosity and diameter with Firmicutes abundance (a, b, Spearmans correlation, 
P=0.046 and P=0.0057 respectively). There was a significant negative relationship between 
fenestration diameter and Bacteroidetes abundance (d, P=0.045) and a non-significant negative 
trend with fenestration porosity and Bacteroidetes (c, P=0.087) 
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6.3.3 Relationship between fenestrations and circulating metabolites and other substrates 
influenced by diet. 
 
Correlative analysis of individual free fatty acids found negative relationships between C16:0 
(palmitic acid) and C20:4 (arachidonic acid) with fenestration porosity (P=0.027 and P=0.037, 
respectively, n=95 mice), while C19:0 (nonadecanoic acid) had negative associations with 
fenestration diameter (P=0.020, Fig. 6.4), as well as frequency (P=0.048, Appendix 6). However, 
model averaging of free fatty acid groups showed that despite the strong influence that dietary fat 
intake has on fenestration morphology, circulating levels of fatty acids are not good predictors of 
fenestration responses, in all cases the relative importance of predictors was less than 0.45, and 
for all three responses the top model set contained the null model (see Supplementary Tables 8, 
9, 10, 11, 12 and 13 in Appendix 6). In addition there were no associations between fenestrations 
and other measures that reflect metabolic health including blood glucose, insulin, triglycerides, 
cholesterol or leptin, although there was a non-significant trend towards a negative relationship 
between fenestration diameter and fasting insulin. 
 
There were no significant relationships between fenestration porosity, diameter or frequency 
with circulating levels of total amino acids, total branched chain amino acids or any of the 
individual amino acids except phenylalanine which had a negative relationship with porosity 
(P=0.037, n=94 mice, Fig. 6.4) and aspartic acid which had a negative relationship with diameter 
(P=0.047). Model averaging of more complex models also indicated that the concentration of 
circulating amino acids were not a good predictor of fenestration diameter or frequency; in both 
cases the top model sets contained the null models (see Supplementary Tables 14, 15, 16 and 17 
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in Appendix 6). The best predictor was abundance of hydroxyl and sulfur selenium amino acids, 
which had a relative importance of 0.832 for the fenestration diameter response, and was 
estimated to have a positive effect but with very poor precision (LM Est. [LCI to UCI] = 11.779 
[-1.075 to 24.633]; Supplementary Table 15). For fenestration porosity, abundance of aliphatic 
amino acids had a relative importance of 1, appearing in all models in the top model set 
(Supplementary Tables 18 and 19). Model averaged estimates indicate that increases in aliphatic 
amino acids were associated with decreases in the porosity of fenestrations (LM Est. [LCI to 
UCI] = -0.431 [-0.799 to 0.063]; Supplementary Table 19).  
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Figure 6.4: The relationship between phenylalanine, and the fatty acids C16:0, C19:0 and C20:4. 
There were significant correlations between porosity and circulating phenylalanine (P=0.037), 
C16:0 (P=0.027) and C20:4 (P=0.037) and between fenestration diameter and C19:0 (P=0.020). 
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6.4 DISCUSSION 
 
In previous studies, fenestrations have been reported to be influenced by reduced intake of food 
and dietary energy. In one study, my laboratory showed that a 48 hour period of fasting in rats 
was associated with increased fenestration diameter of about 10%(O'Reilly et al., 2010). In 
another study from my laboratory it was found that caloric restriction over a lifetime in rats was 
associated with increased fenestration frequency and porosity of about 60% in old age (Jamieson 
et al., 2007b). These studies indicate that fenestrations are dynamic structures that are influenced 
by dietary manipulation. However, such studies where only one nutritional dimension, energy, is 
manipulated cannot determine whether the outcome is a result of a reduction in total energy or 
one of the individual macronutrient components of the diet (Simpson et al., 2015). One of the 
key advantages of using the Geometric Framework is that the different components of the diet – 
energy, protein, carbohydrates and fat plus their interactions – can be evaluated across a 
nutritional landscape (Simpson and Raubenheimer, 2012). The results of this study have revealed 
that the main dietary component that influences fenestration porosity is fat, such that higher fat 
intakes are associated with reduced fenestration frequency and overall porosity. A low fat intake 
of approximately 20 kJ/mouse/day was associated with maximum porosity below which porosity 
decreased again slightly. According to the phenotype response surfaces, porosity varied between 
about 2.8% and 4.4% depending upon the dietary fat intake. Fat intake had its main impact on 
fenestration frequency while protein and carbohydrate intakes influenced fenestration diameter, 
although this was not sufficient to alter total porosity.  
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A number of nutritional interventions have been found to influence ageing and lifespan. The 
most widely studied is caloric restriction. We have previously shown that caloric restriction is 
associated with increased fenestrations in old age (Jamieson et al., 2007b). The results in our 
current study suggest that this might be secondary to a reduction in each of the macronutrients 
acting via different mechanisms: the reduction in fat intake leads to increased fenestration 
diameter, the reduction in protein and carbohydrate intake leads to increased fenestration 
frequency. On the other hand, our studies in insects (Lee et al., 2008) and mice (Solon-Biet et al., 
2014) have indicated that low protein, high carbohydrate diets are linked with longer lifespan 
and improved latelife health. We did not find any direct beneficial impact of low protein, high 
carbohydrate diets on fenestrations, perhaps as a consequence of the opposing effects of low 
protein and high carbohydrate on fenestration diameter. 
 
Having established that macronutrients influence fenestrations we then sought to elucidate 
possible mechanisms that could link diet with LSEC ultrastructure. We performed analysis of gut 
microbiome and circulating fatty acids and amino acids. Analysis of the gut microbiome data 
showed that there was a positive relationship between fenestrations and diet-induced changes in 
the Firmicutes phylum and a negative relationship and/or trend with the Bacteroidetes phylum. 
Firmicutes and Bacteroidetes make up the most abundant phyla within the gut microbiome. 
Although the abundances of Firmicutes and Bacteroidetes have been linked to various health 
states, these phyla include a broad diversity of different taxa of bacteria, thus analysis limited to 
Firmicutes and Bacteroidetes can only be considered to be a blunt interpretation of gut 
microbiota (Jandhyala et al., 2015, Ha et al., 2014). It is interesting that the abundance of 
Firmicutes declines with age while Bacteroidetes increases (Jandhyala et al., 2015, Mariat et al., 
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2009). Ageing is associated with a reduction in fenestrations which is a key part of age-related 
pseudocapillarisation of the hepatic sinusoid (Le Couteur et al., 2008a, Le Couteur et al., 2001) 
which might therefore be mechanistically linked with age-related changes in the relative 
abundances of Firmicutes and Bacteroidetes. There has also been a growing focus on the role of 
the gut microbiome in the pathogenesis of hepatic diseases including in particular hepatosteatosis 
and cirrhosis (Wieland et al., 2015). This is in part because the liver receives the majority of its 
blood supply from the intestinal portal circulation, and is therefore exposed to a diverse array of 
microbial toxins and metabolites. Hepatosteatosis has been reported to be associated with 
reduced Firmicutes and increased Bacteroidetes, while various liver diseases are associated with 
leaky gut with subsequent increased exposure of the liver to bacterial toxins and bacteria 
(Wieland et al., 2015, Paolella et al., 2014, Dobbs et al., 1994). With respect to the LSEC, we 
have shown that defenestration can be caused by direct exposure to two bacterial toxins: 
lipopolysaccharide endotoxin (Dobbs et al., 1994) and pseudomonal pyocyanin (Cheluvappa et 
al., 2007).  
 
We then investigated the relationship between circulating substrates that might reflect changes in 
dietary intake of macronutrients. Our previous studies have demonstrated that fenestrations form 
in the non-lipid raft segments of the LSEC cell membrane (Svistounov et al., 2012). Moreover, 
interventions that disrupted lipid rafts and the non-raft membranes had significant effects on 
fenestrations and porosity. We concluded that one of the factors regulating fenestrations were 
lipid rafts (Svistounov et al., 2012, Cogger et al., 2013a). Lipid rafts are potentially influenced by 
diet, in particular dietary fatty acids (Pike, 2009). The lipid rafts contain a high proportion of 
saturated fatty acids while long chain polyunsaturated fatty acids increase the clustering of 
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proteins within lipid rafts (Pike, 2009). A number of different fatty acids, including arachidonic 
acid (C20:4) partition rapidly into cell membranes and perturb lipid rafts (Catalá, 2012). Further 
it has been demonstrated that metabolites of arachidonic acid have been shown to contribute to 
LSEC dysfunction in the setting of portal hypertension (Bosch et al., 2010). Therefore it is of 
note that circulating levels of the saturated fatty acids, C16:0, C19:0 and the polyunsaturated 
fatty acid, C20:4 were associated with fenestrations. However, more complex models could not 
find substantial correlations between fatty acid groups and fenestrations. 
 
In the Geometric Framework study of the effects of macronutrients on ageing, it was found that 
branched chain amino acids appeared to mediate some of the benefits of a low protein high 
carbohydrate diet on age-related health and lifespan (Solon-Biet et al., 2014). Here we did not 
find any association between branched chain amino acids and fenestrations. Examination of the 
other amino acids revealed an inverse association between porosity and phenylalanine 
concentrations Although this could be a chance finding, it is of note that an elevated level of 
phenylalanine is a risk factor for hypertriglyceridemia (Mook-Kanamori et al., 2014), while 
defenestration is a mechanism for hyperlipidemia through impaired hepatic uptake of 
chylomicron remnants (Hilmer et al., 2005). 
 
In conclusion, macronutrients had complex effects on LSEC fenestrations. Overall, reduced 
intake of macronutrients was associated with increased measures of fenestration frequency 
and/or diameter, with fat having the dominant influence on porosity mediated by its effect on the 
frequency of fenestrations. There was an association between microbiome (Firmicutes, 
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Bacteroidetes) and free fatty acids with fenestrations which might provide mechanistic links 
between dietary macronutrients and LSEC ultrastructure in old age.  
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CHAPTER 7: GENERAL DISCUSSION 
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The liver is the main organ in the body responsible for a wide variety of biological processes 
regulated by insulin such as glucose homeostasis and hepatic insulin clearance. Glucose 
metabolism is significantly impaired with ageing (Fink et al., 1983) and impaired insulin action 
with age contributes to disease and morbidity.  
 
Age-related changes in the liver have been established in a variety of species. In addition to a 
reduction in both liver size and blood flow, the endothelial changes of pseudocapillarisation- 
decreased porosity, increased thickness and increased basal lamina - have been reported. These 
alterations have contributed to reduced hepatic clearance of many substrates with age. My 
laboratory has previously demonstrated that ageing is associated with an impaired clearance of 
chylomicron remnant secondary to defenestration in ageing, contributing to the development of 
atherosclerosis. Similarly it has been shown here that age- and disease related loss of 
fenestrations may form a barrier for insulin action, contributing to insulin resistance in ageing.  
 
The majority of previous liver studies examining insulin action focus on the hepatocyte, however 
as postulated here the cells of the hepatic sinusoid are also crucial to liver function. The work of 
this thesis focuses on the vital role of the LSEC on insulin action and glucose homeostasis in the 
liver during health, ageing and also toxicity (P407).  
 
In Chapter 3, the impact of age-related pseudocapillarisation of the liver sinusoidal endothelium 
has shown, for what we believe is the first time, that fenestrations are essential for efficient 
insulin transfer across the liver sinusoidal endothelium and subsequent insulin and glucose 
homeostasis. Mechanistically, we have demonstrated defenestration such as occurs in ageing and 
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liver disease, restricts insulin access to the hepatocellular membrane through impaired trans- 
endothelial transfer, resulting in hyperinsulinemia, impaired hepatic insulin signaling, reduced 
glycogen storage, compensatory muscle and fat uptake of insulin and glucose and dysregulated 
gluconeogenesis. Future studies showing a correlation between insulin transfer and consequent 
signaling events are needed to obtain a full picture of the LSEC role in metabolism homeostasis.  
 
However, as it is recognised that ageing is a multifactorial process where many fundamental 
cellular processes are affected and considerable adaptations develop overtime to support 
metabolic homeostasis, testing the role of LSEC fenestrations in insulin transfer in a singular 
model of defenestration is important. Chapter 4 used P407 induced defenestration to explore the 
impact of acute defenestration on insulin and glucose transfer. This work showed that 
defenestration alone reduced the transfer of insulin and glucose from the sinusoid into the 
extracellular space and reduced insulin action in hepatocytes with an impact on glucose 
homeostasis. This was associated with hyperinsulinaemia, glucose intolerance and deranged 
glucose metabolism in the liver. While not all of the ageing changes in the liver are recapitulated 
by P407 these results are in agreement with the findings in Chapter 3, and are also in parallel 
with a previous study showing that defenestration of the LSEC in ageing leads to impaired 
transendothelial transfer of various other substances such as lipoproteins and medications into 
the liver (Hilmer et al., 2005, Mitchell et al., 2012, Mitchell et al., 2011).  
 
Following up on the loss of fenestrations in vivo by P407 in Chapter 4, an in vitro analysis of 
isolated LSECS treated with P407 was performed in Chapter 5. This work explored the 
mechanism for defenestration in this model and demonstrates that loss of fenestrations is caused 
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by the depletion of the non-lipid raft domains in the LSEC membrane, inhibiting the formation of 
fenestrations. . Further studies will need to be performed to further support this work and should 
include observations of these changes via live-cell imaging or with additional treatment of 
insulin to add to the results obtained in vivo. This finding has strengthened the sieve-raft 
hypothesis and further facilitated the study of fenestration biology as the changes can be detected 
by fluorescence rather than electron microscopy. As there is increased recognition of the role of 
LSECs in liver pathology, it is important that the mechanisms that regulate fenestrations are 
elucidated so we can enhance understanding of the risk factors for LSEC changes and potentially 
target these mechanisms for development of therapies for the management of diseases and old 
age. Future studies examining the cellular mechanisms behind age- and disease-related 
defenestration are required, however extrapolating from these and other related studies suggest 
that examining the lipid properties of the cell membranes would be beneficial. 
 
Chapter 6 investigates the effects of macronutrient intake on the ageing vasculature of the liver 
and its association with gut microbiome and circulating fatty acids. Reduced intake of 
macronutrients was associated with increased fenestration frequency and/or diameter, with fat 
having the dominant influence on porosity mediated by its effect on the frequency of 
fenestrations. There was an association between microbiome (Firmicutes, Bacteroidetes) and 
free fatty acids with fenestrations which might provide mechanistic links between dietary 
macronutrients and LSEC ultrastructure in old age. This indicates that the rate of development of 
changes in LSEC is influenced not only by ageing but also by dietary manipulation, and possibly 
that pseudocapillarisation may be attenuated or indeed prevented by diet. 
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The studies in this thesis have shed light on the importance of the endothelium in the liver, as 
similarly in other tissues, in the maintenance of normal function and regulation of metabolic 
homeostasis. This establishes not only the importance of the fenestrated endothelium for the 
transfer of insulin in the liver, but also further validates the poloxamer 407 model for examining 
substrate transfer across the ageing sinusoidal endothelium. The role of pseudocapillarisation in 
age-related insulin resistance could be further established using experimental models that 
defenestrate the normal LSEC and/or regenerate fenestrations in aged-related 
pseudocapillarisation. Future studies are needed to understand fenestration biology and the 
mechanism that underlies loss of fenestrations. This understanding may allow the prevention of 
pseudocapillarisation and initiate the development of therapies to attenuate age-related structural 
changes. Such interventions are important for the prevention and management of impaired 
metabolic homeostasis such as insulin resistance and hyperlipidemia in older people.  
 
In conclusion, the integrity of the liver microvasculature is essential for the lifelong maintenance 
of insulin and glucose homeostasis. The morphology of the liver sinusoidal endothelial cell is 
dependent on the properties of the cell membranes, which can be altered through diet and 
exposure to circulating macronutrients and gut microbiome-derived factors. These results 
suggest interesting avenues to pursue for the treatment and prevention of age-related 
defenestration and the diseases and morbidities associated with age. Future research should focus 
on therapeutic agents that maintain the ultrastructure of the LSEC in old age as a potential 
therapy for the treatment and prevention of insulin resistant and diabetes in older people 
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APPENDIX 1 
Supplementary information for Chapter 3: Insulin tolerance test showing similar performance 
between young and old group. 
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APPENDIX 2 
Supplementary information for Chapter 3: RT-PCR data for insulin signaling pathway in young 
vs old livers 
Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave Ct 
(HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- or 
Down-
Regulation 
OLD YOUNG OLD YOUNG 
OLD 
/YOUNG 
p value 
OLD 
/YOUNG 
Acaca A01 3.11 2.33 1.2E-01 2.0E-01 0.58 0.294059 -1.71 
Acox1 A02 5.05 6.38 3.0E-02 1.2E-02 2.52 0.965517 2.52 
Adra1d A03 9.45 10.32 1.4E-03 7.8E-04 1.83 0.342633 1.83 
Aebp1 A04 7.88 6.60 4.2E-03 1.0E-02 0.41 0.402924 -2.42 
Akt1 A05 4.15 4.00 5.6E-02 6.3E-02 0.90 0.814608 -1.11 
Akt2 A06 6.83 8.03 8.8E-03 3.8E-03 2.30 0.863440 2.30 
Akt3 A07 7.14 7.38 7.1E-03 6.0E-03 1.18 0.600176 1.18 
Araf A08 2.64 2.74 1.6E-01 1.5E-01 1.08 0.685440 1.08 
Bcl2l1 A09 6.30 5.66 1.3E-02 2.0E-02 0.64 0.511245 -1.55 
Braf A10 5.00 5.19 3.1E-02 2.7E-02 1.14 0.961619 1.14 
Cap1 A11 2.44 3.16 1.8E-01 1.1E-01 1.65 0.322493 1.65 
Cbl A12 7.53 7.76 5.4E-03 4.6E-03 1.17 0.952396 1.17 
Cebpa B01 2.33 2.18 2.0E-01 2.2E-01 0.91 0.732909 -1.10 
Cebpb B02 6.27 7.75 1.3E-02 4.6E-03 2.80 0.996637 2.80 
Cfd B03 7.67 8.33 4.9E-03 3.1E-03 1.58 0.539415 1.58 
Dok1 B04 9.19 10.19 1.7E-03 8.5E-04 2.01 0.341850 2.01 
Dok2 B05 9.17 9.79 1.7E-03 1.1E-03 1.53 0.394094 1.53 
Dok3 B06 9.31 9.86 1.6E-03 1.1E-03 1.46 0.421388 1.46 
Dusp14 B07 8.27 7.45 3.2E-03 5.7E-03 0.57 0.780596 -1.76 
Eif2b1 B08 4.71 4.08 3.8E-02 5.9E-02 0.64 0.272332 -1.55 
Eif4ebp1 B09 1.85 1.24 2.8E-01 4.2E-01 0.66 0.306678 -1.53 
Ercc1 B10 7.74 9.01 4.7E-03 1.9E-03 2.42 0.801794 2.42 
Fasn B11 3.80 -0.91 7.2E-02 1.9E+00 0.04 0.022161 -26.22 
Fbp1 B12 8.02 8.14 3.9E-03 3.5E-03 1.09 0.859602 1.09 
Fos C01 7.14 8.67 7.1E-03 2.5E-03 2.90 0.789263 2.90 
Frs2 C02 6.62 6.94 1.0E-02 8.1E-03 1.25 0.505022 1.25 
Frs3 C03 5.82 7.04 1.8E-02 7.6E-03 2.33 0.711226 2.33 
G6pc C04 7.95 6.89 4.0E-03 8.4E-03 0.48 0.672318 -2.08 
Gab1 C05 5.29 5.70 2.6E-02 1.9E-02 1.32 0.796305 1.32 
Gcg C06 6.57 7.70 1.1E-02 4.8E-03 2.18 0.659937 2.18 
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AVG ΔCt               
(Ct (GOI) - Ave Ct 
(HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- or 
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Regulation 
  OLD YOUNG OLD YOUNG 
OLD 
/YOUNG 
p value 
OLD 
/YOUNG 
Gck C07 6.22 6.58 1.3E-02 1.0E-02 1.28 0.789675 1.28 
Gpd1 C08 7.75 7.34 4.6E-03 6.2E-03 0.75 0.542770 -1.33 
Grb10 C09 6.06 6.65 1.5E-02 1.0E-02 1.51 0.698559 1.51 
Grb2 C10 6.82 8.10 8.8E-03 3.7E-03 2.42 0.753414 2.42 
Gsk3b C11 8.84 10.07 2.2E-03 9.3E-04 2.34 0.324282 2.34 
Hk2 C12 6.37 7.40 1.2E-02 5.9E-03 2.04 0.594500 2.04 
Hras D01 5.97 6.82 1.6E-02 8.9E-03 1.80 0.448238 1.80 
Igf1r D02 9.29 8.83 1.6E-03 2.2E-03 0.73 0.928575 -1.37 
Igf2 D03 4.72 6.40 3.8E-02 1.2E-02 3.21 0.822011 3.21 
Igfbp1 D04 9.45 9.57 1.4E-03 1.3E-03 1.09 0.477142 1.09 
Ins1 D05 9.45 10.32 1.4E-03 7.8E-04 1.83 0.342633 1.83 
Ins2 D06 7.44 9.41 5.8E-03 1.5E-03 3.93 0.196303 3.93 
Insl3 D07 6.61 8.45 1.0E-02 2.9E-03 3.60 0.598694 3.60 
Insr D08 2.46 2.86 1.8E-01 1.4E-01 1.32 0.813029 1.32 
Irs1 D09 3.77 3.50 7.3E-02 8.9E-02 0.83 0.845756 -1.21 
Irs2 D10 4.55 5.13 4.3E-02 2.8E-02 1.50 0.363243 1.50 
Jun D11 3.66 2.75 7.9E-02 1.5E-01 0.53 0.247933 -1.87 
Klf10 D12 7.21 6.06 6.7E-03 1.5E-02 0.45 0.531329 -2.23 
Kras E01 4.77 4.76 3.7E-02 3.7E-02 0.99 0.756316 -1.01 
Ldlr E02 6.48 7.70 1.1E-02 4.8E-03 2.33 0.728540 2.33 
Lep E03 7.17 8.40 6.9E-03 3.0E-03 2.34 0.817543 2.34 
Map2k1 E04 3.11 3.09 1.2E-01 1.2E-01 0.99 0.728693 -1.01 
Mapk1 E05 4.74 4.46 3.7E-02 4.6E-02 0.82 0.748205 -1.22 
Mtor E06 9.45 10.32 1.4E-03 7.8E-04 1.83 0.342633 1.83 
Nos2 E07 7.70 8.94 4.8E-03 2.0E-03 2.36 0.898031 2.36 
Npy E08 7.33 8.50 6.2E-03 2.8E-03 2.26 0.880665 2.26 
Pck2 E09 6.22 5.92 1.3E-02 1.7E-02 0.81 0.712001 -1.23 
Pdpk1 E10 4.94 4.86 3.3E-02 3.4E-02 0.94 0.950127 -1.06 
Pik3ca E11 6.87 8.17 8.5E-03 3.5E-03 2.47 0.846339 2.47 
Pik3cb E12 8.86 10.32 2.1E-03 7.8E-04 2.74 0.296042 2.74 
Pik3r1 F01 3.18 3.15 1.1E-01 1.1E-01 0.98 0.692093 -1.02 
Pik3r2 F02 5.97 5.30 1.6E-02 2.5E-02 0.63 0.464881 -1.59 
Pklr F03 6.24 4.80 1.3E-02 3.6E-02 0.37 0.464414 -2.71 
Pparg F04 9.45 9.94 1.4E-03 1.0E-03 1.41 0.404963 1.41 
Ppp1ca F05 2.65 2.72 1.6E-01 1.5E-01 1.05 0.961231 1.05 
Prkcg F06 7.51 8.98 5.5E-03 2.0E-03 2.78 0.660055 2.78 
Prkcz F07 7.05 6.57 7.5E-03 1.0E-02 0.72 0.980219 -1.39 
Prl F08 7.20 8.70 6.8E-03 2.4E-03 2.82 0.811913 2.82 
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Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave Ct 
(HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- or 
Down-
Regulation 
  OLD YOUNG OLD YOUNG 
OLD 
/YOUNG 
p value 
OLD 
/YOUNG 
Ptpn1 F09 6.93 8.58 8.2E-03 2.6E-03 3.14 0.713847 3.14 
Raf1 F10 1.89 2.55 2.7E-01 1.7E-01 1.58 0.363834 1.58 
Retn F11 9.45 10.32 1.4E-03 7.8E-04 1.83 0.342633 1.83 
Rps6ka1 F12 7.87 9.15 4.3E-03 1.8E-03 2.43 0.661146 2.43 
Rras G01 4.90 4.07 3.4E-02 6.0E-02 0.56 0.477690 -1.78 
Rras2 G02 3.97 4.70 6.4E-02 3.9E-02 1.66 0.329842 1.66 
Serpine1 G03 5.59 5.51 2.1E-02 2.2E-02 0.94 0.806348 -1.06 
Shc1 G04 5.09 5.11 2.9E-02 2.9E-02 1.01 0.729800 1.01 
Slc27a4 G05 7.29 8.70 6.4E-03 2.4E-03 2.66 0.899783 2.66 
Slc2a1 G06 7.26 8.72 6.5E-03 2.4E-03 2.76 0.835286 2.76 
Slc2a4 G07 6.46 7.41 1.1E-02 5.9E-03 1.93 0.922519 1.93 
Sos1 G08 6.28 5.85 1.3E-02 1.7E-02 0.74 0.568297 -1.34 
Srebf1 G09 1.82 1.09 2.8E-01 4.7E-01 0.60 0.291791 -1.66 
Tg G10 9.45 10.21 1.4E-03 8.4E-04 1.70 0.355179 1.70 
Ucp1 G11 9.26 10.32 1.6E-03 7.8E-04 2.08 0.333236 2.08 
Vegfa G12 6.48 7.75 1.1E-02 4.6E-03 2.42 0.782530 2.42 
Actb H01 -1.03 -1.43 2.0E+00 2.7E+00 0.76 0.658113 -1.31 
B2m H02 2.82 1.90 1.4E-01 2.7E-01 0.53 0.769787 -1.89 
Hprt1 H03 -0.84 0.20 1.8E+00 8.7E-01 2.06 0.922424 2.06 
Ldha H04 0.42 0.03 7.5E-01 9.8E-01 0.77 0.809575 -1.30 
Rplp1 H05 -1.36 -0.71 2.6E+00 1.6E+00 1.57 0.388136 1.57 
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APPENDIX 3: 
Supplementary information for Chapters 3 & 4:  Quantitative phosphoproteomics of 47 peptides 
containing insulin-regulated sites from the KEGG insulin signaling pathway for old vs young 
and control vs P407 group. Z-scores of >+/-1.0 were considered significant. Log2 values are 
provided to show statistical variation. 
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APPENDIX 4 
Supplementary information for Chapter 4: Average MID outflow curves for pyruvate and the 
extracellular marker sucrose for (a) control and (b) P407 rats. There are no changes in the 
volume of distribution of pyruvate for both groups. 
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APPENDIX 5 
Supplementary information for Chapter 4: RT-PCR data for insulin signaling pathway in Control 
vs P407 livers 
Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave 
Ct (HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- 
or Down-
Regulation 
P407 Saline P407 Saline 
P407 
/Saline 
p value 
P407 
/Saline 
Acaca A01 5.57 5.30 2.1E-02 2.5E-02 0.83 0.883138 -1.20 
Acox1 A02 2.79 2.10 1.4E-01 2.3E-01 0.62 N/A -1.62 
Adra1d A03 14.67 N/A 3.8E-05 N/A N/A N/A N/A 
Aebp1 A04 10.31 10.92 7.9E-04 5.2E-04 1.53 0.168876 1.53 
Akt1 A05 5.86 6.12 1.7E-02 1.4E-02 1.20 0.555182 1.20 
Akt2 A06 5.04 5.27 3.0E-02 2.6E-02 1.18 0.605222 1.18 
Akt3 A07 9.65 9.65 1.2E-03 1.2E-03 1.00 0.917337 -1.00 
Araf A08 4.09 3.69 5.9E-02 7.7E-02 0.76 N/A -1.31 
Bcl2l1 A09 5.98 5.40 1.6E-02 2.4E-02 0.67 0.168497 -1.49 
Braf A10 7.66 7.80 4.9E-03 4.5E-03 1.10 0.511738 1.10 
Cap1 A11 5.01 5.07 3.1E-02 3.0E-02 1.05 0.732696 1.05 
Cbl A12 9.68 10.05 1.2E-03 9.4E-04 1.30 0.407195 1.30 
Cebpa B01 3.67 6.27 7.9E-02 1.3E-02 6.08 0.950302 6.08 
Cebpb B02 12.79 12.65 1.4E-04 1.6E-04 0.90 N/A -1.11 
Cfd B03 4.32 4.13 5.0E-02 5.7E-02 0.88 0.706524 -1.14 
Dok1 B04 10.94 10.94 5.1E-04 5.1E-04 1.00 0.607590 1.00 
Dok2 B05 12.17 12.12 2.2E-04 2.2E-04 0.97 0.722672 -1.03 
Dok3 B06 10.00 11.15 9.7E-04 4.4E-04 2.21 0.083272 2.21 
Dusp14 B07 9.72 9.60 1.2E-03 1.3E-03 0.92 0.577725 -1.08 
Eif2b1 B08 7.00 7.31 7.8E-03 6.3E-03 1.24 N/A 1.24 
Eif4ebp1 B09 4.97 4.98 3.2E-02 3.2E-02 1.00 0.966788 1.00 
Ercc1 B10 11.91 11.99 2.6E-04 2.5E-04 1.06 0.874044 1.06 
Fasn B11 3.81 4.29 7.1E-02 5.1E-02 1.40 N/A 1.40 
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Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave 
Ct (HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- 
or Down-
Regulation 
  P407 Saline P407 Saline 
P407 
/Saline 
p value 
P407 
/Saline 
Fbp1 B12 1.80 1.47 2.9E-01 3.6E-01 0.80 0.502627 -1.26 
Fos C01 10.57 10.77 6.6E-04 5.7E-04 1.15 0.745289 1.15 
Frs2 C02 7.57 7.39 5.3E-03 5.9E-03 0.89 0.419211 -1.13 
Frs3 C03 12.21 12.40 2.1E-04 1.8E-04 1.14 0.509824 1.14 
G6pc C04 4.98 3.17 3.2E-02 1.1E-01 0.28 0.841671 -3.53 
Gab1 C05 8.92 8.99 2.1E-03 2.0E-03 1.05 0.909824 1.05 
Gcg C06 14.67 N/A 3.8E-05 N/A N/A N/A N/A 
Gck C07 6.55 5.77 1.1E-02 1.8E-02 0.58 N/A -1.72 
Gpd1 C08 3.87 3.46 6.8E-02 9.1E-02 0.75 0.553015 -1.33 
Grb10 C09 12.21 12.34 2.1E-04 1.9E-04 1.09 0.605081 1.09 
Grb2 C10 3.71 3.83 7.6E-02 7.0E-02 1.09 N/A 1.09 
Gsk3b C11 6.79 6.93 9.1E-03 8.2E-03 1.11 0.726290 1.11 
Hk2 C12 12.22 12.62 2.1E-04 1.6E-04 1.33 0.380887 1.33 
Hras D01 3.37 3.25 9.7E-02 1.1E-01 0.92 0.813262 -1.09 
Igf1r D02 11.65 11.63 3.1E-04 3.2E-04 0.98 0.863731 -1.02 
Igf2 D03 12.16 12.28 2.2E-04 2.0E-04 1.09 0.576069 1.09 
Igfbp1 D04 2.69 2.49 1.5E-01 1.8E-01 0.87 0.931905 -1.15 
Ins1 D05 11.76 13.16 2.9E-04 1.1E-04 2.63 N/A 2.63 
Ins2 D06 12.79 13.16 1.4E-04 1.1E-04 1.29 N/A 1.29 
Insl3 D07 11.97 12.65 2.5E-04 1.6E-04 1.60 N/A 1.60 
Insr D08 5.44 5.88 2.3E-02 1.7E-02 1.35 0.227271 1.35 
Irs1 D09 5.58 5.47 2.1E-02 2.3E-02 0.92 0.655403 -1.09 
Irs2 D10 8.80 9.62 2.2E-03 1.3E-03 1.76 0.026492 1.76 
Jun D11 6.91 7.43 8.3E-03 5.8E-03 1.44 0.441436 1.44 
Klf10 D12 7.66 7.78 4.9E-03 4.6E-03 1.08 0.663021 1.08 
Kras E01 7.66 7.48 4.9E-03 5.6E-03 0.88 0.310540 -1.13 
Ldlr E02 5.63 6.27 2.0E-02 1.3E-02 1.55 0.278261 1.55 
Lep E03 14.67 N/A 3.8E-05 N/A N/A N/A N/A 
Map2k1 E04 6.25 6.31 1.3E-02 1.3E-02 1.05 0.967957 1.05 
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Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave 
Ct (HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- 
or Down-
Regulation 
  P407 Saline P407 Saline 
P407 
/Saline 
p value 
P407 
/Saline 
Mapk1 E05 3.93 3.98 6.6E-02 6.3E-02 1.03 0.755070 1.03 
Mtor E06 7.07 7.00 7.5E-03 7.8E-03 0.95 0.748041 -1.05 
Nos2 E07 13.20 12.65 1.1E-04 1.6E-04 0.68 N/A -1.46 
Npy E08 7.95 7.37 4.1E-03 6.0E-03 0.67 0.380978 -1.49 
Pck2 E09 4.99 5.84 3.1E-02 1.8E-02 1.79 0.184082 1.79 
Pdpk1 E10 6.53 6.55 1.1E-02 1.1E-02 1.01 N/A 1.01 
Pik3ca E11 6.84 6.98 8.7E-03 7.9E-03 1.10 0.689183 1.10 
Pik3cb E12 6.91 7.01 8.3E-03 7.8E-03 1.07 0.798322 1.07 
Pik3r1 F01 6.65 5.81 1.0E-02 1.8E-02 0.56 0.188509 -1.79 
Pik3r2 F02 8.40 8.53 3.0E-03 2.7E-03 1.09 0.804854 1.09 
Pklr F03 3.86 2.86 6.9E-02 1.4E-01 0.50 0.477493 -2.00 
Pparg F04 10.40 10.21 7.4E-04 8.5E-04 0.88 0.749064 -1.14 
Ppp1ca F05 3.57 3.67 8.4E-02 7.9E-02 1.07 0.633707 1.07 
Prkcg F06 12.43 12.62 1.8E-04 1.6E-04 1.14 0.587596 1.14 
Prkcz F07 8.73 8.95 2.4E-03 2.0E-03 1.16 0.775432 1.16 
Prl F08 12.79 12.62 1.4E-04 1.6E-04 0.89 0.757958 -1.13 
Ptpn1 F09 7.38 7.69 6.0E-03 4.8E-03 1.24 0.562210 1.24 
Raf1 F10 3.73 3.92 7.5E-02 6.6E-02 1.14 0.453272 1.14 
Retn F11 14.67 13.16 3.8E-05 1.1E-04 0.35 N/A -2.85 
Rps6ka1 F12 7.12 7.18 7.2E-03 6.9E-03 1.04 0.944111 1.04 
Rras G01 5.37 5.85 2.4E-02 1.7E-02 1.39 0.235829 1.39 
Rras2 G02 5.35 6.16 2.4E-02 1.4E-02 1.75 N/A 1.75 
Serpine1 G03 11.18 11.67 4.3E-04 3.1E-04 1.40 0.765379 1.40 
Shc1 G04 5.22 5.56 2.7E-02 2.1E-02 1.27 0.643608 1.27 
Slc27a4 G05 7.79 7.78 4.5E-03 4.6E-03 0.99 0.956394 -1.01 
Slc2a1 G06 11.55 10.78 3.3E-04 5.7E-04 0.59 0.262772 -1.70 
Slc2a4 G07 12.79 13.16 1.4E-04 1.1E-04 1.29 N/A 1.29 
Sos1 G08 6.78 6.66 9.1E-03 9.9E-03 0.92 0.898960 -1.09 
Srebf1 G09 9.09 9.58 1.8E-03 1.3E-03 1.41 N/A 1.41 
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Symbol Well 
AVG ΔCt               
(Ct (GOI) - Ave 
Ct (HKG)) 
2^-ΔCt 
Fold 
Change 
T-TEST 
Fold Up- 
or Down-
Regulation 
  P407 Saline P407 Saline 
P407 
/Saline 
p value 
P407 
/Saline 
Tg G10 11.90 10.99 2.6E-04 4.9E-04 0.53 0.010198 -1.88 
Ucp1 G11 13.22 12.14 1.1E-04 2.2E-04 0.47 N/A -2.11 
Vegfa G12 4.95 4.90 3.2E-02 3.4E-02 0.96 0.857308 -1.04 
Actb H01 0.68 0.92 6.3E-01 5.3E-01 1.19 0.551329 1.19 
B2m H02 -2.55 -2.89 5.8E+00 7.4E+00 0.79 0.059386 -1.27 
Hprt1 H03 1.68 0.98 3.1E-01 5.1E-01 0.62 0.239562 -1.63 
Ldha H04 0.34 0.88 7.9E-01 5.4E-01 1.46 0.108750 1.46 
Rplp1 H05 -0.15 0.10 1.1E+00 9.3E-01 1.19 0.175467 1.19 
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APPENDIX 6 
Supplementary Information for Chapter 6 
 
Supplementary Fig. 1 Circulating C19 levels and LSEC fenestration frequency 
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Supplementary Table 1. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for 
the effects of bacterial abundance on fenestration diameter. Given for each model is the model 
form, degrees of freedom (df), models log likelihood (logLik), AICc, change in AICc from the 
top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Bacteroidaceae + 1 3 -341.329 688.988 0 0.204 
z.Rikenellaceae + 1 3 -341.541 689.412 0.424 0.165 
z.Bacteroidaceae + z.Clostridiaceae + 1 4 -340.868 690.291 1.303 0.106 
z.Clostridiaceae + z.Rikenellaceae + 1 4 -340.946 690.448 1.46 0.098 
1 2 -343.203 690.568 1.581 0.093 
z.Bacteroidaceae + z.Rikenellaceae + 1 4 -341.032 690.62 1.632 0.09 
z.Lachnospiraceae + z.Rikenellaceae + 1 4 -341.12 690.795 1.808 0.083 
z.Bacteroidaceae + z.Eubacteriaceae + 1 4 -341.148 690.853 1.865 0.08 
z.Bacteroidaceae + z.Lachnospiraceae + 1 4 -341.151 690.857 1.869 0.08 
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Supplementary Table 2. 
The Relative Importance (RI) of abundance of bacterial families in explaining fenestration diameter. Model averaged coefficient (Coef.) 
estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model 
averaged coefficients Est. with shrinkage. 
 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 87.545 2.399 82.843 92.247 87.545 
z.Bacteroidaceae 0.561 -9.174 5.442 -19.84 1.492 -5.149 
z.Rikenellaceae 0.436 -8.849 5.935 -20.482 2.784 -3.862 
z.Clostridiaceae 0.205 -5.451 5.517 -16.264 5.362 -1.116 
z.Lachnospiraceae 0.163 3.777 5.188 -6.391 13.945 0.615 
z.Eubacteriaceae 0.08 2.81 4.838 -6.672 12.292 0.226 
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Supplementary Table 3. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of bacterial abundance on 
percentage porosity of fenestration (proportion logit-transformed). Given for each model is the model form, degrees of freedom (df), models log 
likelihood (logLik), AICc, change in AICc from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
1 2 -46.384 96.931 0 0.128 
z.Ruminococcaceae + 1 3 -45.307 96.944 0.013 0.127 
z.Eubacteriaceae + 1 3 -45.71 97.748 0.817 0.085 
z.Lachnospiraceae + 1 3 -45.71 97.748 0.818 0.085 
z.Lachnospiraceae + z.Rikenellaceae + 1 4 -44.624 97.803 0.873 0.083 
z.Clostridiaceae + z.Rikenellaceae + 1 4 -44.656 97.867 0.937 0.08 
z.Rikenellaceae + z.Ruminococcaceae + 1 4 -44.794 98.143 1.212 0.07 
z.Clostridiaceae + 1 3 -45.954 98.237 1.306 0.066 
z.Rikenellaceae + 1 3 -45.989 98.306 1.375 0.064 
z.Lachnospiraceae + z.Ruminococcaceae + 1 4 -44.97 98.496 1.566 0.058 
z.Bacteroidaceae + 1 3 -46.174 98.677 1.747 0.053 
z.Lachnospiraceae + z.Rikenellaceae + z.Ruminococcaceae + 1 5 -43.918 98.682 1.751 0.053 
z.Bacteroidaceae + z.Ruminococcaceae + 1 4 -45.156 98.868 1.937 0.048 
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Supplementary Table 4. 
The Relative Importance (RI) of abundance of bacterial families in explaining percentage porosity of fenestration (proportion logit-transformed). 
Model averaged coefficient (Coef.) estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are 
given. Also given are model averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA -3.281 0.051 -3.381 -3.181 -3.281 
z.Ruminococcaceae 0.356 0.141 0.105 -0.065 0.347 0.05 
z.Eubacteriaceae 0.085 0.117 0.104 -0.087 0.321 0.01 
z.Lachnospiraceae 0.279 0.134 0.114 -0.089 0.357 0.037 
z.Rikenellaceae 0.349 -0.141 0.117 -0.37 0.088 -0.049 
z.Clostridiaceae 0.146 -0.147 0.123 -0.388 0.094 -0.021 
z.Bacteroidaceae 0.102 -0.061 0.104 -0.265 0.143 -0.006 
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Supplementary Table 5. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of bacterial abundance on 
fenestration frequency (log + 0.5). Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), AICc, 
change in AICc from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Bacteroidaceae + z.Lachnospiraceae + 1 4 -84.532 177.619 0 0.476 
z.Bacteroidaceae + z.Lachnospiraceae + z.Ruminococcaceae + 1 5 -83.865 178.575 0.957 0.295 
z.Bacteroidaceae + z.Eubacteriaceae + z.Lachnospiraceae + 1 5 -84.12 179.084 1.466 0.229 
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Supplementary Table 6. 
The Relative Importance (RI) of abundance of bacterial families in explaining fenestration frequency (log + 0.5). Model averaged coefficient 
(Coef.) estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model 
averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 1.33 0.086 1.161 1.499 1.33 
z.Bacteroidaceae 1 -0.603 0.179 -0.954 -0.252 -0.603 
z.Lachnospiraceae 1 0.422 0.183 0.063 0.781 0.422 
z.Ruminococcaceae 0.295 -0.2 0.18 -0.553 0.153 -0.059 
z.Eubacteriaceae 0.229 -0.157 0.18 -0.51 0.196 -0.036 
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Supplementary Table 7. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of fatty acids on fenestration 
diameter. Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), AICc, change in AICc from the top 
model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Very.long + 1 3 -421.656 849.576 0 0.164 
z.Saturated + 1 3 -422.219 850.702 1.126 0.093 
1 2 -423.29 850.711 1.135 0.093 
z.Medium.chain + z.Very.long + 1 4 -421.207 850.859 1.283 0.086 
z.Long + z.Very.long + 1 4 -421.293 851.031 1.455 0.079 
z.Medium.chain + z.Saturated + 1 4 -421.344 851.132 1.556 0.075 
z.Medium.chain + z.Saturated + z.Very.long + 1 5 -420.241 851.156 1.58 0.074 
z.Unsaturated + z.Very.long + 1 4 -421.41 851.265 1.69 0.07 
z.Saturated + z.Very.long + 1 4 -421.418 851.28 1.704 0.07 
z.Long + 1 3 -422.558 851.379 1.804 0.066 
z.Essential.FA + z.Very.long + 1 4 -421.486 851.416 1.84 0.065 
z.Long + z.Medium.chain + z.Very.long + 1 5 -420.399 851.472 1.896 0.063 
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Supplementary Table 8. 
The Relative Importance (RI) of each fatty acid group in explaining fenestration diameter. Model averaged coefficient (Coef.) estimates (Est.), 
their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model averaged coefficients 
Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 85.998 2.158 81.768 90.228 85.998 
z.Very.long 0.672 -7.779 4.672 -16.936 1.378 -5.229 
z.Saturated 0.313 -6.981 5.692 -18.137 4.175 -2.182 
z.Medium.chain 0.299 6.422 5.355 -4.074 16.918 1.921 
z.Long 0.209 -4.809 4.597 -13.819 4.201 -1.005 
z.Unsaturated 0.07 -2.964 4.349 -11.488 5.56 -0.209 
z.Essential.FA 0.065 -2.49 4.391 -11.096 6.116 -0.162 
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Supplementary Table 9. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of fatty acids on fenestration 
frequency (log + 0.5). Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), AICc, change in AICc 
from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Medium.chain + 1 3 -122.869 252.001 0 0.122 
1 2 -124.052 252.234 0.233 0.109 
z.Saturated + 1 3 -123.126 252.516 0.515 0.094 
z.Long + 1 3 -123.295 252.853 0.852 0.08 
z.Essential.FA + 1 3 -123.441 253.146 1.145 0.069 
z.Medium.chain + z.Very.long + 1 4 -122.465 253.375 1.375 0.061 
z.Essential.FA + z.Medium.chain + 1 4 -122.467 253.378 1.377 0.061 
z.Unsaturated + 1 3 -123.691 253.645 1.644 0.054 
z.Saturated + z.Very.long + 1 4 -122.623 253.691 1.69 0.052 
z.Essential.FA + z.Long + z.Saturated + 1 5 -121.513 253.7 1.699 0.052 
z.Long + z.Medium.chain + 1 4 -122.637 253.719 1.718 0.052 
z.Medium.chain + z.Unsaturated + 1 4 -122.682 253.808 1.807 0.049 
z.Essential.FA + z.Medium.chain + z.Unsaturated + 1 5 -121.567 253.808 1.807 0.049 
z.Medium.chain + z.Saturated + 1 4 -122.72 253.884 1.883 0.048 
z.Essential.FA + z.Unsaturated + 1 4 -122.748 253.94 1.939 0.046 
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Supplementary Table 10. 
The Relative Importance (RI) of each fatty acid group in explaining fenestration frequency (log + 0.5). Model averaged coefficient (Coef.) 
estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model 
averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 1.199 0.093 1.017 1.381 1.199 
z.Medium.chain 0.443 0.271 0.201 -0.123 0.665 0.12 
z.Saturated 0.247 0.535 0.717 -0.87 1.94 0.132 
z.Long 0.184 -0.553 1.423 -3.342 2.236 -0.102 
z.Essential.FA 0.278 0.828 0.916 -0.967 2.623 0.23 
z.Very.long 0.114 -0.191 0.208 -0.599 0.217 -0.022 
z.Unsaturated 0.199 -0.486 0.93 -2.309 1.337 -0.097 
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Supplementary Table 11. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of fatty acids on percentage porosity 
of fenestration (proportion logit-transformed). Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), 
AICc, change in AICc from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Saturated + 1 3 -57.756 121.776 0 0.134 
z.Long + 1 3 -57.832 121.927 0.151 0.124 
z.Medium.chain + z.Saturated + 1 4 -56.743 121.93 0.155 0.124 
1 2 -58.905 121.941 0.165 0.123 
z.Saturated + I (z.Saturated^2) + 1 4 -57.23 122.905 1.129 0.076 
z.Essential.FA + z.Long + 1 4 -57.278 123.001 1.225 0.072 
z.Unsaturated + 1 3 -58.479 123.223 1.447 0.065 
z.Essential.FA + z.Long + z.Medium.chain + 1 5 -56.334 123.342 1.566 0.061 
z.Long + z.Medium.chain + 1 4 -57.457 123.359 1.583 0.061 
z.Long + z.Unsaturated + 1 4 -57.565 123.575 1.799 0.054 
z.Very.long + 1 3 -58.674 123.611 1.835 0.053 
z.Essential.FA + 1 3 -58.683 123.63 1.855 0.053 
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Supplementary Table 12. 
The Relative Importance (RI) of each fatty acid group in explaining percentage porosity of fenestration (proportion logit-transformed). Model 
averaged coefficient (Coef.) estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. 
Also given are model averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA -3.386 0.047 -3.478 -3.294 -3.386 
z.Saturated 0.333 -0.2 0.124 -0.443 0.043 -0.067 
z.Long 0.372 -0.235 0.182 -0.592 0.122 -0.087 
z.Medium.chain 0.245 0.14 0.116 -0.087 0.367 0.034 
I (z.Saturated^2) 0.076 0.078 0.078 -0.075 0.231 0.006 
z.Essential.FA 0.186 0.141 0.209 -0.269 0.551 0.026 
z.Unsaturated 0.119 0.016 0.185 -0.347 0.379 0.002 
z.Very.long 0.053 -0.063 0.095 -0.249 0.123 -0.003 
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Supplementary Table 13 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of amino acids on fenestration 
diameter. Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), AICc, change in AICc from the top 
model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Aliphatic + z.Hydroxyl.or.Sulfur.Selenium + 1 4 -413.077 834.604 0 0.324 
z.Hydroxyl.or.Sulfur.Selenium + 1 3 -414.456 835.179 0.575 0.243 
1 2 -415.897 835.926 1.322 0.168 
z.Essential + z.Hydroxyl.or.Sulfur.Selenium + 1 4 -413.952 836.353 1.749 0.135 
z.Acidic.and.their.Amide + z.Aliphatic + z.Hydroxyl.or.Sulfur.Selenium + 1 5 -412.88 836.442 1.838 0.129 
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Supplementary Table 14. 
The Relative Importance (RI) of each amino acid group in explaining fenestration diameter. Model averaged coefficient (Coef.) estimates (Est.), 
their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model averaged coefficients 
Est. with shrinkage. 
 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 86.115 2.097 82.005 90.225 86.115 
z.Aliphatic 0.454 -10.536 6.402 -23.084 2.012 -4.781 
z.Hydroxyl.or.Sulfur.Selenium 0.832 11.779 6.558 -1.075 24.633 9.805 
z.Essential 0.135 -6.007 6.144 -18.049 6.035 -0.813 
z.Acidic.and.their.Amide 0.129 3.137 5.167 -6.99 13.264 0.406 
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Supplementary Table 15. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of amino acids on fenestration 
frequency (log + 0.5). Given for each model is the model form, degrees of freedom (df), models log likelihood (logLik), AICc, change in AICc 
from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
1 2 -126.953 258.039 0 0.219 
z.Aliphatic + z.Basic + 1 4 -125.26 258.97 0.931 0.137 
z.Basic + 1 3 -126.384 259.034 0.995 0.133 
z.Aromatic + 1 3 -126.391 259.048 1.009 0.132 
z.Aromatic + z.Basic + 1 4 -125.504 259.458 1.42 0.108 
z.Aliphatic + z.Essential + 1 4 -125.595 259.639 1.6 0.098 
z.Aliphatic + 1 3 -126.773 259.812 1.773 0.09 
z.Hydroxyl.or.Sulfur.Selenium + 1 3 -126.863 259.992 1.953 0.082 
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Supplementary Table 16. 
The Relative Importance (RI) of each amino acid group in explaining fenestration frequency (log + 0.5). Model averaged coefficient (Coef.) 
estimates (Est.), their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are given. Also given are model 
averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. (Shrinkage) 
(Intercept) NA 1.155 0.098 0.963 1.347 1.155 
z.Aliphatic 0.326 -0.345 0.313 -0.958 0.268 -0.112 
z.Basic 0.378 0.295 0.232 -0.16 0.75 0.112 
z.Aromatic 0.24 -0.23 0.201 -0.624 0.164 -0.055 
z.Essential 0.098 0.521 0.348 -0.161 1.203 0.051 
z.Hydroxyl.or.Sulfur.Selenium 0.082 0.083 0.198 -0.305 0.471 0.007 
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Supplementary Table 17. 
Top model set based on Akaike Information Criterion corrected for small sample size (AICc) for the effects of amino acids on percentage 
porosity of fenestration (proportion logit-transformed). Given for each model is the model form, degrees of freedom (df), models log likelihood 
(logLik), AICc, change in AICc from the top model (AICc) and model weight (1 indicates the intercept). 
 
Model Form df logLik AICc AICc weight 
z.Aliphatic + z.Aromatic + z.Essential + 1 5 -52.651 115.983 0 0.177 
z.Aliphatic + z.Essential + 1 4 -54.176 116.801 0.818 0.118 
z.Aliphatic + z.Aromatic + z.Essential + z.Non.essential + 1 6 -51.964 116.894 0.911 0.112 
z.Aliphatic + z.Basic + 1 4 -54.28 117.01 1.027 0.106 
z.Acidic.and.their.Amide + z.Aliphatic + z.Aromatic + z.Essential + 1 6 -52.122 117.21 1.227 0.096 
z.Aliphatic + z.Aromatic + z.Essential + z.Hydroxyl.or.Sulfur.Selenium + 1 6 -52.16 117.285 1.302 0.093 
z.Aliphatic + z.Essential + z.Hydroxyl.or.Sulfur.Selenium + 1 5 -53.44 117.562 1.579 0.081 
z.Aliphatic + z.Hydroxyl.or.Sulfur.Selenium + 1 4 -54.6 117.65 1.667 0.077 
z.Aliphatic + z.Aromatic + z.Basic + 1 5 -53.526 117.734 1.751 0.074 
z.Aliphatic + z.Aromatic + z.Basic + z.Essential + 1 6 -52.496 117.958 1.975 0.066 
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Supplementary Table 18. 
The Relative Importance (RI) of each amino acid group in explaining percentage porosity of 
fenestration (proportion logit-transformed). Model averaged coefficient (Coef.) estimates (Est.), 
their Standard Error (SE), and Lower to Upper 95% Confidence Interval (LCI and UCI) are 
given. Also given are model averaged coefficients Est. with shrinkage. 
 
Coef. RI Est. SE LCI UCI Est. 
(Shrinkage) 
(Intercept) NA -3.407 0.046 -3.497 -3.317 -3.407 
z.Aliphatic 1 -0.431 0.188 -0.799 -0.063 -0.431 
z.Aromatic 0.618 -0.175 0.107 -0.385 0.035 -0.108 
z.Essential 0.743 0.352 0.182 -0.005 0.709 0.261 
z.Non.essential 0.112 0.174 0.154 -0.128 0.476 0.02 
z.Basic 0.246 0.175 0.136 -0.092 0.442 0.043 
z.Acidic.and.their.Amide 0.096 0.118 0.119 -0.115 0.351 0.011 
z.Hydroxyl.or.Sulfur.Selenium 0.25 0.177 0.147 -0.111 0.465 0.044 
 
 
 
